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SUMMARY 
Coxiella burnetii, the causative agent of Q fever in humans and animals, is an 
obligate intracellular bacterium with zoonotic potential. This bacterium has a worldwide 
distribution and can infect a wide range of hosts, including domestic ruminants. Like many 
other European countries, the presence of C. burnetii has been reported for several years 
in Denmark, and detection of the agent in animals in Denmark was made notifiable from 
December 2004. Since the recent C. burnetii epidemic in goats, sheep and man during 
2007-2010 in the Netherlands, epidemiological research on Q fever in both animals and 
humans has gained more attention from researchers in many European countries, 
including Denmark.  At that time, there was only limited information about its prevalence, 
the risk factors for C. burnetii infection, the dynamics of the infection and the validity of 
the tests used for the diagnosis of the infection or its seropositivity in cattle. Thus, the 
overall objectives of this thesis were to investigate the epidemiology of the C. burnetii 
antibody positivity in the Danish cattle population related to its frequency and risk factors, 
and also to evaluate the performance of the diagnostic tests used in identifying C. burnetii 
antibody positivity in animals or herds.  
To reach these objectives, the thesis is based on a series of epidemiological studies 
using Danish data collected during 2008-2009 from 100 randomly selected dairy herds, 
during 2012-2013 from 120 randomly selected dairy herds, and in 2012 from 800 
slaughtered cattle. The data comprised laboratory testing for the presence of C. burnetii 
antibodies in milk and blood samples from individual cattle, and in samples from bulk 
tank milk (BTM) of dairy herds. This data was supplemented with herd level data from 
questionnaire interviews with farmers and with relevant secondary animal and herd level 
data from the Danish Cattle Database. 
A cross-sectional study including 120 randomly selected Danish dairy herds in July 
2012, showed that BTM samples of 79% of herds were C. burnetii antibody positive, and 
this prevalence was significantly higher than that estimated in the study in 2008 (Chapter 
3). An adverse effect of increasing herd size and average cattle density on the risk of 
seropositivity was identified in the same study.  
To identify the risk factors for C. burnetii antibody positivity in Danish dairy cattle 
herds, BTM samples from 100 randomly selected herds were analysed in a cross-sectional 
study (Chapter 4a). To obtain the management and herd biosecurity information, farm 
managers were telephone interviewed about labour, biosecurity, housing and herd health 
during the 12 months prior to the study. Results showed that sharing of machines between 
farms (Yes vs. No, odds ratio (OR) =3.6), human contact (Yes vs. No, OR=4.2), 
insemination by people other than artificial insemination technicians (Yes vs. No, OR=7.7), 
a herd health contract with a veterinarian (Yes vs. No, OR=4.3) and improved hygiene 
precautions taken by veterinarians (No vs. Yes, OR=5) were significantly associated with 
antibody positivity. This study confirms that strict biosecurity procedures are important 
for the prevention of C. burnetii infection in dairy herds. 
The study population of 24 stratified randomly selected dairy herds from 2008; 
along with cow level and herd level management information obtained from the Danish 
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Cattle Database and from a questionnaire survey was used to identify factors associated 
with C. burnetii antibody positivity in Danish dairy cows (Chapter 4b). Results of 
multivariable logistic regression analysis, accounting for hierarchical structures (cow and 
herd), showed that the risk of being seropositive was higher in the Danish Holstein breed 
than in other dairy breeds and during summer compared to other seasons. The risk 
increased with the increasing number of parity and high milk protein contents; but 
decreased with increasing milk yield and a high milk fat content. Herd size, tie stall 
housing systems, quarantine of newly purchased animals and good hygienic precautions 
taken by the veterinarian before entering the stable, were also significantly associated with 
reduced odds of C. burnetii antibody positivity.  
Within herd prevalence of antibody positivity was also estimated in 24 selected 
dairy herds used in Chapter 4b. These herds comprised ten randomly sampled herds out of 
herds that tested positive on the BTM at the start of the study, ten randomly sampled herds 
among herds that tested negative on the BTM and four randomly sampled herds among 
herds that tested intermediate on the BTM (Chapter 4b). Results showed that the 
prevalence in initially BTM positive, intermediate and negative herds was 27%, 23% and 
0.9%, respectively. Within herd prevalence, in initially BTM positive and BTM 
intermediate herds, remained stable at three sampling time points during an 11-month 
follow-up period. This indicated a long lasting stability of within herd seroprevalence. The 
prevalence increased significantly in initially BTM negative herds during the same study 
period. These changes in the within herd prevalence (Chapter 4b) indicated that the 
antibody status of some cows shifted from positive to negative, or vice versa during the 
study period.  
Blood and milk samples from 568 lactating cows from 17 Danish dairy cattle herds 
collected in 2008 were used to determine the Se and Sp of an ELISA for detection of C. 
burnetii antibodies in milk and blood samples, using latent class models in a Bayesian 
analysis (Chapter 5). Based on the estimates of a differential positive rate (DPR), the best 
combination of the Se and Sp estimates was revealed at a sample to positive (S/P) cut-off 
of 40 for both blood and milk ELISAs. At this cut-off, the Se and Sp of milk ELISA were 
0.86 and 0.99, respectively; whereas the Se and Sp of blood ELISA were 0.84 and 0.99, 
respectively. The difference between the Se estimates of these two tests was not statistically 
significant, indicating an equal diagnostic capability of these two test methods. Therefore, 
the choice of test can be based on the context of the study. For serological surveillance of 
lactating dairy cows, the milk ELISA test could be the preferred method, and the blood 
ELISA test can be useful for serological studies in non-lactating cattle. No conditional 
dependence was observed between the Sp estimates of the two test methods, and the Se 
estimates of both tests were significantly reduced only when a conditional covariance ≥40 
was used. This implies that there is no absolute dependence between these two test 
methods, and hence, neither of them affects the Se and Sp estimates when comparisons are 
made between them. The Se and Sp of blood ELISA estimated in this study were used to 
calculate the true prevalence of C. burnetii seropositivity in Danish slaughter cattle. 
Another cross-sectional serosurvey in slaughtered cattle was conducted to estimate 
the seroprevalence of C. burnetii in cattle raised for meat production (Chapter 6). The level 
of antibodies was analysed in blood samples from 800 randomly selected slaughter cattle 
from six major Danish slaughter houses between August and October 2012. Bayesian 
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models, allowing an adjustment for the test sensitivity (Se) and specificity (Sp), were used 
to estimate apparent prevalence (AP), true prevalence and true prevalence using a random 
effect model for different breeds (Chapter 6). The overall AP and TP in Danish slaughter 
cattle were 5.6%. Significant differences in the prevalence were observed between the 
slaughtered cattle of dairy (AP=9.1%; TP=9.5%) and beef breeds (AP=4.3%; TP=3.5%); 
between male (AP=3.6%; TP=2.6%) and female (AP=9.1%; TP=9.4%); and between dairy 
(AP=15.1%; TP=16.7%) and beef (AP=4.5%; TP=3.6%) herds that the cattle delivered from 
to slaughter. The results indicated that cattle sent to slaughter have a lower seroprevalence 
than lactating dairy cows; and among the slaughtered cattle, the majority of seropositives 
originated from dairy breeds.  A Bayesian logistic regression model identified positive 
associations between C. burnetii seropositivity and age, breed type and number of 
movements between herds. 
In conclusion, the results from this PhD thesis show that the C. burnetii antibody 
positivity is highly prevalent in Danish dairy herds and dairy cows, and the prevalence is 
relatively low in cattle raised for meat production and sent to slaughter. It was also shown 
that several management and biosecurity factors were strongly associated with antibody 
positivity in dairy herds and dairy cows. Animal level factors like breed, age and parity 
were associated with C. burnetii antibody positivity in Danish cattle. However, studies 
show a long persistence within herd seroprevalence in dairy herds. 
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SAMMENDRAG 
Coxiella burnetii, som er årsag til Q-feber hos mennesker og dyr, er en obligat 
intracellulær bakterie med zoonotisk potentiale. Bakterien forekommer over hele verden 
og kan inficere en lang række værter, herunder domesticerede drøvtyggere. Ligesom i 
mange andre europæiske lande er forekomsten af C. burnetii blevet rapporteret i flere år i 
Danmark, og påvisning af agens i dyr i Danmark blev gjort anmeldepligtig fra december 
2004. Siden den seneste C. burnetii epidemi i geder, får og mennesker i Holland i perioden 
2007-2010, har epidemiologisk forskning vedrørende Q-feber i både dyr og mennesker fået 
mere opmærksomhed fra forskerne i mange europæiske lande, herunder Danmark. 
Dengang var der kun begrænset viden om prævalens, risikofaktorer og dynamik af 
infektion med C. burnetii, og om gyldigheden af de diagnostiske tests, der anvendes til 
påvisning af infektion eller antistoffer i kvæg. De overordnede mål for denne afhandling 
var derfor at undersøge epidemiologien af C. burnetii antistof positivitet i den danske 
kvægbestand relateret til frekvens og risikofaktorer, og også at evaluere resultaterne af de 
diagnostiske tests, der anvendes til at påvise C. burnetii antistof positive dyr eller 
besætninger.  
For at nå disse mål er afhandlingen baseret på en række danske epidemiologiske 
undersøgelser med indsamling af data i 2008-2009 fra 100 tilfældigt udvalgte 
malkekvægsbesætninger og i løbet af 2012-2013 fra 120 tilfældigt udvalgte 
malkekvægsbesætninger og i 2012 fra 800 slagtede kvæg. De indsamlede data omfatter 
laboratorieundersøgelser for tilstedeværelse af C. burnetii-antistoffer i mælke- og 
blodprøver fra individuelle kreaturer og i prøver fra tankmælk i malkekvægsbesætninger. 
Disse data blev suppleret med data på besætningsniveau fra spørgeskemainterviews med 
landmænd og med relevante sekundære data på individ- og besætningsniveau fra Den 
Danske Kvægdatabase. 
Et tværsnitsstudie med 120 tilfældigt udvalgte danske malkekvægsbesætninger i juli 
2012 viste, at tankmælksprøver af 79 % besætninger var C. burnetii-antistofpositive og 
denne udbredelse var væsentligt højere end ved en tidligere undersøgelse i 2008 (kapitel 
3). En negativ indvirkning af stigende besætningsstørrelse og den gennemsnitlige 
kvægtæthed på risikoen for seropositivitet blev identificeret i samme undersøgelse. 
For at identificere risikofaktorer for C. burnetii-antistof positivitet på 
besætningsniveau i danske malkekvægsbesætninger blev tankmælksprøver fra 100 
tilfældigt udvalgte besætninger analyseret i en tværsnitsundersøgelse (kapitel 4a). For at få 
oplysninger om pasningsforhold og smittebeskyttelsesrutiner blev driftslederne 
telefoninterviewet om arbejdskraft, smittebeskyttelse, opstaldning og besætningssundhed i 
de 12 måneder forud for undersøgelsen. Resultaterne viste, at deling af maskiner mellem 
flere bedrifter (Ja versus Nej, odds ratio (OR) = 3,6), besætningskontakt med fremmede 
mennesker (Ja versus Nej, OR = 4,2), insemination gennemført af andre personer end 
inseminører (Ja versus Nej, OR = 7,7), om der var en sundhedsrådgivningsaftale med 
dyrlægen (Ja versus Nej, OR = 4,3), og om dyrlægen tog hygiejniske forholdsregler inden 
indgang i besætningen (Nej versus Ja, OR = 5) var signifikant associerede med antistof 
positivitet. Denne undersøgelse bekræfter, at strenge smittebeskyttelsesprocedurer er 
vigtige for forebyggelse af infektion med C. burnetii i malkekvægsbesætninger. 
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Diagnostiske resultater fra de samme 24 tilfældigt udvalget malkekvægsbesætninger 
fra 2008 blev, med supplerende data på ko- og besætningsniveau fra Den Danske Kvæg 
Database og data fra en spørgeskemaundersøgelse, brugt til at identificere risikofaktorer 
for C. burnetii-antistof positivitet i malkekøerne (kapitel 4b). Resultaterne fra 
multivariable logistiske regressionsanalyser med hierarkiske strukturer (ko og besætning) 
viste, at risikoen for at en ko bliver seropositiv var højere i dansk Holstein Frisisk race end 
i andre malkeracer og om sommeren i forhold til andre årstider. Risikoen øges med 
stigende paritet og stigende proteinindhold i mælken, men faldt med stigende mælkeydelse 
og højt fedtindhold i mælken. Besætningsstørrelse, bindestaldssystem, karantæne af 
nyindkøbte dyr og dyrlægers gode hygiejniske forholdsregler inden de kommer ind i 
stalden var også signifikant associeret med reducerede odds for C. burnetii antistof 
positivitet. 
Prævalensen af antistof positivitet inden for besætningen blev beregnet i 24 
stratificeret tilfældigt udvalgte malkekvægsbesætninger (kapitel 4b). Disse besætninger 
omfattede ti tilfældigt udvalgte besætninger blandt besætninger, der var testet positive i 
tankmælken ved starten af undersøgelsen, ti tilfældigt udvalgte malkekvægsbesætninger 
blandt besætninger, der var testet negative i tankmælken, og fire tilfældigt udvalgte 
malkekvægsbesætninger blandt besætninger, der var test-intermediære i 
tankmælken(kapitel 4b). Resultaterne viste, at prævalens inden for tankmælkspositive, -
intermediære og -negative besætninger var henholdsvis 27 %, 23 % og 0,9 %. Prævalensen 
inden for tankmælkspositive og -intermediære besætninger forblev stabil ved tre 
prøveudtagningstidpunkter i en 11-måneders opfølgningsperiode. Dette indikerede en 
langvarig stabilitet i besætningsprævalensen. Prævalensen steg markant i 
tankmælksnegative besætninger i samme undersøgelsesperiode. Disse ændringer i 
prævalensen af testpositive køer i besætningen (kapitel 4b) antydede, at antistof-status i 
nogle køer ændredes fra positiv til negativ eller omvendt i løbet af undersøgelsesperioden.  
Blod-og mælkeprøver fra 568 lakterende køer fra 17 danske 
malkekvægsbesætninger indsamlet i 2008 blev ved hjælp af latent-klasse-modeller i 
Bayesiansk analyse (kapitel 5) anvendt til at beregne Se og Sp af den diagnostiske ELISA 
metode, der blev brugt til påvisning af C. burnetii antistoffer i mælke- og blodprøver. 
Baseret på estimater for differential positive rate (DPR) blev den bedste kombination af Se 
og Sp fundet ved et cutoff i S/P ratio på 40 for både blod- og mælkeprøver. Ved dette cutoff 
var Se og Sp i mælk hhv. 0,86 og 0,99, hvorimod Se og Sp i blod hhv. var 0,84 og 0,99. 
Forskellen mellem Se-estimater for de to tests var ikke statistisk signifikant. Derfor kan 
valget af testen baseres på rammerne af undersøgelsen. For serologisk overvågning af 
lakterende malkekøer vil mælke-ELISA-testen være den foretrukne metode, og blod-
ELISA-testen kan benyttes til serologiske undersøgelser i ikke-lakterende kvæg. Der blev 
ikke observeret nogen betinget afhængighed mellem Sp-estimaterne for de to testmetoder 
og Se-estimaterne for begge prøver blev kun signifikant reduceret, når betingede 
kovarianser ≥ 40 blev anvendt. Det betyder, at der ikke er nogen absolut afhængighed 
mellem disse to testmetoder, som påvirker Se og Sp estimaterne. Se og Sp for blod-ELISA 
beregnet i undersøgelsen blev brugt til at beregne de sande prævalenser for C. burnetii 
seropositivitet i danske slagtedyr. 
Et andet tværsnitstudie af slagtet kvæg blev gennemført for at vurdere 
seroprævalensen mod C. burnetii i kvæg, der opdrættes til kødproduktion (kapitel 6). 
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Niveauet af antistoffer blev analyseret i blodprøver fra 800 tilfældigt udvalgte 
slagtekreaturer fra seks store danske slagterier mellem august og oktober 2012. 
Bayesianske modeller, med justering for den diagnostiske tests følsomhed, sensitivitet (Se) 
og specificitet (Sp), blev anvendt til at estimere tilsyneladende prævalens (AP), sand 
prævalens og sand prævalens med justering for en tilfældig effekt for forskellige racer 
(kapitel 6). Den samlede AP og TP i danske slagtekvæg var 5,6 %. Signifikante forskelle i 
forekomsten blev observeret mellem slagtet kvæg af malkeracer (AP = 9,1%, TP = 9,5%) og 
kødkvægracer (AP = 4,3%; TP = 3,5%), mellem handyr (AP = 3,6%; TP = 2,6%) og hundyr 
(AP = 9,1%, TP = 9,4%) og mellem typen af oprindelsesbesætning, dvs. 
malkekvægsbesætninger (AP = 15,1%; TP = 16,7%) versus kødkvægsbesætninger (AP = 
4,5%; TP = 3,6%). Resultaterne viste, at kvæg sendt til slagtning har lavere seroprævalens 
end lakterende malkekøer og blandt de slagtede kreaturer var størstedelen af de test 
positive dyr af malkerace. En Bayesiansk logistisk regressionsmodel identificeret en positiv 
sammenhæng mellem C. burnetii seropositivitet og alder, race, og antallet af flytninger 
mellem besætninger inden dyret blev sendt til slagtning. 
Som konklusion viser resultaterne af denne PhD-afhandling, at C. burnetii antistof 
positivitet er meget udbredt i danske malkekvægsbesætninger og i malkekøer, og 
forekomsten er relativt lav i kødkvæg. Det blev også vist, at flere pasnings- og 
smittebeskyttelsesforhold var stærkt associeret med antistof positivitet i 
malkekvægsbesætninger og malkekøer. Individfaktorer som race, alder og paritet var 
forbundet med C. burnetii-antistof positivitet i dansk kvæg. Det blev også fundet, at C. 
burnetii antistofstatus i enkeltdyr ikke var stabilt i en længere periode i malkekøer i 
Danmark. Derimod viser vores undersøgelser at seroprævalensen inden for besætningerne 
er ret konstant. 
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OUTLINE OF THE THESIS 
This PhD thesis is organized into eight chapters -  
The first chapter (Chapter 1) provides a short introduction of the background and the 
overall aim of this thesis.  
Chapter 2 contains a general overview of Q fever/C. burnetii infection, including 
bacteriology, pathogenesis, distribution, transmission, reservoir, risk factors, clinical 
manifestation in animals and humans, diagnosis, treatment and prevention and control.  
Chapter 3 describes the prevalence of C. burnetii antibody positivity in Danish dairy cattle 
herds. This chapter also briefly describes the risk factors associated with seroprevalence in 
dairy cattle herds. Only those risk factors, which were readily available in the Danish Cattle 
Database (DCD), were included in this study. The study was designed as follows: 
 
 
 
Herd level and cow level risk factors associated with C. burnetii antibody positivity in 
Danish dairy cattle are discussed in Chapters 4A and 4B. Chapter 4A includes a herd level 
risk factor study designed as follows: 
 
 
 
Chapter 4B describes factors associated with C. burnetii antibody positivity in Danish dairy 
cows, and includes lactating cows from 24 randomly selected dairy herds from the 100 
herds described in Chapter 4A. The design and data structure of this study are as follows: 
 
 
 
 
 
Random selection of 120 
dairy herds in July 2012   
Level of C. burnetii antibodies in 
bulk tank milk (BTM) 
Herd information available in the 
DCD 
Estimation of herd 
prevalence and 
risk factors 
All lactating cows of 24 
randomly selected herds 
from 100 herds involved 
in a prevalence study in 
2008 
Level of C. burnetii antibodies 
in cow milk samples 
estimated at three time points 
• Animal level information 
from the DCD 
• Herd information from 
farmers’ interviews and 
from the DCD (as 
described in Chapter 4A) 
Estimation of within 
herd prevalence and 
factors associated with 
C. burnetii antibody 
positivity in cows 
Level of C. burnetii 
antibodies in BTM in 
100 randomly selected 
Danish dairy herds in 
2008 
Herd information from farmers’ 
interviews with emphasis on 
herd management and 
biosecurity, and also data from 
the DCD 
Identification of herd 
level risk factors 
18 
 
Chapter 5 evaluates the performance of the antibody ELISA used for identifying C. burnetii 
antibody positive cows in a study design as follows:  
 
 
 
 
Chapter 6 describes the prevalence and risk factors of C. burnetii antibody positivity in 
Danish slaughter cattle. Estimates of this chapter were adjusted from uncertainty of 
diagnostic tests. Test characteristics obtained from Chapter 5 were used to calculate true 
prevalence and risk factors in this chapter. The design and data structure of this study are: 
 
 
 
A general discussion of the results obtained from the different studies, perspectives and 
conclusions for future research and practical applications are presented in Chapter 7.  
Chapter 8 of this thesis includes the annexes.   
  
Blood samples from 
800 randomly selected 
Danish slaughter cattle  
Level of C. burnetii antibodies 
in collected blood samples 
Animal and herd information 
available in the DCD 
Estimation of prevalence 
and risk factors adjusted 
for test uncertainty. 
Random selection of 
eight BTM C. burnetii 
antibody positive, six 
BTM negative and three 
intermediate herds from 
the study population of 
Chapter 4a  
Blood and milk 
samples from 
30 randomly 
selected 
milking cows 
from each herd 
Level of C. burnetii 
antibodies in blood 
samples by ELISA 
Level of C. burnetii 
antibodies in milk 
samples by ELISA 
Evaluation of 
the performance 
of blood and 
milk antibody 
ELISA by 
Bayesian 
method 
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CHAPTER 1 
GENERAL INTRODUCTION 
 
 
 
 
 
SYNOPSIS 
This chapter provides a brief introduction on the magnitude and distribution of Coxiella 
burnetii infection (Q fever) in humans and cattle in the European Union; a brief 
description of cattle production in Denmark and the epidemiological studies on Q fever in 
cattle in Denmark. This chapter also presents the objectives and related research questions 
of the thesis.  
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GENERAL INTRODUCTION 
Coxiella burnetii infection (Q fever) in the European Union (EU) 
Occurrence in humans 
Coxiella burnetii, a highly contagious bacterium, is the causative pathogen of Q 
fever. Q fever is a well-known zoonotic disease with worldwide distribution, and is enlisted 
in the multiple species disease category on the OIE (World Organization for Animal 
Health) list. It is one of the 47 enlisted communicable diseases within the EU legal 
framework of communicable disease surveillance and notification (Commission Decision 
2000/96/EC). According to this legal framework, human Q fever cases must be notified in 
EU member states (MS) using a harmonised case definition (EFSA, 2010). Generally, Q 
fever occurs in almost all EU MSs, but persists at a low frequency. Reported human cases 
are either sporadic or discrete clusters from a specific source (Orr et al., 2006; Wilson et 
al., 2010), or a part of clusters of known community based outbreaks. The annual 
proportion of notification ranges from 500 to 2000 cases per annum (EFSA, 2010). 
Human outbreaks in the EU are infrequent and typically 1-3 human outbreaks are reported 
annually. Outbreaks are relatively small involving 10 to 500 human cases, and generally do 
not persist constantly over the years in the same country (EFSA, 2010).  
In 2007, 637 confirmed human cases were reported from 14 MSs, of which the 
majority of cases were reported from the Netherlands (1.03 cases/105) and Slovenia (4.6 
cases/105) (EFSA, 2010). The first human outbreak in the Netherlands was reported in 
2007, from a localised area which was believed to be linked with an outbreak on a goat 
farm (Roest et al., 2011). In subsequent years, the Netherlands faced several human 
outbreaks of unprecedented size within the same cluster, however, with wider geographical 
spread (Karagiannis et al., 2007; Schimmer et al., 2009; Schimmer et al., 2008; Schimmer 
et al., 2010). In 2008, 24 EU MSs reported 1594 confirmed human cases (0.5 cases/105), 
which was 170% higher than 2007 (EFSA, 2010). This sharp increase was mainly due to 
the increase in the Netherlands (1011 cases; 6.2 cases/105) and Germany (370 cases; 0.5 
cases/105). The total number of confirmed human cases in EU MSs increased further (1988 
cases from 15 MSs) in 2009, and yet again the majority of cases were attributed to the 
Netherlands (1623 cases) and Germany (191 cases) (EFSA, 2012; EFSA/ECDC, 2010). 
Twenty four MSs reported a total of 1414 confirmed human cases (0.36cases/105) in 2010, 
of which seven MSs reported zero cases. Eighty-one percent of the total reported cases 
occurred in the Netherlands and Germany (EFSA, 2012). France reported human cases of 
Q fever for the first time in 2010 (286 cases; 0.44 case/105). This proportion of 
notifications in all MSs was 28.9% less than in 2009, and the largest decrease was 
observed in the Netherlands (67%) (EFSA, 2012). Massive veterinary control measures 
were put in place, i.e. culling all pregnant small ruminants from Q fever positive farms, a 
ban on breeding and transport and vaccination, these precautions were likely the reason 
for the reduction of human Q fever cases in the Netherlands. However, the adverse 
weather conditions in 2010, might have also contributed to this reduction (Roset et al. 
2011). Descriptive analysis of confirmed cases from 2007 to 2010, shows that the 
proportion of notifications was higher in the age group 45-64, with the highest proportion 
(1.09/105) in 2009 (EFSA, 2010; EFSA, 2012; EFSA/ECDC, 2009; EFSA/ECDC, 2010). 
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Cases were rarely reported among children less than 15 years of age. A proportion of 
notifications of confirmed cases was higher in men than in women, with male to female 
ratios of 1.78 and 1.58 in the year 2007 and 2009, respectively (EFSA, 2010). Seasonal 
variation was observed in notification proportions, and most outbreaks were reported in 
May to July with few exceptions (EFSA, 2010; EFSA, 2012). A large outbreak was observed 
in August 2009 in the Netherlands; and in 2010, another sharp pick of reported cases was 
observed, which was probably related to lambing or kidding season (EFSA, 2012). Among 
the EU MSs, Austria and Denmark do not have any national active surveillance system for 
human Q fever; i.e. only passive surveillance. These two MSs along with Italy have not 
reported any human cases so far (EFSA, 2010; EFSA, 2012).  
The Q fever surveillance system in the EU is based on the notification of clinical 
cases, but no harmonised surveillance system is available to assess the seroprevalence 
(EFSA, 2012). Several serological studies were conducted to assess the rate of 
seroconversion. Comparison of the outputs of these studies is not always possible, as the 
studies varied significantly in terms of design, target population and diagnostic tests used. 
However, broadly between 2-10% of the total population included in these studies were 
exposed to C. burnetii infection (EFSA, 2010; EFSA, 2012; EFSA/ECDC, 2010). In recent 
studies, a high level of seroconversion was observed in occupational groups or in groups 
with extended exposure to animals (Bartolome et al., 2007; Bosnjak et al., 2010; Cisak et 
al., 2003; Monno et al., 2009; Orr et al., 2006). But, there is no scientific evidence that the 
occurrence of the clinical disease was higher in these risk groups. A recent study in 
Denmark involving risk group populations (i.e., farmers, farm workers, veterinarians, 
inseminators, etc.) indicated that the risk of seroconversion is higher in veterinarians than 
in other occupational groups (Bosnjak et al., 2010). Although serological studies varied 
substantially, results indicate that clinical cases of Q fever were significantly 
underreported. This is because of the pleomorphic nature of the disease (mostly 
asymptomatic or with non-specific symptoms), and failure to identify the infection in 
animal hosts. Thus, estimation of the real number of confirmed human Q fever cases in the 
EU is troublesome (EFSA/ECDC, 2009). 
Occurrence in cattle 
Q fever/C. burnetii infection is included in list B of diseases (‘other zoonoses and 
zoonotic agents that shall be monitored according to the epidemiological situation in an 
MS) in Annex I of Directive 2003/99/EC. But, it is not included in the notifiable disease 
list in domestic ruminants in the EU legislation (Directive 82/849/EEC), or in the 
Regulation 2160/2003/EC for zoonosis control options. Therefore, there are no rules for 
notification or monitoring/surveillance and also for control of intra-country imports 
concerning Q fever. This disease is nationally notifiable in only 14 EU MSs (Sidi-
Boumedine et al. 2010). According to veterinary legislation (Act no. 432 of 09/06/2004), 
Q fever has been a notifiable disease in Denmark since December 2004 (Anonymous, 
2010). Based on the available information in the EFSA/ECDC zoonoses database, it is not 
possible to make a conclusive statement about the exact scenario of Q fever in domestic 
ruminants in EU MSs. This is because disease reporting systems in EU MSs are not 
harmonised, and significant variation is observed in the level of reporting. Moreover, most 
of these reports were based on clinical investigations/suspected samples (EFSA, 2010; 
EFSA, 2012). So, animals included in these investigations do not represent the population. 
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This indicates the need for a harmonised monitoring/surveillance system in the EU to 
make an unbiased comparison of Q fever occurrence in animals between EU MSs and over 
time. A scientific report on developing harmonised schemes for monitoring and reporting 
of Q fever in animals in the EU was submitted to the EFSA in 2010 (Sidi-Boumedine et al., 
2010).  
From 2008 to 2010, 18 EU MSs reported information regarding Q fever/C. burnetii 
infection in domestic ruminants in the ECDC/EFSA zoonoses database, of which eight MSs 
reported infection/disease in cattle (EFSA, 2012; EFSA/ECDC, 2010). From the available 
information, it is obvious that infection with C. burnetii is endemic in all of these reporting 
countries. Although there are variations in prevalence among the MSs, no spatial cluster 
was observed across Europe, and no upward trend of Q fever was observed within EU MSs 
(EFSA, 2010). However, caution should be taken in interpreting this information, as the 
reporting system in the EU is not harmonised. In 2010, the occurrence of C. burnetii 
infection in cattle at the animal level was 2.8% (EFSA, 2012), which was lower than that in 
2008 (9.9%) and 2009 (9.0%) (EFSA, 2010). Denmark reported the highest occurrence in 
bovines (29%), followed by Spain (11.6%). Reports from both countries were based on 
suspected samples and serology, which may have contributed to the comparatively higher 
occurrence. Denmark reported the largest decrease in occurrence of C. burnetii in cattle in 
2010, compared to the occurrence in 2009 (54.5%). In MSs, where more than 2000 cattle 
were sampled, the proportion of positivity ranged from 0.4% to 10.5%. Only four MSs 
reported herd level information regarding C. burnetii infection in cattle in 2010 (EFSA, 
2012). The proportions of herd level positivity were reported to be 25.5%, 11.9% and 6.1% 
in 2008, 2009 and 2010, respectively (EFSA, 2010; EFSA, 2012). Yet again, Denmark 
reported the highest herd-level occurrence (75%) based on serology and non-randomly 
selected clinically suspected samples; followed by Sweden (61.4%). The report from 
Sweden also based on serology and sampling, was carried out in a known high prevalence 
area. Germany and Poland examined a substantial amount of herd-level samples and 
reported a 17.7% and a 0.6% occurrence, respectively.  
On top of this official reporting system, several prevalence studies of C. burnetii 
infection in cattle were carried out in EU MSs and non-EU countries, and most of them 
were seroprevalence studies. The results of these studies were summarised in a review 
article (Guatteo et al., 2011). However, studies varied greatly in terms of study design, 
sampling population and diagnostic tests used, and only in few studies were animals/herds 
selected randomly. The animal level prevalence ranged from 6.2% to 22% in the studies 
where animals were selected by random sampling (Cabassi et al., 2006; Capuano et al., 
2001; McCaughey et al., 2010; Ruiz-Fons et al., 2010). The highest prevalence was 
reported in Italy (Cabassi et al., 2006). Prevalence is generally higher in dairy cattle than 
beef cattle (McCaughey et al., 2010; Ruiz-Fons et al., 2010; Ryan et al., 2011). The herd 
level prevalence ranged from 29% to 71.2% in the studies where herds were selected 
randomly (Agger et al., 2010; Czaplicki et al., 2012; McCaughey et al., 2010; Ruiz-Fons et 
al., 2010). The herd level prevalence in Denmark was 59% in 2008 (Agger et al., 2010), 
which was higher than what was stated in the EFSA report (46.4%) in the same year 
(EFSA, 2010).  
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Cattle production in Denmark  
Cattle production in Denmark consisted of 13,387 cattle herds in 2011, of which 
4,062 and 9,325 herds were dairy and non-dairy (with suckler cows + without dairy cows) 
herds, respectively (Anonymous, 2012a; Anonymous, 2012b). In 2011, a 4.41% reduction in 
the number of dairy herds was observed, compared to 2010. The average herd size of the 
total cattle population was 117.1 heads/herd in 2011, with a visible difference between dairy 
and non-dairy herds (Anonymous, 2012a; Anonymous, 2012b). In 2011, the herd size of 
dairy cattle (132 heads/herd) increased about two fold, compared to 20o1 (Anonymous, 
2012b). Sixty-one percent of dairy herds contained more than 100 heads of animals and 
represented 84.4% of the total dairy cattle population (Anonymous, 2012a). In contrast, 
the average herd size of the suckler cows in 2011 (11.9 head/herd) remained the same as in 
2009 and 2010. Sixty-two percent of total suckler cow herds contained less than ten cows 
and represented only 23.1% of the total population (Anonymous, 2012a). Most of the cattle 
herds were in Jutland, with the highest herd and cattle proportion in the southern part of 
Jutland. According to 2011 statistics, 24.6% of the total cattle herds were located in this 
part of the country, which represented 32.5 % of the total cattle population (Anonymous, 
2012a).  
The total number of cattle was estimated to be 1,615,000 in 2011, of which 579,000 
were dairy cattle (Anonymous, 2012a; Anonymous, 2012b). Danish Holstein is the 
predominant breed among dairy cows (72.86%), followed by Danish Jersey (12.55%) and 
crossbred cows (8.36%). Average milk yield per cow in October year 2010/11 was 8,919 kg 
which was higher than the EU average (EUROSTAT, 2012). In 2011, 21.9% of total export 
values of agricultural products were gained from dairy products in Denmark (Anonymous, 
2012b). The annual average per capita milk and milk products (excluding cheese) 
consumption in Denmark was recorded 137.4 kg in 2008 (Anonymous, 2009). Danish beef 
cattle population comprises of several breeds, of which Limousine and Hereford are 
predominant (Anonymous, 2009). In 2011, a total of 513,134 cattle were slaughtered in the 
authorized abattoirs in Denmark which produced approximately 133,000 tonnes of beef 
(Anonymous, 2012a). Denmark was the country with the second highest consumption of 
beef in the EU, with an annual average per capita consumption of 28.1 kg (Anonymous, 
2012a). According to Eurostat estimations in 2011, the annual average per capita in the EU 
countries was 16.7 kg with the highest consumption in Luxemburg (EUROSTAT, 2012). 
Beef and veal shares the 32.7% of total meat consumption in Denmark (Anonymous, 
2012a).  
Epidemiological studies on Q fever in cattle in Denmark 
Although notifiable, no national active surveillance system exists for Q fever/C. 
burnetii infection in domestic animals in Denmark (Anonymous, 2010) except for the 
classical passive surveillance where animal owners have the obligation to call their 
veterinary practitioner when animals show clinical signs of a severe disease. Herd level 
seroprevalence of C. burnetii infection in cattle was reported in a few epidemiological 
studies. Proportions of positivity were 22.2%, 37.5% and 49.6% in 2003, 2004 and 2006, 
respectively (Christoffersen, 2007). In 2007, the proportion of positive herds was 57% 
(Bødker and Christoffersen, 2008). However, the above mentioned studies were based on 
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non-randomly selected clinically suspected samples, or samples submitted by veterinarians 
for routine testing of animals intended for export. Therefore, these samples were not 
representative of the total population, and the results of these studies could not be 
generalised.  
In 2008, bulk tank milk (BTM) samples of 100 randomly selected dairy herds were 
tested for the presence of C. burnetii antibodies in a prevalence study; of which, 59 % of 
herds were BTM positive (antibody level [S/P]≥40) (Agger et al., 2010).  Thirty percent of 
these 100 samples were negative (S/P < 30), and the remaining 11% were intermediate 
(S/P 30 -39). Ten positive, ten negative and four intermediate herds; and animals within 
these herds from the previous study were followed up on in a number of studies. Nielsen et 
al. (2011) did not find any association between stillbirth and/or neonatal mortality with the 
level and monthly changes of BTM antibodies in these 24 herds. In another study, cow 
milk samples from 12 herds (ten positive, one negative and one intermediate) were 
collected repeatedly at three time points over an 11-month period, and tested by ELISA and 
real time PCR (Angen et al., 2011). Results showed that the level of bacterial shedding and 
antibodies in cow milk were stable in most of the herds; and bacterial shedding was 
significantly associated with the antibody level in cow milk or in BTM. The level of 
bacterial shedding increased with increasing parity and increasing protein concentration. 
The relationship between the presence and level of C. burnetii infection and cotyledonary 
lesions were studied by Hansen et al. (2011). In this study, 170 cotyledons from 19 herds 
were analysed by real time PCR, 110 of which were examined by histology, 
immunohistochemistry and fluorescence in situ hybridisation (in case of high infection 
level only). Placental infection was found in cows from herds at all BTM antibody levels, 
with higher levels in positive and intermediate herds. Mild cotyledonary and no 
inflammatory changes were observed for C. burnetii infection. Beyond identification of 
bacteria and estimation of herd seroprevalence, these previous studies barely tried to 
estimate the animal level prevalence and herd and animal level risk factors of both dairy 
and beef cattle. Therefore, the important epidemiological indices such as frequency, 
distribution and risk factors of C. burnetii infection in the Danish cattle population remain 
unknown. Furthermore, the performances of the diagnostic tests used in these previous 
studies were not thoroughly evaluated under Danish conditions, and therefore, the validity 
of the findings of these previous studies may be under question. These points explain the 
necessity for further epidemiological research on Q fever in the Danish cattle population.  
Aim of the thesis 
The overall objective of this thesis was to investigate the epidemiology of the C. 
burnetii antibody positivity in the Danish cattle population. The main focus was on the 
estimation of prevalence and risk factors of C. burnetii antibody positivity in Danish cattle; 
and also on evaluation of the performance of the diagnostic tests used in identifying a 
positive C. burnetii antibody in animals or herds. To ascertain this objective, data was 
collected from Danish cattle under a series of epidemiological studies with several specific 
objectives: 
Objective 1: To estimate the prevalence of C. burnetii antibody positivity in Danish 
dairy cattle herds. The research question addressed under objective 1 is: 
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a) Was the prevalence of C. burnetii antibody positivity in Danish dairy cattle herds 
similar in 2008 and 2012? 
Objective 2: To investigate the risk factors associated with C. burnetii antibody 
positivity in Danish cattle. The research questions addressed under objective 2 are: 
a) What are the risk factors for Danish dairy cattle herds found to have positive C. 
burnetii antibodies? 
b) What are the cow-level and herd-level risk factors associated with C. burnetii antibody 
positivity in Danish dairy cows? 
Objective 3: To estimate the sensitivity and specificity of the antibody ELISA test 
used for detection of C. burnetii antibodies in milk and blood samples from Danish dairy 
cows. The research question addressed under objective 3 is: 
a) Do the sensitivity and specificity estimates of this diagnostic test differ when applied in 
the analysis of milk and blood samples of dairy cows? 
 Objective 4: To estimate the prevalence and risk factors of C. burnetii antibody 
positivity in Danish slaughter cattle adjusted for diagnostic test uncertainty. The research 
questions addressed under objective 4 are: 
a) What is the true prevalence of C. burnetii antibody positivity in Danish slaughter 
cattle? 
b) What are the risk factors for the true prevalence of C. burnetii antibodies in Danish 
slaughter cattle? 
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CHAPTER 2 
COXIELLA BURNETII INFECTION (Q FEVER): AN 
OVERVIEW 
 
 
 
 
 
SYNOPSIS 
This chapter presents a brief overview of Coxiella burnetii infection (Q fever), which 
includes bacteriology, pathogenesis, epidemiology (distribution, transmission, reservoir 
and risk factors), clinical manifestation and diagnosis of infection and disease, treatment, 
general prevention and control measures; and finally, some concluding remarks. 
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COXIELLA BURNETII INFECTION (Q FEVER): AN 
OVERVIEW 
Bacteriology 
C. burnetii is a non-motile obligate intracellular bacterium. This pleomorphic rod 
shaped organism possesses a cell membrane similar to that of other Gram-negative 
bacteria (Maurin and Raoult, 1999). Although Gram-negative, it cannot be stained by the 
Gram staining method, but Gimenez’s method is, however, useful (Gimenez, 1965). Stamp, 
Macchiavello, modified Ziehl–Neelsen method and modified Koster, can also be used to 
stain bacteria. C. burnetii was classified as a member of the order Rickettsiale, family 
Rickettsiaceae, the tribe Rickettsiae and the genera Rickettsia. The bacterium was 
reclassified into the order Rickettsiales, based on 16S rRNA sequence analysis and 
phylogenetic studies (Maurin and Raoult, 1999). It now belongs to the gamma subdivision 
of the Proteobacteria. Within this Proteobacteria group, Francisella and Legionella are 
the phylogenetic neighbours of C. burnetii (Maurin and Raoult, 1999). After 
internalisation, C. burnetii, like Ehrlichiae, remains within a parasitophorous vacuole (PV) 
of infected cells and completes all of its life cycle stages within this vacuole (McCaul and 
Williams, 1981). A high number of bacteria are generated within the PV, as they replicate at 
an estimated doubling time of 20-45 h (Mertens and Samuel, 2007). Electron microscopy 
shows that the organism has two metabolic forms: 1) the small-cell variant (SCV) is a 
compact, small rod and has a very electron-dense centre of condensed nucleoid filament; 
and 2) the large-cell variant (LCV) which is comparatively larger and less electron-dense 
than the metabolically active intracellular form of C. burnetii. Unlike other members of the 
tribe Rickettsiae, C. burnetii is highly resistant to physical and chemical exposure, and it 
can form a small structure similar to an endospore within the infected cell (McCaul and 
Williams, 1981). The organism is also able to resist extreme environmental conditions such 
as desiccation, ultraviolet light and survives in the environment for a long time (Babudieri, 
1959; Scott and Williams, 1990). The antigenic variation (phase variation) of the bacterium 
is determined by lipopolysaccharides (LPS) (Angelakis and Raoult, 2010). Phase I bacteria 
(wild virulent type) with a smooth full length LPS were isolated from infected humans, 
animals and arthropods (Maurin and Raoult, 1999). Phase I bacterium converts to an 
avirulent phase II with rough LPS after several passages in embryonated egg or cell 
cultures (Hotta et al., 2002). However, virulent phase II, an intermediate phase with semi-
rough LPS, has been described in some of the studies (Amano et al., 1987; Vodkin and 
Williams, 1986). Based on the restriction fragment length polymorphism (RFLP), strains 
of C. burnetii are grouped into six (I-VI) genomic groups (Maurin and Raoult, 1999). The 
virulence and the pathogenicity of the C. burnetii are associated with genetic 
characteristics, plasmid groups and type of strains (Hendrix et al., 1991), and also with 
host factors such as pregnancy (Woldehiwet, 2004). Plasmid groups I, II and III are 
responsible for acute infection, whereas groups IV and V are the cause of chronic infection 
(Hendrix et al., 1991).  
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Pathogenesis 
The pathogenesis of C. burnetii infection in humans and animals is not clearly 
understood. But, it is believed that bacterial LPSs play an important role in the 
pathogenesis of Q fever in both humans and animals (Angelakis and Raoult, 2010, Maurin 
and Raoult, 1999). The organism probably follows the oropharyngeal route as its port of 
entry into the lungs and intestines of both humans and animals (Gardon et al., 2001; 
Woldehiwet, 2004). It is highly infectious, and a very low dose is sufficient to initiate 
infection (McQuiston et al., 2002). Primary multiplication takes place in the regional 
lymph nodes after the initial entry, and a transient bacteraemia develops which persists for 
five to seven days, as shown in sheep (Woldehiwet, 2004). An old study has claimed that 
the bacteria localise in the mammary glands or in the placenta of pregnant animals after 
the initial multiplication (Babudieri, 1959). C. burnetii enters monocytes or macrophages; 
the only known target cells, by phagocytosis in humans (Marrie et al., 1996; Mege et al., 
1997). The phagocytotic process differs for phase I and phase II bacteria. Phase II bacteria 
enter the host’s cells through CR3-receptor mediated phagocytosis by activating the CR3 
receptors ( Mege et al., 1997). On the other hand, the attachment of phase I C. burnetii to a 
monocyte is aided by leukocyte response integrin (LRI) αvβ3, and integrin-associated 
protein (IAP) (Mege et al., 1997). In spontaneous infections, the phase I C. burnetii 
survives within the phagocytic cells, as the internalisation of the bacteria by these cells is 
poor. In contrast, uptake of the phase II C. burnetii by monocyte is rapid (Mege et al., 
1997). After internalisation in phase II, C. burnetii initiates phagolysosomal pathways 
within monocytes which rapidly kill the bacteria (Maurin and Raoult, 1999).  
Following passive entry, invading C. burnetii bacteria embed in the phagosomes of 
host cells. Infected phagosomes fuse progressively with lysosomes to form a large vacuole, 
PV (Hackstadt and Williams, 1981; Howe et al., 2003). C. burnetii is an acidophilic 
bacterium, and therefore, can survive and multiply in an acidic environment within the PV. 
Acidic pH allows the entry of necessary nutrients for bacterial metabolism (Chen et al., 
1990; Hackstadt and Williams, 1983; Hendrix and Mallavia, 1984). It also alters the 
activity of antibiotics and prevents bacterial killing (Hackstadt and Williams, 1981). Within 
the PV, C. burnetii undergoes a complex intracellular life cycle to form a spore-like stage. 
SCVs, the extracellular metabolically inactive and highly resistant form of the bacteria, 
attach to the host’s cell membrane. After the formation of PV, the acidic environment 
triggers the activation of the SCVs to form LCVs. LCVs then undergo a sporulation-like 
process to form a resistant, spore-like form of the bacterium (McCaul and Williams, 1981). 
Binary fission is the process of cell division for both activated SCVs and LCVs.  
C. burnetii is capable of producing chronic infection in both humans and animals 
(Baca and Paretsky, 1983), which may persist for months and perhaps, even for years 
(Marmion et al., 2005; Raoult et al., 2000). Although C. burnetii persists for a long time 
within the host cell, it has a very slow intracellular multiplication. Therefore, it may not 
alter the host cell’s characteristics significantly (Maurin and Raoult, 1999). Moreover, the 
septum positions itself asymmetrically close to one end of the mother LCV cell during the 
cell division process to develop a sporulation-like form. So, only one daughter cell receives 
the PV when an infected cell divides (Hechemy et al., 1993). This phenomenon might also 
play a role in the persistence of the C. burnetii infection. C. burnetii bacteria show a special 
affinity to reproductive tissues in pregnant animals. In an experimental study, the bacteria 
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have been shown to first infect the trophoblastic cells of chorioallantoic membranes in 
pregnant goats, and maximum bacterial proliferation was observed in the foetal placental 
part (Sanchez et al., 2006). This feature might explain why C. burnetii infection is 
sometimes associated with abortion. 
Both cell-mediated and humoral immunities are required for the clearance of 
intracellular pathogens (Casadevall and Pirofski, 2006). In the case of C. burnetii infection 
in animals, cell-mediated immune response is the key for bacterial elimination (Turco et 
al., 1984), and the role of humoral immunity is not clearly understood. Two cytokines, 
namely interferon γ (INF-γ) and tumour necrosis factor (TNF) play the key role in the C. 
burnetii elimination process (Dellacasagrande et al., 1999; Turco et al., 1984). An in-vitro 
study has shown that INF-γ has the capacity of restricting the growth of C. burnetii in 
infected monocytes (Turco et al., 1984). This cytokine, together with TNF induces an 
apoptosis to kill the C. burnetii infected monocytes (Dellacasagrande et al., 1999; Mege et 
al., 1997). It is believed that INF-γ mediates the killing of C. burnetii through the alteration 
of conditions within the phagosomes of infected cells (Ghigo et al., 2002). Phase I C. 
burnetii stimulates the synthesis of TNF from the infected monocytes in humans (Capo et 
al., 1996). It is a general belief that antibodies have little impact on C. burnetii infection 
(Norlander, 2000). However, during the bacteraemic phase of acute infection, antibodies 
can play a role in bacterial elimination. But, in chronic infection, immune complexes may 
cause pathology (Raoult, 1990). Antibodies are produced following the infection and 
antigenic properties of invading C. burnetii determine the type of antibody production. 
Infection with phase II C. burnetii induces secretion of both IgG and IgM, whereas phase I 
C. burnetii can only induce IgM production (Maurin and Raoult, 1999).  
Distribution  
Until the recent outbreaks of Q fever in the Netherlands, C. burnetii infections in 
animals had gained very limited attention, and it was considered to be an infection with 
very little impact on the health and production of domestic animals. Therefore, 
information on geographical distribution of animal coxiellosis was very limited. In a recent 
review article, it was stated that since 1960, C. burnetii infection in domestic ruminants 
has been reported in 35 countries which cover five continents (Guatteo et al., 2011). 
Human Q fever has been reported from almost all parts of the world, which includes all 
continents except Antarctica (Marrie, 1990; Woldehiwet, 2004). Since 1956, human Q 
fever has been reported from over 70 countries (Woldehiwet, 2004). The only country that 
claims to be free from Q fever is New-Zealand. However, a study found evidence of 
seropositivity in humans (three positive out of 97 serum sample tested) in New-Zealand 
(Greenslade et al., 2003). Epidemiological studies in man and animals suggested that C. 
burnetii infection is highly prevalent in tropical regions (Woldehiwet, 2004). 
Transmission 
C. burnetii bacteria have unique properties which contribute to their transmission 
between hosts: (1) unlike other members of the Rickettsiaceae, the life cycle of C. burnetii 
is not dependent on arthropods as vectors; and (2) the SCV form is highly resistant in 
external environments. Inhalation of contaminated fomites is the most common mode of 
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transmission to humans (Marrie, 1990). Domestic ruminants serve as the most important 
known source of human infection (Maurin and Raoult, 1999). However, many other animal 
species may play a role in C. burnetii transmission. Parturient cattle, ewes and goats can 
excrete very high quantities of bacteria through amniotic fluid and foetal membranes 
(Arricau-Bouvery et al., 2005). Direct contamination by aerosols may occur from these 
products of parturition. Abortive animals may continue to shed bacteria for a long period 
(Berri et al., 2001). Infected animals may also shed C. burnetii in milk, urine, faeces and 
uterine discharge (Arricau-Bouvery et al., 2005; Guatteo et al., 2006). Milk is the most 
common shedding route for goats and cattle, whereas ewes shed bacteria most commonly 
in faeces and vaginal mucus (Rodolakis et al., 2007). Excreted bacteria contaminate 
fomites such as wool, clothing, straw, manure etc., which may serve as vehicles for 
transmission (Tissot-Dupont et al., 1992). Indirect transmission to humans may result 
from the handling of contaminated farm utensils, straw or manure, or by dust from farm 
vehicles. C. burnetii may also spread through the air, and therefore, infection may occur in 
a person without any history of animal contact (Marrie and Raoult, 1997; Tissot-Dupont et 
al., 1999). However, in some studies, it was shown that wind spread is not an important 
mode of C. burnetii transmission (Gardon et al., 2001). Ingestion of contaminated milk 
and milk products could be a potential source of human infection (Babudieri, 1959; 
Fishbein and Raoult, 1992; Tylewskawierzbanowska et al., 1991). However, it was not 
evident in an experimental study (Cerf and Condron, 2006). Rare, but sporadic cases of 
human-to-human transmission of Q fever have occurred to attendants during autopsies 
and following contact with a pregnant woman (Harman, 1949; Marmion and Stoker, 1950; 
Raoult and Stein, 1994). Sexual transmission of C. burnetii infection was also reported in a 
study (Milazzo et al., 2001). 
Inhalation of bacteria from the infected environment and ingestion of contaminated 
straw, hay or pasture are likely the most important sources of C. burnetii infection in 
animals. Animals which live in or come in contact with contaminated premises or infected 
animals may acquire the infection. Sandford et al. (1994) described three newly purchased 
goats with a known history of C. burnetii infection introducing infection and abortion in a 
goat farm. Dogs and wild carnivores may be infected by ingestion of contaminated 
ruminant placenta or birth products, or by the aerosol route (Angelakis and Raoult, 2010). 
Although ticks are not essential for the life cycle of C. burnetii, they may still play an 
important role in transmission of the infection in wild vertebrates (Lang, 1990). 
Transmission of C. burnetii infection to guinea pigs via tick bites was shown in an 
experimental study. Possible sexual transmission of C. burnetii infection was reported in 
mice (Kruszewska and Tylewskawierzbanowska, 1993). Insemination might be a source of 
infection, as viable C. burnetii was found in bull semen (Kruszewska and 
Tylewskawierzbanowska, 1997). 
Reservoir 
C. burnetii is considered to be a pathogen with no host specificity and it was shown 
that infection may occur in a wide range of vertebrates, which includes wild and domestic 
mammals, birds and arthropods (Angelakis and Raoult, 2010, Babudieri, 1959, Maurin and 
Raoult, 1999). Babudieri (1959) in his review paper stated that C. burnetii bacteria were 
detected in virtually all of the animal kingdom. However, the clinical form of the infection, 
Q fever, is mostly seen in humans. Cattle, sheep and goats are considered to be the most 
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common source of human infection (Marrie, 1990). C. burnetii infection, without showing 
any clinical signs has been reported in horses, pigs, dogs, cats, camels, and buffalos, and 
also from wild and domestic chickens, pigeons, ducks, geese and turkeys (Babudieri, 1959). 
This organism was also isolated from rabbits, cats, squirrels, mice, deer and many other 
free living animals ( Marrie et al., 1986). C. burnetii was also isolated from 40 species of 
ticks (Maurin and Raoult, 1999).  
Risk factors 
Agent factors 
The severity of the infection depends on the strains of the infecting bacteria. Phase I 
type bacteria are more virulent than the phase II type (Amano and Williams, 1984). Acute 
infection in humans is caused by C. burnetii genomic type I-III, whereas type IV and V are 
responsible for chronic infection. The virulence of type VI is unknown (Hendrix et al., 
1991). Clinical manifestations of Q fever are sometimes dependent upon the route of 
invasion. Pneumonic lesions are often observed when the infection is gained by inhalation. 
On the other hand, an infection through the oral route may produce hepatitis (Marrie et 
al., 1996). 
Host factors  
Age and gender are the two risk factors which are shown to influence the occurrence 
of Q fever in humans. People aged 30-60 years are the most vulnerable group, and the 
clinical disease is mostly prevalent in men (Maurin and Raoult, 1999; Tissot-Dupont et al., 
1992). However, other studies did not find any relationship between gender and the 
occurrence of Q fever (Marrie and Pollak, 1995; Tissot-Dupont et al., 1992). People with a 
previous history of valvulopathy, an immunosuppressive disease like AIDS and pregnant 
women (Raoult, 1990; Raoult and Marrie, 1995; Raoult and Stein, 1994) are more prone to 
develop chronic Q fever. People in certain occupations like veterinarians, animal farm 
workers, abattoir workers and laboratory personnel are at a higher risk of being infected or 
seropositive than others; and studies show a comparatively higher prevalence in these 
groups (Bosnjak et al., 2010, Maurin and Raoult, 1999). 
A relationship of C. burnetii infection with age and sex was also found in animals, 
particularly in cattle. Several studies have shown that the prevalence of C. burnetii 
infection increases with age or with the number of parity in cattle and sheep (Bottcher et 
al., 2011; Garcia-Ispierto et al., 2011; Kennerman et al., 2010; McCaughey et al., 2010). 
Prevalence is higher in dairy cows than in beef cattle (McCaughey et al., 2010; Ryan et al., 
2011). Among the dairy cattle breeds, prevalence was reported to be higher in Holstein 
than other breeds (McCaughey et al., 2010).  
Season, environment and management factors 
Seasonal variation is observed in the occurrence of human Q fever. This variation, 
however, varies according to geographical region. But most cases of Q fever have been 
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reported in the spring or in early summer (Maurin and Raoult, 1999). Human Q fever has 
been shown to have a relationship with rainfall rather than season, based on a study in 
France (Gardon et al., 2001). A high prevalence of Q fever was observed among people 
living in close proximity to infected animals or in areas with a high livestock density 
(Maurin and Raoult, 1999; Smit et al., 2012). 
Seasonality in the occurrence of C. burnetii infection was also reported in animals. 
In Japan, most of the Q fever cases in animals were reported in winter (Hellenbrand et al., 
2001). On the other hand, in Germany most of the animal cases were reported in summer 
(Hellenbrand et al., 2001) and in autumn in Cyprus (Cantas et al., 2011). Increasing animal 
density increases the infection load in the environment, and is therefore, a potential risk 
factor of C. burnetii infection. Several studies in cattle identified that seroprevalence 
increases with an increasing herd size (McCaughey et al., 2010; Paul et al., 2012). Flock 
size is reported to have a similar effect in sheep (Kennerman et al., 2010). Several 
management factors such as housing systems, isolation of a newly introduced animal etc., 
may also contribute to the seroprevalence of C. burnetii infection in animals (Capuano et 
al., 2001; Paul et al., 2012).  
Clinical manifestation in humans and animals 
C. burnetii infection can produce both acute and chronic forms of clinical 
manifestations in humans. However, in most cases (60%) infection remains asymptomatic 
and among the symptomatic cases, only a few patients develop a severe illness (Arricau-
Bouvery and Rodolakis, 2005; Maurin and Raoult, 1999). The incubation period of Q fever 
is 2-3 weeks, depending on the route of infection (Maurin and Raoult, 1999). Clinical signs 
of acute Q fever are nonspecific and vary among patients. A self-limited febrile illness is 
probably the most frequent manifestation in most clinical cases, which is accompanied by 
severe headaches, myalgia, arthralgia and a cough (Tissot-Dupont and Raoult, 2007). A 
prolonged fever, which may reach 39-40oC, usually stays for 2-4 days and then gradually 
decreases to a normal level through the following 5-14 days (Maurin and Raoult, 1999). 
Atypical pneumonia is another common symptom of acute Q fever. Pneumonia is mild in 
most cases being characterised by a dry cough, fever, and minimal respiratory distress. 
Patients may also develop hepatitis with hepatomegaly, but without jaundice, subclinical 
hepatitis and granulomatous hepatitis with a prolonged fever (Maurin and Raoult, 1999). 
Generally, hepatitis develops in young immunosuppressed patients, whilst pneumonia is 
often seen in older patients (Fournier et al., 1998). Myocarditis is found in 2% of patients 
with the acute illness, which may be accompanied by pericarditis (Fournier et al., 2001). 
Skin rashes and neurologic disorders such as meningoencephalitis or encephalitis, 
lymphocytic meningitis and peripheral neuropathy have also been observed in acute Q 
fever cases (Bernit et al., 2002; Maurin and Raoult, 1999). Spontaneous abortion, 
intrauterine foetal death, premature delivery or retarded intrauterine growth may occur in 
women that become infected during pregnancy (Carcopino et al., 2007). However, recent 
studies in Denmark did not find any evidence of association between C. burnetii antibody 
positivity and spontaneous abortion, preterm birth or other adverse pregnancy outcomes 
(Nielsen et al., 2013). Pregnant woman may become chronically infected and abort in 
subsequent pregnancies (Maurin and Raoult, 1999).  
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 Mortality is a rare outcome of the acute form of the disease. However, severe 
respiratory distress and myocarditis may lead to death (Fournier et al., 2001; Tissot-
Dupont et al., 1992). 
An infection which lasts for more than six months after the onset is defined as 
chronic Q fever. This happens in less than 5% of cases (Raoult and Marrie, 1995). The 
major clinical manifestation of this form of the disease is endocarditis (Tissot-Dupont and 
Raoult, 2007). It occurs in 60-70% of all chronic cases (Maurin and Raoult, 1999). The 
case fatality of Q fever endocarditis is less than 10% when patients are treated with 
antibiotics (Maurin and Raoult, 1999). The aortic and mitral valves are usually affected 
(Maurin and Raoult, 1999). Unspecific signs like intermittent fever, cardiac failure, 
weakness, fatigue, weight loss or anorexia may be present. Other manifestations are 
osteomyelitis, osteoarthritis, chronic hepatitis, hepatomegaly, splenomegaly, digital 
clubbing, purpuric rash and an arterial embolism (Maurin and Raoult, 1999; Tissot-
Dupont and Raoult, 2007; Williams and Sanchez, 1994). 
The term coxiellosis is considered to be more appropriate than animal Q fever, as 
most cases of animal infection are asymptomatic (Lang, 1988). The organism is found in 
the blood, lungs, liver and spleen during acute experimental infection, whereas chronically 
infected animals persistently shed bacteria in their faeces and urine. Infection in most 
domestic animals remains unrecognised. Coxiellosis is considered a cause of abortion and 
reproductive disorders in domestic animals (Williams and Sanchez, 1994). There is 
scientific evidence to support the hypothesis that C. burnetii can induce epidemics of 
reproductive failure in sheep and goats, but not in cattle (Agerholm, 2013). Reproductive 
disorders in domestic animals include endometritis, metritis, stillbirth, reduced birth 
weight and infertility. In a number of studies, C. burnetii bacteria or antibodies were 
identified from clinical cases of stillbirth, retained placenta, infertility, endometritis and 
metritis; however, the evidence was lacking for their association with C. burnetii infection 
in cattle (Bildfell et al., 2000; Cabassi et al., 2006; Garcia-Ispierto et al., 2012; Muskens et 
al., 2011; Muskens et al., 2012). The herd level perinatal mortality and rate of still birth 
were not associated with the level of C. burnetii antibodies in bulk tank milk in Danish 
dairy cattle (Nielsen et al., 2011). If abortions occurred, then the rates generally remained 
low; however, it ranged from 3-80% (Marrie, 2007). Abortion rate is comparatively higher 
in ewes and goats than in cows. Abortion is usually observed in late pregnancy in both 
ewes and cattle (Lang, 1990). In most abortive cases, the aborted foetus appears normal. 
Discoloured exudate and intracotyledonary fibrous thickening may be observed in an 
infected placenta. Severe myometrial inflammation and metritis are the frequently 
observed clinical manifestations in goats and cows, respectively (Arricau-Bouvery and 
Rodolakis, 2005).  
Diagnosis 
There are no specific clinical signs of C. burnetii infection in humans and animals. 
Therefore, laboratory diagnosis is the only way to confirm the disease. Since C. burnetii is 
highly infectious, biosafety level 3 laboratories and experienced laboratory personnel are 
required to handle the contaminated specimens (Fournier et al., 1998). Several human 
specimens have to be taken in order to detect C. burnetii. However, the clinical condition 
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of the patient determines the type of specimen. Aborted placenta and amniotic fluid are the 
best specimens for detection and identification of C. burnetii in animals. Milk, faeces, 
urine and uterine discharge can also be used to identify shedder animals. Nowadays, milk 
and blood samples are widely used to identify seropositive animals in epidemiological 
studies.  
Culture and animal inoculation  
Standard biological media are not suitable for the growth of C. burnetii (Maurin and 
Raoult, 1999). Therefore, isolation of bacteria is done using the shell-vial cell culture 
techniques or culture in the yolk sacs of embryonated eggs. Guinea pigs, although rarely 
used nowadays, develop a fever 5-8 days after intraperitoneal inoculation (Woldehiwet, 
2004). Further isolation can be done by culturing bacteria in the cell lines or yolk sac from 
the heavily infected spleen of the inoculated guinea pig.  
Staining and immunodetection 
Fixed impression or smears prepared from aborted placenta, uterine discharge and 
other secretions from cows, ewes and goats can be stained with Machiavello or modified 
Ziehl Neelsen stains to detect the organisms (Angelakis and Raoult, 2010; Woldehiwet, 
2004). Antigen detection from impression smears or histological sections can be done by 
direct or indirect immunofluorescence or immunohistochemical techniques (Woldehiwet 
and Aitken, 1993), or by flourescence in situ hybridization (Hansen et al., 2011). 
Serology 
Complement fixation test (CFT) 
A Complement fixation test (CFT) was a widely used laboratory technique for 
diagnosis of human Q fever in the past, and it is still an OIE recommended test for C. 
burnetii infection in animals. The advantage of CFT is that it does not require host specie-
specific antibodies (Peter et al., 1985). This test is highly specific, but weakly sensitive 
(Kovacova et al., 1998; Peter et al., 1985). Moreover, CFT cannot detect early stages of 
infection as the complement fixing antibodies do not appear in exposed individuals in early 
stages of the infection (Peter et al., 1985). Therefore, samples from both convalescent and 
acute phases are required to accurately diagnose the infection. It has been shown that the 
antigens used in CFT often fail to identify seropositive sheep and goats (Kovacova et al., 
1998).  
Indirect immunofluorescence assay (IFA) 
Indirect immunofluorescence assay (IFA) has been widely used and remains as a 
frequently used method for diagnosis of human infection (Bosnjak et al., 2010, Maurin and 
Raoult, 1999; Nielsen et al., 2013, Tissot-Dupont et al., 1994). It requires a very small 
amount of antigens and can detect IgG, IgM and IgA against phase I and phase II antigens; 
and therefore, acute and chronic infections can be differentiated by an IFA test (Tissot-
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Dupont et al., 1994). In an acute case, antibodies can be detected 7-15 days after the onset 
of clinical signs. An elevated level of IgG against phase II antigens (≥ 200) and a much 
lower level of IgM against phase I antigens (≥ 50) indicate an acute infection (Tissot-
Dupont et al., 1994). A high level of IgG against both phases I and II and a slightly elevated 
level of IgA against phase I antigens, although not exclusively predictive, can be detected in 
a chronic infection. An IgG titre ≥ 800 and an IgA titre ≥ 50 against phase I antigens are 
often found in chronic infections (Tissot-Dupont et al., 1994). IFA is a species specific test 
and is not often used for diagnosis of C. burnetii infection in animals. 
Enzyme-linked immunosorbent assay (ELISA) 
Several studies in humans have shown that enzyme-linked immunosorbent assay 
(ELISA) has a higher sensitivity than CFT and IFA (Peter et al., 1985; Peter et al., 1987; 
Soliman et al., 1992), and was recommended as a useful diagnostic tool for 
seroepidemiological studies (Peter et al., 1987). ELISA can detect antibodies against both 
phase I and phase II antibodies (Maurin and Raoult, 1999). This test has a higher 
sensitivity than the CFT in animal studies (Emery et al., 2012; Horigan et al., 2011; Rousset 
et al., 2010), and is a quick diagnostic technique (Rousset et al., 2010). It allows the testing 
of a large number of samples at the same time and is a popular tool for seroepidemiological 
studies in animals (Rousset et al., 2010).  
Polymerase chain reaction (PCR)  
Recently, several polymerase chain reaction (PCR) techniques have been developed 
and successfully used to detect C. burnetii DNA in cell cultures and in clinical samples 
(Berri et al., 2000; Brennan and Samuel, 2003; Fenollar et al., 2004; Fenollar and Raoult, 
2007). This technique is highly sensitive and specific, and is a rapid tool for C. burnetii 
detection (Rousset et al., 2010). PCR also has improved the diagnostics of Q fever in 
veterinary science (Berri et al., 2003). Insertion sequence IS1111 is one of the most 
commonly used primers in real time PCR for detection and quantification of bacterial DNA 
(Angen et al., 2011; Berri et al., 2000). Primers specific for the superoxide dismutase 
(sodB) gene; com1 encoding a 27 kDa outer membrane protein; heat shock operon 
encoding two heat shock proteins (htpA and htpB); isocitrate dehydrogenase (icd); and 
macrophage infectivity potentiator protein (cbmip) are also used in PCR. A high degree of 
specificity has been shown by the primers specific to some plasmid mediated genes (QpRs, 
QpH1, cbbE) (Willems et al., 1994), primers specific to the htpAB-associated repetitive 
element (Willems et al., 1994), superoxide dismutase gene (Stein and Raoult, 1992) and 
the 16s rRNA (Willems et al., 1994).  
Treatment  
Doxycycline (200 mg daily for 14 day) is the recommended drug for acute cases of Q 
fever in adults and children (Maurin and Raoult, 1999). Alternatively, fluoroquinolones 
can also be used for the patients with meningoencephalitis. Cotrimoxazole and rifampin 
are the drugs of choice for the patients allergic or contradicted to tetracyclines (Maurin and 
Raoult, 1999). Long-term (>5 weeks) use of cotrimoxazole with folinic acid is 
recommended for pregnant women (Carcopino et al., 2007). It has been shown that this 
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treatment is protective against placental infection, obstetric complications and foetal 
death. Doxycycline (100 mg/day) and hydroxychloroquine (600 mg) are the recommended 
treatment for chronically infected patients (Carcopino et al., 2007). This treatment, 
however, must be continued for more than 18 months.  
Two injections of oxytetracycline (20 mg per kg body weight) in the last trimester of 
pregnancy are usually recommended for animals, although this may not completely 
supress abortions or stop bacterial shedding during parturitions (Berri et al., 2007).  
Options for prevention and control 
Like other zoonoses, control of Q fever in humans is largely dependent upon the 
control of C. burnetii infection in animals. The control of infection in domestic animals 
requires knowledge about the factors contributing to the introduction and spread of the 
infection. However, only a few risk factor studies have been conducted. Based on the 
available knowledge and experience from the recent outbreaks in the Netherlands, it can 
be concluded that legislative measures (e.g. culling of animals, banding movement and 
transport, mandatory vaccination) (Roset et al. 2011b) and improved biosecurity measures 
(e.g., avoiding contact between farm animals and visitors, quarantine of newly introduced 
animals and improved hygienic precautions of farm personnel) may also play roles in 
controlling C. burnetii infection (Paul et al., 2012). Other control measures which can be 
implemented to reduce the number of infected animals and environmental contamination 
are: lime or calcium cyanide 0.4% treatment of manure (Angelakis and Raoult, 2010); safe 
disposal of aborted foetuses, foetal membranes and contaminated bedding materials to 
avoid their ingestion by domestic or wild carnivores (Woldehiwet, 2004); thorough 
cleaning and disinfection of utensils and transporting vehicles (Woldehiwet, 2004). 
Appropriate measures should be taken to reduce the tick burden in the environment. 
Appropriate biosecurity measures should be implemented in animal farms and industries, 
and also in diagnostic laboratories to prevent the personnel from acquiring infection 
(Woldehiwet, 2004). Avoiding exposure to raw milk and the pasteurisation of milk and 
milk products can contribute to the reduction of Q fever burden in humans. 
In the recent outbreaks in some EU Member States, a wide range of control 
measures were pursued in order to minimise the exposure to humans and to reduce spill-
over from animals to humans. These included the restriction of infected farm visits in the 
Netherlands (EFSA, 2010; Roset et al. 2011b; Van den Brom and Vellema, 2009), avoiding 
human gatherings in high-risk areas (EFSA,2010; Panaiotov et al., 2009); the closing of 
schools during an outbreak during 2004 in Bulgaria (Panaiotov et al., 2009); banning 
blood donation programs in affected areas in France during 2002 and 2007, and in 
Germany during 2005 (EFSA,2010; Georgiev et al., 2013; INVS, 2009); shifting infected 
herds/flocks from human locations in Bulgaria during 2004 (Panaiotov et al., 2009); and 
introduction of a ban on animal movements (Georgiev et al., 2013). Furthermore, changes 
in the farming practices including manure management such as covering and natural 
composting or ploughing of manure, treating manure with lime (in the Netherlands) or 
calcium cyanide (in France and Germany) (EFSA,2010; Roset et al. 2011b; Van den Brom 
and Vellema, 2009, Vellema et al. 2010) and the removal of animal birth and abortion 
products (EFSA, 2010; Georgiev et al., 2013), disinfection of infected premises including 
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paths and general environments of holding in Bulgaria during 2004 (Panaiotov et al., 
2009); and the implementation of a farm animal breeding ban in the Netherlands during 
2007–2010 (EFSA, 2010; Roset et al. 2011b), have also been practised. Moreover, in 2010, 
more than 50,000 pregnant small ruminants from PCR bulk tank milk positive farms were 
culled in the Netherlands with an aim of reducing the shedding of C. burnetii in order to 
reduce the human exposure from environmental contamination. This culling program was 
supplemented by a program of repopulation with immunised animals from PCR bulk tank 
milk negative farms only. A compensation scheme was also available for the farmers 
affected by the culling program (Roest et al., 2011a; Roest et al., 2011b). However, the 
effectiveness of different control measures remains uncertain. It has been reported that the 
prevalence of C. burnetii in an infected herd usually declines over time, even without 
taking any control measures. This is probably due to the ‘natural’ immunisation of 
susceptible animals (Georgiev et al., 2013). However, enough strong scientific evidence is 
still unavailable to make a final conclusion. 
Q fever is considered to be a professional hazard, therefore, vaccination is primarily 
considered for those who are professionally at risk such as livestock farmers, producers of 
animal products, veterinarians and laboratory workers (Maurin and Raoult, 1999). Three 
types of vaccines can be used for preventing Q fever in humans: the attenuated live 
vaccine, a chloroform-methanol reside extracted vaccine and other extracted vaccines and 
the whole-cell formalin-inactivated vaccine. A vaccination program for people at risk from 
chronic Q fever, such as patients with cardiac valve disease, aortic aneurisms and vascular 
prostheses was launched in the Netherlands in July 2010, which commenced in January 
2011, after the Q fever outbreak in the Netherlands had subsided (Georgiev et al., 2013; 
van der Hoek, 2012). Vaccinations have been shown to reduce abortion, shedding of C. 
burnetii and the occurrence of infection in animals (Arricau-Bouvery and Rodolakis, 2005; 
Hogerwerf et al., 2011; Kovacova and Kazar, 2002). It has been recommended that 
vaccination has to be sustained for at least several years (Astobiza et al., 2011; de Cremoux 
et al., 2012). Outbreak vaccination, i.e. vaccinating herds that are already infected 
(Astobiza et al., 2011; Guatteo et al., 2008) or otherwise under high infection pressure (de 
Cremoux et al., 2012), is less effective than regular vaccinations. Phase I vaccine is 
recommended for animals, as it is more protective than the phase II vaccine. The 
vaccination of animals was implemented during the outbreak in France during 2009; and 
in the Netherlands during 2007-2010 (Hermans et al., 2011; Rodolakis, 2009; Roest et al., 
2011b). In the Netherlands, the vaccination program was initiated in October 2008, 
through a voluntary scheme involving dairy sheep and dairy goats on farms with more than 
50 goats or sheep, petting zoos and nursing farms in a restricted high risk zone. This 
program was made mandatory in January 2010, subsequently introduced in an enlarged 
area (EFSA, 2010; Georgiev et al., 2013; Roest et al., 2011b). Nationwide mandatory 
vaccination coverage was achieved in 2011, which also included small ruminants attending 
animal shows (EFSA, 2010).  
Conclusion  
 C. burnetii is a widely distributed bacterium with zoonotic potentials. Since its first 
discovery in 1937, knowledge about this bacterium and the disease Q fever has increased 
quite a lot. However, there are still knowledge gaps which require further scientific studies. 
C. burnetii infection in domestic animals has been reported from almost all countries in 
44 
 
the world including Denmark. Despite this, very little is known about the pathogenesis of 
C. burnetii infection in domestic animals. It is also known to be a cause of reproductive 
failure in domestic animals, including cattle. However, available literature has failed to 
prove the association between infection and the reproductive failures in cattle, and this 
area demands more systematic studies. Although there is a long history of existence, the 
complete epidemiology of C. burnetii infection in cattle has not been explored sufficiently. 
In light of exploring the epidemiology, the following chapters of this thesis will discuss the 
frequencies and risk factors of C. burnetii antibody positivity in Danish cattle and the 
potential of diagnostic tests used to identify the positive animals.    
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Abstract 
A study based on bulk tank milk samples from 120 randomly selected dairy cattle 
herds was conducted to estimate the prevalence of Coxiella burnetii seropositive dairy 
herds to describe the geographical distribution, and to identify the risk factors. Using the 
CHEKIT Q-fever Antibody ELISA Test Kit (IDEXX), the study revealed a prevalence of 
79.2% seropositive herds, 18.3% seronegative herds and 2.5% serointermediate herds, 
based on the instructions provided by the manufacturer. Multifactorial logistic regression 
showed statistically significant associations (P<0.01) between C. burnetii seropositivity 
and increasing herd size (OR=1.02 per cow increment) and an increasing regional average 
number of cattle per dairy herd (OR=1.02 per animal increment). The regional average 
number of cattle herds per square kilometre was borderline significantly related to the 
occurrence of seropositive dairy herds (P=0.06). The results show an increased prevalence 
of seropositive dairy herds since the latest survey in 2008 and an adverse impact of 
increasing herd size and cattle density on the risk of seropositivity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Key words: Coxiella burnetii; seroprevalence; herd size; cattle and herd density; bulk 
tank milk. 
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Introduction 
Repeated surveys of the frequency of infectious diseases are necessary for farmers, 
agricultural organizations and veterinary services to evaluate the needs for implementing 
disease control procedures. Coxiella burnetii, an obligate intracellular bacterium and a 
zoonotic agent that may cause Q fever in animals and humans, occurs in cattle almost 
worldwide (Angelakis and Raoult, 2010; Maurin and Raoult, 1999). The prevalence of C. 
burnetii antibody positive Danish dairy herds in 2008 was 59% (Agger et al., 2010) based 
on bulk tank milk samples (BTM) from 100 randomly selected herds. Since then 
publications indicate increasing prevalence in several European countries. Thus, C. 
burnetii infection had been detected in 13 member states of the European Union in 2010 
(European Food Safety Authority (EFSA), 2012). Publications based on BTM samples 
representative of the target populations of dairy herds reported the prevalence of antibody 
positive dairy herds to be 79% in the Netherlands (Muskens et al., 2011), 38 % in the 
Republic of Ireland (Ryan et al., 2011), 65% in Northern Ireland (McCaughey et al., 2010), 
67% in Northern Spain (Astobiza et al., 2012), and 71% in Wallonia, Belgium (Czaplicki et 
al., 2009). Our objectives were therefore, in a repeated study, to estimate the prevalence of 
C. burnetii seropositive dairy herds, to describe the geographical distribution, and identify 
risk factors using the herd as the analytical unit based on BTM samples. 
Materials and methods  
In a cross sectional designed survey we randomly selected 120 dairy herds to be 
tested for the presence of C. burnetii antibodies in BTM samples. The sample size was 
calculated using the formula n=Z2pq/l2 with an assumed prevalence p=0.50 and an 
allowable error on the estimate of l=0.10 at the 95% confidence level. Although we had a 
prior knowledge of p=0.59 (Agger et al., 2010) we used p=0.50 to maximize the sample 
size. The calculated sample size was 97 herds. Taking the possibility of losing samples 
during collection and laboratory handling into account, we decided to include 120 herds. 
However, no samples were lost. The inclusion criteria were that the herd was delivering 
milk to a dairy plant at the time of selection in July 2012 and that the herd participated in a 
milk recording scheme and had all lactating cows milk yield controlled at least 11 times per 
year. All Danish herds which met the inclusion criteria were assigned a random number 
between 0 and 1 (SAS function Ranuni (0)), and the 120 herds with the lowest numbers 
were included in this study. The samples were tested at the Eurofins Steins Laboratorium 
A/S Denmark for antibodies against C. burnetii, using the commercially available CHEKIT 
Q-fever Antibody ELISA test (IDEXX, Liebefeld-Bern, Switzerland) based on C. burnetii 
inactivated phase 1 and 2 antigens following the manufacturer’s instructions. The optical 
density (OD) of each sample was corrected by subtracting the OD of the negative control. 
The results were expressed as sample-to-positive values and estimated as S/P= [(OD sample 
– OD negative control) / (OD positive control – OD negative control) X 100]. According to the 
manufacturer, S/P ≥ 40%, S/P < 30% and results in the interval 30% ≤ S/P < 40% were 
considered as positive, negative and intermediate, respectively. However, for the purpose 
of risk factor analysis in logistic regression, we dichotomised the test results as positive for 
samples with S/P≥40%, and as negative for samples with S/P<40%. Supplementary herd 
information for the year 2012 was extracted from the Danish Cattle Database. 
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The data was analysed in SAS. The prevalence of positive, negative and intermediate 
results with the confidence interval was estimated using the Proc SURVEYFREQ 
command. The Chi-square (χ2) test was used to compare the prevalence found in this study 
with the prevalence in 2008. An association between herd antibody status and herd size, 
dominant milk breed type, animal purchase, bulk tank milk somatic cell count, average fat 
and protein percentage, average milk delivery to dairy plant per cow, herd type 
(organic/conventional), regional number of cattle herds per km2 (all cattle types) and 
regional average number of cattle per dairy herd, and regional average number of cattle per 
cattle herd (all cattle types), were tested by univariable logistic regression followed by 
multivariable logistic regression with backward elimination of non-significant variables. 
Statistical significance of the covariates was assessed using the likelihood ratio test based 
on P ≤ 0.05. Collinearity among the selected variables was assessed, and variables with 
correlation coefficients |ρ| ≤ 0.5 were considered for inclusion in the final model. The 
values of Hosmer-Lemeshow goodness of fit test were used to validate the final model.  
Twenty nine of the 120 BTM samples were tested twice using two separate ELISA 
plates to validate the precision of the diagnostic test. This was evaluated in a Pearson 
correlation analysis considering S/P values as measured on a continuous scale and as a 
categorised variable (S/P≥40 as positive and S/P<40 as negative), estimating Kappa (κ) 
for the agreement between the test results and McNemar’s test.  
Results and discussion 
Descriptive analysis showed that the S/P values of the BTM samples ranged from 1 
to 293 (Figure 1). The apparent prevalence of positive, negative and intermediate herds 
was 79.2%, 18.3% and 2.5%, respectively. Table 1 represents the summary statistics for the 
three test categories. The prevalence of positive herds in the present study was significantly 
higher (P<0.01) than the estimated prevalence (59%) in the study in 2008 (Agger et al., 
2010).   
Table 1: Summary statistics of Coxiella burnetii antibody status of 120 randomly selected 
dairy herds in July 2012.  
Herd 
category 
No. of 
herds 
Apparent  prevalence 
(95% CI) 
Mean S/P  
value ± SE 
Range of  
S/P value 
Positive  95 79.17 (71.80; 86.54) 132.80 ± 5.79 44.00 – 293.00 
Negative  22 18.33 (11.31; 25.36) 6.82 ± 1.08 1.00 – 23.00 
Intermediate 3 2.50 (0.00; 5.33) 34.67 ± 1.45 32.00 – 37.00 
Herd size, average milk delivery per cow to dairy plant and regional average number 
of animals per dairy herd and regional average number of cattle per cattle herd (all cattle 
types) were all found to be significant in univariable analyses (P<0.05).  A regional number 
of cattle herds per km2 (all cattle types) was borderline significant (P=0.06). In the final 
multivariable model (Table 2), increasing herd size and increasing regional average 
number of cattle per dairy herd were significantly associated with C. burnetii 
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seropositivity. The Hosmer-Lemeshow value confirmed good fit to the data of the final 
model (P=0.74). The regional number of cattle herds per km2 (all cattle types) and the 
distribution of the sampled herds are presented in Figure 2.  
 
Figure 1: Array of antibody S/P values to Coxiella burnetii in bulk tank milk samples from 
120 randomly selected Danish Dairy herds in July 2012. 
Table 2: Multivariable logistic regression model of risk factors associated with Coxiella 
burnetii antibody status (positive or negative). 
Variables 
Odds ratio 
(95% confidence interval) 
P-value 
Herd sizea  1.02 (1.01-1.03) <0.001 
Regional average number of cattle per dairy herda 1.02 (1.00-1.03) 0.02 
a Odds ratio calculated per unit change in measurement. 
A comparison  of duplicate test results of 29 BTM samples in two separate ELISA 
plates showed a high correlation between the two test results (r2=0.96). When categorising 
the 29 duplicate tests as positive or negative, there was full agreement between the test 
results (κ =1.00 and P=1). This shows a high precision of the laboratory procedure. 
The prevalence of 79% C. burnetii seropositive Danish dairy herds in 2012 is a clear 
increase compared to the prevalence of 59% in 2008. This corresponds well to an 
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increasing trend in results from other European countries, as reviewed above and in 
reviewed literature in Agger et al. (2010).  
The cattle herd density is highest in the south western and in the north western 
areas of Denmark. These are also the areas where most of the sampled herds are located. 
However, there is no clear clustering of herd status compared to density. Garcia-Seco et al. 
(2011) did not find clustering of positive herds in a study in the Madrid region in Spain. 
However, Beaudeau et al. (2012) in a study of BTM samples from 2600 dairy herds in the 
region of western France identified some clustering, indicating a wind borne impact on the 
spread of the infection. 
Like in our study, Ryan et al. (2011) and McCaughey et al. (2010) also found a 
positive relationship between increasing herd size and test positivity in BTM samples. A 
recent Danish multilevel study with cows as the analytical unit also found an increasing 
risk of seropositive cows with increasing herd size (Paul et al., 2012). 
 
Figure 2: Regional number of cattle herds per km2 (all cattle types) and distribution of 
120 randomly selected Danish dairy herds tested for antibodies against Coxiella burnetii in 
July 2012.  
The study is based on a random sample of herds and thus, the results are considered 
valid for the current prevalence of C. burnetii seropositive dairy herds in Denmark. 
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However, the sample of 120 herds may be slightly too small for a more detailed cluster 
analysis, and that is why we have only used simple mapping of the study herds compared 
to the herd density (Figure 2).  
It is concluded that the prevalence of seropositive dairy herds has increased since 
the latest survey in 2008, and that there is an adverse impact of increasing herd size and of 
the regional average dairy herd size on the risk of a dairy herd being seropositive. 
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Abstract 
The aim was to identify risk factors associated with Coxiella burnetii antibody 
positivity in bulk tank milk (BTM) samples from 100 randomly selected Danish dairy cattle 
herds. Antibody levels were measured by an enzyme-linked immuno-sorbent assay. Before 
testing the herds, the farm managers were interviewed about hired labour, biosecurity, 
housing and herd health during the 12 months prior to the study.  Variables considered 
important for C. burnetii antibody positivity in multivariable logistic regression analysis 
included the sharing of machines between farms (OR=3.6), human contacts (OR=4.2), 
artificial insemination by other people than artificial insemination technicians (OR=7.7), 
herd health contract with the veterinarian (OR=4.3) and hygiene precautions taken by 
veterinarians (OR=5). In addition, herd size, hired labour, trading of cattle between farms, 
quarantine and use of calving and disease pens also showed significant association in 
univariable analysis. This study demonstrates that strict biosecurity is important for the 
prevention of infections with C. burnetii. 
 
 
 
 
 
 
 
 
 
 
 
 
Key words: Coxiella burnetii; cattle; risk factors; biosecurity. 
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Introduction 
Control of infectious diseases in livestock is to a great extent based on prevention of 
introducing infectious microorganisms into susceptible populations. Therefore, 
identification of risk factors plays a key role in the management of biosecurity at farm level 
and there are increasing demands on development of biosecurity plans in livestock 
production in the European Union. Herd risk factors for Q fever, a zoonotic infection 
caused by the bacterium Coxiella burnetii, have not been well studied. Although C. 
burnetii has been found almost worldwide and despite rather high prevalences in many 
cattle populations (Guatteo et al. 2011), there is still need for knowledge on how to protect 
uninfected cattle herds from becoming infected. Thus the aim of this study was to identify 
risk factors for Danish dairy cattle herds having C. burnetii antibodies in bulk tank milk 
(BTM). 
Materials and methods  
A cross sectional design was used to study 100 randomly selected dairy herds among 
the 4785 milk producing Danish dairy herds mandatorily listed in the Danish Cattle 
Database (Agger et al. 2010). Farmers of the selected herds were interviewed by telephone 
during 20-30 minutes using a standardized questionnaire with closed and semi-open-
ended questions [ANNEX]. The questions concerned the use of hired labour, the housing 
system, general health of the herd, and farm management routines generally known to be 
of importance for herd biosecurity. A BTM sample from each herd was examined for C. 
burnetii antibodies using the commercial CHEKIT Q fever Antibody ELISA test kit 
(IDEXX, Liebefeld-Bern, Switzerland). The test was based on C. burnetii inactivated phase 
1 and 2 antigens and the results were expressed as sample-to-positive values and estimated 
as S/P= [(OD sample – OD negative control) / (OD positive control – OD negative control) 
X 100]. According to the manufacturer, S/P ≥ 40%, S/P < 30% and results in the interval 
30% ≤ S/P < 40% were considered as positive, negative and intermediate respectively. 
However, in our risk factor analysis in logistic regression we dichotomized the test results 
as positive for samples with S/P≥40% and as negative for samples with S/P<40%, as 
recommended by the manufacturer. The prevalence of seropositive herds was 59 %, as 
previously reported (Agger et al. 2010). Fisher’s exact test was applied to test relationships 
between C. burnetii antibody status and all ordinal and dichotomized variables. To account 
for possible nonlinear relations, values of all continuous variables were categorized into 
biological meaningful classes when appropriate before further analysis. Variable 
associations with P ≤ 0.25 in univariable analyses were included in the following 
multivariable logistic regression. Backward elimination of nonsignificant variables 
(P>0.05) was used to select the final model, and the values of Hosmer-Lemeshow 
goodness of fit test were used to validate the models. Correlations among the exposure 
variables were checked by Spearman’s correlation test to avoid collinearity. There was no 
significant (P≤0.05) correlation and no variables were removed due to this.  
Results and discussions 
Eighteen out of 49 variables that had P ≤ 0.25 in univariable analysis were included in the 
multivariable analysis. The final logistic regression model (Table 1) showed that the risk of 
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a seropositive BTM sample increased if the herd shared equipment (machines) with other 
farms, if cattle were in contact with visitors, if artificial insemination (AI) was done by 
other people than AI technicians, if the herd had a routine herd health contract with the 
veterinarian, and if hygiene precautions (changing boots and/or clothes, etc.) were not 
taken by the veterinarian before entering the herd. The Hosmer-Lemeshow value for 
goodness-of-fit of the final model was considered acceptable (P = 0.86) (Hosmer and 
Lemeshow, 2000).  
Table 1: Multivariable logistic regression model for risk factors jointly associated with 
bulk tank milk antibody positivity to Coxiella burnetii in 100 randomly selected Danish 
dairy cattle herds collected in February 2008. 
Variables 
Respondents 
Odd Ratio  
(95% CI) 
P-value* 
Total 
No. (%) 
positive 
Sharing equipment (machines) with other herds 0.04 
Yes 23 17 (73.91) 3.62 (1.03 - 12.76)  
No 77 42 (54.55) 1  
Animals’ contact with visitors 0.01 
Yes 70 47 (79.66) 4.17 (1.41 - 12.5)  
No 30 12 (20.34) 1  
Insemination by other than artificial insemination (AI) technician 0.01 
Yes 13 12 (92.31) 7.69 (2.08 - 16.95)  
No 87 47 (54.02) 1  
Health contract with veterinarian 0.01 
Yes 56 40 (71.43) 4.32 (1.51 - 12.36)  
No 44 19 (43.18) 1  
Hygienic precautions by veterinarian before entering the herd 0.004 
No 61 40 (65.57) 5.00 (1.66 - 15.12)  
Yes 39 19 (48.72) 1  
*P-value for the significant addition of the variable given the other variables in the model. 
The final multivariable model (Table 1) primarily contains factors associated with 
introduction of infection into a herd. The factors: animal contact with human visitors from 
outside the farm, AI insemination by other people than AI technician, and herd health 
contract for routine health evaluation of the herd by the veterinarian were associated with 
increased antibody positivity (IAP). The most likely explanation is probably that such 
persons act as mechanical vectors carrying C. burnetii bacteria into the herd as stated in a 
review by Woldehiwet (2004). We found that AI done by other people than AI technicians 
increased the risk of BTM antibody positivity. Danish farmers who want to perform AI on 
their own cattle need authorization based on a course offered by the AI associations and 
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semen is provided by AI associations. So the finding is difficult to explain; also because 
consequent reduced access of AI technicians to the herd should probably have lowered the 
risk. Farms with a routine herd health contract with a veterinarian had higher OR of being 
antibody positive than farms without such a contract thus suggesting that the veterinarian 
might bring the bacterium into the farm. Hygiene precautions taken by veterinarian, i.e. 
changing boots and/or clothes were found significantly to reduce the risk of IAP. In a 
multilevel analysis of data from the same study, but with cow as the analytical unit, we also 
found that the hygienic precautions reduced the risk of antibody positivity (Paul et al., 
2012). The similarity in results between cow and herd level analysis corresponds with our 
estimation of correlation between BTM antibody level and the within herd seroprevalence 
(R2= 0.36; P<0.001) in a previous study (Angen et al., 2011) of a subsample of 12 of the 
same herds as in the present study. However, Taurel et al. (2012) only found a moderate 
correlation (R2=0.15) between BTM antibody level and within herd seroprevalence. In the 
present study we also observed that sharing farm equipment (machines) with other farms 
was significantly associated with IAP. Although our study indicates the importance of 
hygienic precautions in relation to personnel and equipment, Taurel et al. (2011) did not 
find such associations in French dairy cattle.  
Herd size, stable type, number of workers, use of calving and disease pens, 
purchasing animals, and quarantine practice were also found to have positive associations 
with IAP in univariable analysis (results not shown). Other studies have also shown 
relationship between IAP and increasing herd size (McCaughey et al. 2010; Paul et al., 
2012), and between IAP and loose housing system (Czaplicki et al., 2012; Paul et al., 2012) 
although a single study did not find relationship between IAP and housing system 
(Capuano et al., 2001). The hypothesis behind IAP and loose housing systems is that 
random movements of animals increase the probability of contact between infected and 
non-infected and increased contact with a contaminated environment and hence increased 
risk of transmission.  
Selection bias in this study was minimized by random sampling and selection bias 
due to non-participation was considered negligible. Misclassification bias may result from 
unknown sensitivity and specificity of the ELISA used. However, the ELISA test for C. 
burnetii antibodies based on individual animal samples shows high sensitivity (Se=0.86) 
and specificity (Sp=0.99) (Paul et al., 2013). 
In this study the following risk factors were found to be associated with increased risk 
of BTM antibody positivity: Herd size > 100 cows, increased number of people managing 
the animals; housing systems with cubicle house and deep bed house compared to tie stall 
house, use of calving and disease pens, purchase of animals, lack of quarantine of 
purchased animals, contact with farm personnel and visitors, herd health contract with the 
veterinarian, lack of basic hygienic precautions taken by veterinarian and sharing of 
machines. Proper management by farmers may help prevent the introduction of   C. 
burnetii into a herd. 
List of abbreviations 
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Abstract  
The aim of the study was to identify associations between the level of Coxiella 
burnetii (C. burnetii) antibodies in individual milk samples and cow and herd level factors 
in Danish dairy cows. The study, designed as a prospective cross sectional study with 
follow up, included 24 herds identified by a stratified random sampling procedure 
according to the level of C. burnetii antibodies in one bulk tank milk (BTM) sample at the 
beginning of the study. Ten herds were BTM positive, ten herds were BTM negative and 
four herds had an intermediate level. The samples were tested with an ELISA and results 
determined as S/P (sample to positive control) values. Three cross sectional studies of all 
lactating cows within each herd were then conducted during an 11 month follow up period 
with collection of a total of 5829 milk samples from 3116 cows. Each sample was tested 
with the same ELISA as used for BTM testing, and cows were considered test positive for 
S/P values ≥40, and otherwise negative. Individual cow information was extracted from 
the Danish Cattle Database and herd information was obtained from a telephone interview 
with each farmer. From multivariable logistic regression analysis accounting for 
hierarchical structures in the data it was concluded that odds for seropositivity increased 
with Danish Holstein breed, increasing number of parity and high milk protein contents, 
but decreased with increasing milk yield and high milk fat contents. Cows were at a higher 
risk during summer than other seasons. Among the herd level factors, herd size, tie stall 
housing system, quarantine of newly purchased animals and good hygienic precautions 
taken by the veterinarian before entering into the stable were also significantly associated 
with reduced odds of C. burnetii antibody positivity. The prevalence of test positive cows 
was almost constant during the study period in herds which were initially BTM positive 
and BTM intermediate, whilst the prevalence of positive cows in a few of the initial BTM 
negative herds changed from almost zero to higher than 60%. This indicates that herd 
infections last quite long and that test negative herds may convert to positive due to a few 
latently infected cows or due to transmissions from other herds.  
 
 
 
 
 
 
 
Key words: Coxiella burnetii; dairy cattle; ELISA; factors; epidemiology. 
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Introduction 
Coxiella burnetii (C. burnetii), the causative agent of Q fever, is an obligate, 
intracellular, pleomorphic bacterium (Maurin and Raoult, 1999; Arricau-Bouvery and 
Rodolakis, 2005). It was first identified in 1937 in Australia (Derrick, 1937) and since then 
it has been reported as an endemic infection throughout the world except for New Zealand 
(Maurin and Raoult, 1999). Q fever is a zoonosis, and domestic ruminants such as cattle, 
sheep, and goats are considered the primary source of human infections (Maurin and 
Raoult, 1999; Angelakis and Raoult, 2010). Sixty percent of human cases are asymptomatic 
and if clinical disease develops it may progress from an acute to a chronic stage (Raoult et 
al., 2000). Infection in dairy cows mostly remains clinically unrecognized (Rodolakis, 
2009). Infection in cattle has a long persistence (Lang, 1990) and infected cattle shed large 
amounts of bacteria via birth fluids and placenta during parturition (Rodolakis et al. 
2007). Other common routes of bacterial shedding are milk (Willems et al., 1994), faeces 
(Guatteo et al., 2006), and urine (Heinzen et al., 1999). Infected cattle may shed bacteria 
via milk for a longer period (Rodolakis et al. 2007). 
Several studies have shown that the risk of C. burnetii infection in ruminants varies 
with individual animal traits such as age and parity, breed, gender, level of milk production 
and lactation stage (McCaughey et al., 2010; Garcia-Ispierto et al., 2011), and also with 
season (Yanase et al., 1997; Cantas et al., 2011). Herd related factors such as herd size, 
housing type and grazing practice can also act as contributing factors (Capuano et al., 
2001; McCaughey et al., 2010; Ruiz-Fons et al., 2010; Ryan et al., 2011; Taurel et al., 2011). 
In recent years a high prevalence of C. burnetii exposure has been reported in 
humans and domesticated animals in several European countries (Gilsdorf et al., 2008; 
McCaughey et al., 2010; Guatteo et al., 2011). Also in Denmark, an increasing number of Q 
fever cases has been reported in humans (Villumsen et al., 2009), and Agger et al. (2010) 
reported a high seroprevalence (59%) in BTM samples from 100 randomly selected Danish 
dairy cattle herds.  
This study aimed at identifying associations between the level of C. burnetii 
antibodies in individual cow milk samples and cow-level and herd-level explanatory 
factors. 
Materials and methods 
Recruitment of study units and detection of antibodies 
The study included 3116 lactating cows as study units from 24 dairy herds selected 
as explained in the following text. Initially 100 dairy herds were randomly selected from 
the Danish Cattle Database to estimate the prevalence of C. burnetii antibody positive 
herds based on one BTM sample (Agger et al., 2010). Milk samples were tested for the level 
of C. burnetii antibodies using the CHEKIT Q fever Antibody ELISA test kit (IDEXX, 
Liebefeld-Bern, Switzerland) based on C. burnetii inactivated phase 1 and phase 2 
antigens. All samples were tested in duplicates and the optical densities (OD) of the 
samples were averaged. The results were expressed as S/P (sample to positive control) 
values calculated using the following equation:  
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                                (1)           
The herds were classified according to the S/P level of antibodies into positive, 
intermediate and negative strata (see Figure 1). Following this initial study, ten BTM 
positive, ten BTM negative and four BTM intermediate herds from the three strata were 
randomly selected for a prospective cross sectional study with follow up. Thus, the 
sampling procedure was random, but the sample size was according to the economic 
conditions in the project. One goal was to contrast bulk tank milk positive and negative 
herds; however, the “intermediate” herds were included in the study due to suspected 
infection dynamics taking place. A total of 5829 individual cow milk samples from 3116 
lactating cows in the 24 herds were collected at three time points during a period of 11 
months from August 2008 to June 2009. All lactating cows in each herd were thus 
sampled one or two or three times at an interval of three to seven months. All samples 
were tested for the level of C. burnetii antibodies by the same ELISA test as used for BTM 
samples. The same milk samples were also tested for fat and protein contents and somatic 
cell count (SCC).  
 
Figure 1: Diagram of design and data collection of a prospective cross sectional study with 
follow-up of associations between Coxiella burnetii antibody positivity and cow and herd 
level factors conducted from August 2008 to June 2009 involving 3116 cows from 24 
Danish dairy herds. * S/P = level of antibodies in the sample.  
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Data collection and management 
The study was based on data from interview with the farmers and on individual cow 
data from the Danish Cattle Database. The 100 farmers including the 24 farmers in the 
present study were telephone interviewed using a structured questionnaire. They were 
asked about labor, stable type, use of maternity and disease pens, animal’s contact with 
other animals or humans, grazing practice, purchasing behaviour, quarantine of newly 
purchased animals, other biosecurity related factors like hygienic precautions taken by the 
herd veterinarian, the inseminator, the truck driver, visitors before entering the stable, use 
of foot bath and herd health during the 12 months prior to BTM sampling.  
Individual cow information extracted from the Danish Cattle Database included 
records of reproductive, gastrointestinal, respiratory, udder and leg diseases treated by 
veterinarians. Some of the cow level variables were calculated using the information 
extracted from the cattle database. For example variable ‘days in milk’ was calculated by 
subtracting the date of last calving from the date of sample collection and the variable ‘days 
in cow barn’ was calculated by subtracting the date of first calving from the sampling date. 
Disease records were restricted to a three-month period around each sampling date i.e. 
from 45 days prior to the sampling date and until 45 days after the sampling date. If a cow, 
for example, was treated for any reproductive problem within 45 days before or after the 
sampling date, then the cow was considered to have a reproductive problem.  
Statistical analysis 
At the cow level a milk sample with S/P value ≥ 40 was considered positive, and 
otherwise negative. Descriptive analyses of the qualitative and quantitative explanatory 
variables were performed to explore the distribution in relation to the dependent variable. 
When appropriate, continuous variables were categorized in order to account for possible 
nonlinear relations. Correlation among the explanatory variables was checked for 
multicollinearity and only one variable from each correlated group was used in the 
multivariable analysis. Univariable and multivariable logistic regression analyses were 
performed for quantifying the associations of explanatory variables with the dichotomous 
response variable using proc GLIMMIX in SAS 9.2. Hierarchical structure of the data was 
accounted for in the logistic regression analyses where ‘herd’ and ‘cow’ were used as 
random effects. Explanatory variables with p-values ≤ 0.25 in univariable logistic 
regression analyses were used in the multivariable model. Based on this criterion 11 cow 
level and 11 herd level variables were selected for further analyses. In multivariable 
analysis, a backward elimination procedure was used. All biologically meaningful 
interactions were also checked. The statistical significance of the explanatory variables was 
assessed by the likelihood ratio test and an explanatory variable with p-value ≤ 0.05 was 
considered to be statistically significant. The predictive ability of the final model was 
evaluated by the receiver operating characteristics (ROC) curve and area under the curve 
(AUC). Intra-class correlation coefficients (ICC) were determined to estimate the 
proportion of the variation explained by cows and herds. The stratum specific prevalences 
of C. burnetii seropositive cows were estimated for the three sampling time points. 
Differences in the cow level prevalence according to the time and stratum were assessed 
using a chi-square test. 
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Results 
Estimation of associations 
The results of the univariable logistic regression analysis with random effect of herd 
and cow are shown in Tables 1 and 2, respectively. The intrinsic factors breed, age in years, 
days in milk, milk yield, and number of days a cow had stayed in the cow barn were 
significantly associated with the level of C. burnetii antibodies in milk (Table 1). The odds 
of being positive were higher in Danish Holstein cows and in cows from “other breeds” 
(pooled breed group) compared to Jersey cows. ORs also increased with increasing days in 
milk. We found a negative association with milk yield and a positive association of 
seropositivity with udder problems (treatment for any problem in the udder for example 
mastitis and udder edema). There were no significant associations with other recorded 
diseases. Cows had higher odds in summer and in winter compared to autumn. Herd level 
factors, initial BTM antibody status, herd size, type of stable, use of maternity pen, contact 
with hoof trimmer, and hygienic precautions taken by the veterinarian before entering the 
stable were also significantly associated with the level of antibodies in milk in the 
univariable analyses (Table 2).  
Table 1: Univariable logistic regression analysis of associations between Coxiella burnetii antibody positivity 
in cow milk samples and cow level factors adjusted for random effects of cow and herd in a prospective cross 
sectional study with follow-up conducted from August 2008 to June 2009 involving 3116 cows from 24 
Danish dairy herds. 
Variables 
No. (%) of 
observations 
(n=5829) 
No. (%) of (+)ve 
observations 
(n=1239) 
Odds ratio 
(95% CI)** 
P*** 
Breed    <0.01 
Danish Holstein 3509 (60.10) 864 (69.73) 2.83 (1.98 - 4.04)   
Other 604 (10.36) 92 (7.43) 2.40 (1.57 - 3.66)  
Jersey 1716 (29.44) 283 (22.84) 1   
Age (year)*   1.10 (1.05 - 1.15) <0.01 
Parity    0.20 
≥ 4 955 (16.41) 222 (17.93) 1.25 (1.01 - 1.56)   
3 918 (15.77) 203 (16.40) 1.14 (0.92 - 1.39)   
2 1581 (27.16) 325 (26.25) 1.04 (0.88 - 1.22)   
1 2367 (40.66) 488 (39.42) 1   
Days in milk †   1.03 (1.01 - 1.04) <0.01 
Milk yield (kg)*   0.99 (0.98 - 1.00) 0.04 
Fat content (%)*   0.97 (0.92 - 1.02) 0.25 
Protein content (%)*   1.07 (0.98 - 1.16) 0.14 
Days in cow barn†   1.01 (1.00 - 1.01) <0.01 
Leg problems      0.07 
Yes 147 (2.52) 49 (3.95) 1.35 (0.97 - 1.88)  
No 5682 (97.48) 1190 (96.05) 1   
Udder problems     0.05 
Yes 638 (10.95) 164 (13.24) 1.20 (1.00 - 1.44)  
No 5191 (89.05) 1075 (86.76) 1   
Season    <0.01 
Summer 2217 (38.03) 504 (40.68) 1.45 (1.25 - 1.69)  
Winter 2199 (37.73) 456 (36.80) 1.24 (1.06 - 1.44)   
Autumn  1413 (24.24) 279 (22.52) 1   
†Odds ratio calculated per 30 days change in measurement  
*Odds ratio calculated per unit change in measurement 
**CI, confidence interval 
***Variables significant at p ≤ 0.25 were included in the table 
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Table 2: Univariable logistic regression analysis of associations between Coxiella burnetii antibody 
positivity in cow milk samples and herd level factors adjusted for random effects of cow and herd in a 
prospective cross sectional study with follow-up conducted from August 2008 to June 2009 involving 3116 
cows from 24 Danish dairy herds. 
Variables 
No. of 
herds 
No. (%) of 
observations 
(n=5829) 
No. (%) of (+)ve 
observations 
(n=1239) 
Odds ratio 
(95% CI)** 
P*** 
Initial bulk tank milk antibody status   0.02 
Positive 10 3584 (61.49) 861 (69.49) 10.00 (1.82 - 55.02)  
Intermediate 4 707 (12.13) 167 (13.48) 10.90 (1.22 - 97.12)  
Negative 10 1538 (26.39 211 (17.03) 1  
Herd size†    2.17 (1.19 - 3.99)  0.01 
Type of stable       0.01 
Loose housing 13 4328 (74.25) 1144 (92.33) 7.33 (1.69 - 31.88)   
Tie stall 11 1501 (25.75) 95 (7.67) 1   
Use of maternity pen       0.05 
Yes  17 4929 (84.56) 1197 (96.61)  6.00 (1.03 - 35.03)   
No  7 900 (15.44) 42 (3.39) 1   
Sharing of machine     0.14 
Yes  10 2209 (37.90) 430 (34.71) 3.28 (0.65 -16.49)   
No  14 3620 (62.10) 809 (65.29) 1   
Purchase animal     0.20 
Yes  18 4385 (75.23) 1035 (83.54) 3.36 (0.50 - 22.72)  
No  6 1444 (24.77) 204 (16.46) 1  
Visitors forbidden to enter the stable   0.10 
No  22 5169 (88.38) 1226 (98.95) 7.43 (0.67 - 82.37)  
Yes  2 660 (11.32) 13 (1.05) 1  
Quarantine of newly purchased animals   0.10 
No 15 3519 (60.37) 961 (77.56) 3.89 (0.77 - 19.73)   
Yes 9 2310 (39.63) 278 (22.44) 1  
Contact with professional hoof trimmer    0.03 
Yes  15 3842 (65.91) 1041 (84.02) 5.38 (1.14 - 25.37)   
No  9 1987 (34.09) 198 (15.98) 1   
Contact with visitors      0.13 
Yes 17 4466 (76.62) 1135 (91.61) 3.73 (0.67 - 20.74)   
No 7 1363 (23.38) 104 (8.39) 1   
Hygienic precautions by veterinarian   0.04 
No 18 4175 (71.62) 1020 (82.32) 7.00 (1.07 - 45.80)   
Yes 6 1654 (28.38) 219 (17.68) 1   
†Odds ratio calculated per 50 units change in measurement  
*Odds ratio calculated per unit change in measurement 
**CI, confidence interval 
***Variables significant at p ≤ 0.25 were included in the table 
The results of the multivariable logistic regression analysis accounting for random 
effect of herd and of cow are shown in Table 3. Ten variables remained in the final model: 
1) breed, 2) parity, 3) milk yield, 4) protein content, 5) fat content, 6) season, 7) herd size, 
8) types of stable, 9) quarantine, and 10) hygienic precautions taken by the veterinarian 
before entering the stable. A ROC curve with AUC as an indication of the predictive 
performance of the final model illustrated that the predictive ability of this model to be 
0.79 (AUC=0.79). In the final model, 53% of the total variation was explained by variation 
between the herds (ICCherd=0.53) and 20% of the total variation was due to the variation 
between the cows (ICCcow=0.20).  
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identify an association between SCC and level of C. burnetii antibodies whereas Barlow et 
al. (2008) demonstrated a positive association between SCC and C. burnetii infection 
(detected by PCR) in a multivariable generalized linear model. These variations may not 
only be due to the different outcome variables modeled but also the different modeling 
approaches used. In the multivariable model we also did not find any association between 
reproductive problems and C. burnetii seropositivity in cows in contrast to the 
observations by Bildfell et al. (2000) and Khalili et al. (2011). However, these two studies 
only used univariable analysis and thus did not adjust for covariates. 
Table 3: Results of the multivariable logistic regression analysis of cow and herd level 
factors associated with Coxiella burnetii antibody positivity in cow milk samples 
accounting for random effects of herd and of cow in a prospective cross sectional study 
with follow-up conducted from August 2008 to June 2009 involving 3116 cows from 24 
Danish dairy herds. 
Variables Odds Ratio (95% CI)** P 
Cow level factors 
Breed  <0.01 
Danish Holstein 3.21 (2.17 - 4.74)  
Other 2.92 (1.86 - 4.58)  
Jersey 1  
Parity  0.02 
≥ 4 1.40 (1.11 - 1.77)  
3 1.27 (1.02 - 1.58)  
2 1.08 (0.90 - 1.29)  
1   
Milk yield (kg)† 0.98 (0.97 - 0.99) <0.01 
Fat content (%)† 0.88 (0.79 - 0.98) 0.02 
Protein content (%)† 1.43 (1.22 - 1.69) <0.01 
Season  <0.01 
Summer  1.55 (1.31 - 1.82)  
Winter  1.27 (1.08 - 1.50)  
Autumn  1  
Herd level factors 
Herd size* 1.75 (1.03 - 3.00) 0.04 
Type of stable   
Loose 4.22 (1.08 - 16.57) 0.03 
Tie stall 1  
Quarantine of newly purchased animals  0.02 
No 3.75 (1.19 - 11.86)  
Yes 1  
Hygienic precautions taken by veterinarian <0.01 
No 8.91 (2.00 - 22.23)  
Yes 1  
†Odds ratio calculated per unit change in measurement  
*Odds ratio calculated per 50 units change in measurement 
**CI, confidence interval 
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This study demonstrates that the risk of a cow being antibody positive varied among 
breeds with a higher risk in Danish Holstein cows than Jersey cows. Our findings agree 
with a previous study in Northern Ireland (McCaughey et al., 2010). However, the reason 
for this apparent variation in breed susceptibility is unknown. Genotypic variation among 
the breeds is a possible explanation which needs to be investigated in depth to resolve this 
question. 
The significant positive associations between the level of C. burnetii antibodies and 
the time duration of a possible exposure to C. burnetii were revealed by several time 
measurements such as cow age, parity and number of days a cow had stayed in the cow 
barn. Due to multicollinearity only the variable ‘parity’ was used in the multivariable 
model. Older cows had stayed in the cow barn for longer time than young animals. Hence 
the probability of being exposed to the bacterium, if present, increases with exposure time 
and therefore, it is not surprising that the C. burnetii antibody positivity increases with 
age. This result is in agreement with previous studies by McCaughey et al. (2010), Bottcher 
et al. (2011) and Garcia-Ispierto et al. (2011).  
This study revealed that seropositivity decreased with increasing milk yield contrary 
to findings of Garcia-Ispierto et al. (2011). We found a positive association of C. burnetii 
antibody positivity with increasing days in milk. A high positive correlation between the C. 
burnetii infection status and cow days in milk was also reported by Barlow et al. (2008). 
However, this finding did not correspond to the findings of Rodolakis et al. (2007). The 
question which remained unanswered was whether this positive relation was due to the 
cows spending more time in cow barn and thus being more exposed to the bacterium or 
whether there was any immunogenic change during a lactation period which caused an 
increase in the antibody titre in milk. In the multivariable model we found that positivity 
increased with increasing level of milk raw protein content also including the 
immunoglobulins and with decreasing milk raw fat contents. The finding of a positive 
association with milk protein contents contradicted the findings of a previous study (Rose 
et al., 1994); however, it was unclear whether that study included measurement of 
immunoglobulins.  
The present study demonstrated a seasonal variation in the occurrence of C. 
burnetii infection in Danish dairy cows with a higher risk in the summer. Seasonality in the 
occurrence of C. burnetii infection has been reported in cattle in Cyprus and Japan (Yanase 
et al., 1997; Cantas et al., 2011). Seasonal variation in occurrence of Q fever in humans has 
been reported by several authors. In most of the studies incidence was higher in spring and 
early summer (Tissot-Dupont et al., 1999; Hellenbrand et al., 2001). 
In the present study seropositivity increased with increasing herd size. The positive 
association of herd size with C. burnetii infection in cattle was also reported by McCaughey 
et al. (2010) and Ryan et al. (2011). This observation may be explained by increased 
transmission probability with increasing number of cows in a herd. We also found that 
cows in loose housing systems had higher probability of being positive than cows housed in 
tie stall system. Loose housing system probably gives more random contact between 
uninfected and infected animals. Hence, risk of transmission probably increased in loose 
housing systems. It might also be due to indirect transmission from random 
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contamination and contact with the barn environment. Variation in the occurrence of C. 
burnetii infection in cattle among different housing types was also reported by Capuano et 
al. (2001).  
Seropositivity in cows seemed to be lower in herds i) where quarantine was 
practiced for newly purchased animals, and ii) where veterinarians took adequate hygienic 
precautions (washing hands and changing cloths and boots before entering the barn). In 
addition, risk of being seropositive was found to be higher in cows from herds i) where 
cows came into contact with professional hoof trimmers and ii) where a maternity pen was 
used during parturition in univariable analyses. A recent study reported that purchase of 
animals increased the risk of introducing C. burnetii infection into cattle herds (EFSA 
Panel on Animal Health and Welfare (AHAW), 2010). This finding correlated with the 
biological assumption and stressed the importance of quarantine practice. Herd 
veterinarians and professional hoof trimmers might act as mechanical carriers and transfer 
the pathogen from infected to non-infected herds. This assumption was supported by a 
review article by Woldehiwet (2004) suggesting that farm personnel often act as 
mechanical transmitters of contaminated fomites from an infected herd to uninfected 
ones. Previous studies reported that risk of shedding C. burnetii bacteria increased during 
the calving period (To et al., 1998; Tissot-Dupont et al., 1999), with a consequent 
contamination of the calving area, e.g. the maternity pen. The infection might be 
transmited to subsequent pregnant cows sharing the same maternity pen at parturition.  
In our modelling approach we found significant clustering effects of herd and of 
cow. The final model (Table 3) showed a significant discriminatory ability (AUC=0.79) to 
classify seropositive and seronegative cows correctly. Our study included a relatively large 
number of cows and we selected most of the explanatory variables carefully assuming their 
plausible association with C. burnetii infection in cattle. The reason for including fat and 
protein contents in the analyses is that we used the milk yield without adjustment for 
energy. In the final multivariable model (Table 3) the inclusion of fat content only changed 
the estimates five percent for breed, and thus, not indicating a confounding effect of breed. 
In this study, 24 herds were selected following a stratified random sampling approach 
from 100 randomly selected herds for a prevalence study. All lactating cows within the 
selected herds were included. Thus, the study sample of 3116 cows represented 0.6 percent 
of the population of 560000 dairy cows. Post study sample size calculations for prevalence 
estimation (prevalence=0.20 ; allowable error=0.05) revealed the need of 255 cows, and 
the necessary sample size for a relative risk of 1.5 for infection in Holsteins versus Jersey 
cows (see data in Table 1) is 392 cows in each group. We met these requirements in the 
study. We therefore believe that the sample was sufficiently big and, due to random 
sampling, also representative of the population and without selection bias.  
Our estimates of stratum specific (BTM antibody level) cow seroprevalences showed 
no significant changes across the time in herds which were initially BTM positive and BTM 
intermediate (Figure 2). Based on this finding we might conclude that if introduced once, 
C. burnetii infection can remain within a population for a long time i.e. at least for 11 
months. Long persistence of C. burnetii infection in animals was also reported by Lang 
(1990). A significant increase in cow prevalence was observed in herds which were initially 
BTM negative. However, a careful evaluation showed that an increased cow prevalence was 
only seen in two of the ten initially negative herds, with an increase from almost zero to 
 89 
 
about 60% during the study period (data not shown). Beyond the identified risk factors we 
could not explain this sudden change in prevalence. 
The diagnostic test might introduce missclassification bias as it is neither 100% 
sensitive nor 100% specific. Horigan et al. (2011) reported high sensitivity (81.3%) and 
specificity (93.9%) of ELISA in cattle and the test has recently been used widely for the 
diagnosis of C. burnetii infection in cattle (Guatteo et al., 2011). Animal level information is 
recorded and updated routinely in the Danish Cattle Database. Disease information is 
dependent on a mandatory reporting after each visit by the herd veterinarian, which might 
introduce misclassification bias. We followed a standardized questionnaire at the 
telephone interviews with the farmers by reading the questions exactly as stated in the 
questionnaire in order to reduce misclassification, although recall bias due to farmers’ lack 
of memory can not be ruled out. However, the procedure followed is standard in veterinary 
epidemiological studies. The quality of questionnaire data was validated on only one 
parameter, namely by comparing farmers’ statements about purchase of animals with the 
information in the Danish Cattle Database. There was complete agreement on that 
variable. 
Conclusion 
The individual animal factors like breed, days in cow barn, milk yield, milk protein 
contents, and the herd level factors like herd size, stable type, use of maternity pen, 
biosecurity related factors and season were found to have significant associations with the 
level of C. burnetii antibodies in cow milk samples. Infection with C. burnetii in herds may 
last quite long and seroconversion of BTM antibody status may occur due to the presence 
of a few latently infected cows or due to transmission from other herds. The results are 
important epidemiological contributions to our knowledge of the presence of C. burnetii 
antibodies.  
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Abstract  
Serological tests for Coxiella burnetii (the causative agent of Q fever) antibodies are 
usually based on enzyme linked immunosorbent assay (ELISA) although this method is 
not thoroughly evaluated. The objective of this study was to determine the sensitivity and 
specificity of an ELISA for detection of C. burnetii antibodies in milk and blood samples, 
using latent class models in a Bayesian analysis. Blood and milk samples of 568 lactating 
cows from 17 Danish dairy cattle herds collected in 2008 were used. 
The best combination of sensitivity and specificity estimates was revealed at a sample 
to positive (S/P) cut-off of 40 for both blood and milk ELISAs. At this cut-off, sensitivity of 
milk ELISA was 0.86 (95% posterior credibility interval [PCI] [0.76; 0.96]). This was 
slightly but insignificantly higher than sensitivity of blood ELISA (0.84; 95% PCI [0.75; 
0.93]). The specificity estimates of the ELISA methods on milk and blood were equal to 
0.99. No conditional dependence was observed between the specificity estimates of the two 
test methods. However, the sensitivity estimates of both tests were significantly reduced 
when conditional covariances ≥ 40 were used. Collection of milk samples from lactating 
cows is relatively easy, non-invasive and inexpensive and hence milk ELISA may be a 
better option for screening lactating cows. But, blood ELISA is an option for screening 
non-lactating cattle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key words: Coxiella burnetii; ELISA; sensitivity and specificity; conditional 
dependence; Bayesian analysis; cattle. 
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Introduction 
Diagnosis of Coxiella burnetii infection (Q fever) in animals depends on detection of 
bacteria, bacterial components or antibodies (Bouvery et al., 2003; Fournier et al., 1998; 
Rodolakis, 2006). Detection of bacteria can be done by culturing, but usually detection of 
bacterial components, e.g. by PCR is used (Rodolakis, 2006). Although PCR is often 
considered the most appropriate technique for C. burnetii detection, it is an expensive and 
time consuming procedure and it depends on the actual presence of bacterial DNA 
(Rousset et al., 2010). Therefore, cheap and fast serological techniques are still widely used 
as screening tests and in large scale epidemiological studies. However, serological tests can 
only identify the antibody response to infection. CFT and ELISA are the two most 
commonly used serological techniques for screening in animals for C. burnetii exposure 
(Rousset et al., 2010). Nowadays, ELISA is becoming more popular than CFT for its better 
reliability and handiness (Rousset et al., 2010) and a recommended test for Q fever 
diagnosis in the European Union (EFSA Panel on Animal Health and Welfare (AHAW), 
2010). ELISA can be used to detect antibodies both in milk and in blood samples. In recent 
years, milk analyses have been widely used in epidemiological studies involving dairy cattle 
since they have some advantages over blood analyses. Milk samples are easier and less 
expensive to collect, and non-invasive and hence minimize stress to the cow. However, 
blood ELISA is still necessary for the studies involving non-lactating cattle. 
The performance of a diagnostic serological test can be evaluated against a perfect 
test with 100% sensitivity and 100% specificity (gold standard). However, none of the 
existing C. burnetii serological tests are perfect, as also known for diagnostic tests of most 
other infections (Rousset et al., 2010). Performance of the C. burnetii antibody ELISA has 
been evaluated in few studies based on the performance of CFT, which gave relative 
estimates of sensitivity and specificity (Emery et al., 2012; Kittelberger et al., 2009). In 
situations where the case definition is determined by an imperfect reference test, selection 
bias and/or misclassification bias might be introduced (Nielsen and Toft, 2002). In a 
situation where a reference test is unavailable, latent class analysis (LCA) is an alternative 
option for estimating sensitivity and specificity of two or more tests without assuming the 
underlying true antibody status of test subjects, which eliminates the chance of selection 
bias in the estimates. LCA can be done either by fitting the model using maximum 
likelihood procedures or by Bayesian analysis (Enøe et al., 2000). In LCA, three 
assumptions known as the Hui-Walter paradigm are generally made: (1) at least two 
populations with different prevalences are required, (2) the sensitivity and specificity of 
the tests do not differ across the populations, and (3) the tests under evaluation are 
conditionally independent given the disease status (Hui and Walter, 1980). However, 
especially for the tests based on the same biological principle, in our case detection of 
antibodies, the assumption about conditional independence given disease status can be 
questioned. In a recent study the performance of CFT and three commercially available 
ELISAs were evaluated in a LCA framework by fitting the model using maximum 
likelihood estimation (Horigan et al., 2011). In that study all the tests were assumed to be 
conditionally independent. This assumption of conditional independence influences the 
test properties. If a positive correlation between the tests under evaluation is ignored it will 
lead to overestimation of the test performance, while ignorance of a negative correlation 
will cause underestimation of the test performance (Vacek, 1985).  
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The objective of this study was to estimate the sensitivity and specificity of milk 
ELISA and blood ELISA for detection of C. burnetii antibodies accounting for the 
conditional dependence between the two test methods, using latent class models in a 
Bayesian analysis in a population of spontaneously infected cows from selected Danish 
dairy cattle herds. 
Materials and methods 
Sample collection and population stratification 
The data included 568 lactating cows from 17 Danish dairy cattle herds. The herds 
were recruited from 100 dairy herds that were randomly selected among 4785 milk 
delivering herds in the spring 2008 and examined for the level of C. burnetii antibodies in 
a bulk tank milk (BTM) sample (Agger et al., 2010). The 100 herds were stratified into 
positive, negative and intermediate herds based on the level of C. burnetii antibodies 
(expressed as S/P value) in a single BTM sample. Based on the cut-off recommended by 
the manufacturer, a herd with S/P ≥ 40 was considered positive and a herd with S/P < 30 
was negative, whereas a herd with S/P 30-39 was classified as intermediate. Following this 
initial study, eight positive, six negative and three intermediate herds were selected by 
systematic random sampling within the three strata. These three groups were used to form 
the subpopulations with assumed differences in animal-level prevalences. Milk of all 
lactating cows within the selected herds were sampled. However, only 568 of these were 
blood sampled due to the economics of the project. Only cows with both sample types were 
included in this study, i.e. 568 cows. The cows to be blood sampled were selected by a 
within herd systematic random sampling procedure. Milk sampling was done by the 
farmers as part of the milk control scheme and the blood samples were taken by the herd 
veterinarians. The time interval between the milk and blood sampling was minimized and 
ranged from zero to three days with median one. All samples were collected between 
August 2008 and October 2008 and sent to the National Veterinary Institute, Technical 
University of Denmark maintaining standard cool chain and tested by ELISA according to 
instructions by the test kit manufacturer.  
Diagnostic tests  
Milk ELISA 
 Ten milliliter milk from each cow was collected for testing. The fat fraction was 
removed from the milk by centrifugation and the non-fat fraction was stored at -20o C until 
tested for antibodies against C. burnetii using the commercial CHEKIT Q-Fever Antibody 
ELISA Test Kit (IDEXX, Liebefeld-Bern, Switzerland) based on C. burnetii inactivated 
phase 1 and phase 2 antigens. All samples were tested in duplicates and the optical 
densities (OD) of the samples were averaged and corrected by subtracting the OD of the 
negative control. The results were expressed as S/P values and estimated using the 
equation recommended by the manufacturer (Agger et al. 2010; Paul et al. 2012). The S/P 
values were estimated on a continuous scale with a theoretical range from zero to “plus 
infinity”. The manufacturer of the test kit recommends a S/P cut-off ≥ 40 for classifying 
test subjects as positive. At this cut-off we considered a sample with S/P <40 as negative. 
However, according to our study objective we investigated the test results according to 
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three different S/P cut-offs where S/P values ≥30, ≥40 and ≥50, respectively were 
considered as test positive, and S/P values <30, <40 and <50 were considered test 
negative, respectively.  
Blood ELISA  
Five to eight milliliter blood from each selected cow was collected. Upon arrival at 
the laboratory, samples were centrifuged at 3000 x g for 10 minutes for serum separation. 
Sera were stored at 50 C and tested for antibodies against C. burnetii. The same ELISA kit 
and laboratory procedure was used for milk and blood samples and the results were 
expressed as S/P values with cut-off values as mentioned above.  
Target condition 
The target condition of this analysis was considered to be cows that had humoral 
antibodies to C. burnetii, i.e. had an immunological response. This implies an underlying 
latent condition, where antibodies are present in the cow although not necessarily at a 
detectable level in either blood or milk.  
Statistical model 
Initially we estimated the sensitivity and specificity of milk and blood ELISAs using a 
LCA using a conditionally independent model (CID model) (Branscum et al., 2005; Mweu 
et al., 2012; Toft et al., 2007a). We assumed that the within herd true prevalence of C. 
burnetii antibody positivity differed across the three populations. Additionally, the 
sensitivity and specificity of each of the two diagnostic tests were modeled to be constant 
across the populations. This model yields nine degrees of freedom (three from each 
population) which are sufficient to estimate seven parameters (sensitivity and specificity of 
each test and prevalences of three populations). A Bayesian model in OpenBUGS version 
3.2.1 rev 781 (Thomas et al., 2006) was implemented to estimate the test parameters and 
population prevalences.  
To evaluate the assumption of conditional independence we compared the estimates 
of the CID model with the estimates of a model which assumed dependency of the two tests 
(COC model). We ran these COC models using a covariance expressed as a proportion (e.g., 
0.00, 0.10, 0.20, 0.25, 0.30, 0.40, 0.50 and 0.75) of the maximum conditional covariance 
BSe (λSe and λSp). The upper and lower limits of λSe and λSp can be derived from the 
probabilities in Probi since these must be between zero and one (Toft et al., 2007a): 
LλSe=max [-(1- MSe )(1- BSe ),- MSe BSe ]≤ λSe ≤ UλSe = min [ MSe (1- BSe ), BSe (1- MSe )]                         (1) 
LλSp=max [-(1- MSp )(1- BSp ),- MSp BSp ]≤ λSp ≤ UλSp= min [ MSp (1- BSp ), BSp (1- MSp )]                               (2) 
where SeM and SeB are the sensitivity of milk ELISA and blood ELISA, respectively. 
The same applies for specificity. L and U are the upper and lower limit of λSe and λSp. Fixing 
the conditional covariances (using the approach from Vacek, 1985) allowed us to estimate 
the remaining seven parameters of the model:  
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where UλSe and UλSp are the fixed proportion of upper limit of conditional covariances 
for the sensitivities and specificities, respectively. For UλSe and UλSp = 0.00, 0.10, 0.20, 
0.25, 0.30, 0.40, 0.50 and 0.75. We have only used the UλSe and UλSp in the model as we 
believe the two test methods are positively correlated, if correlated at all. This model will 
be the CID model if we consider UλSe and UλSp =0. Estimating the sensitivity and specificity 
at different predefined fixed proportions of conditional covariances allowed us to evaluate 
the effect of conditional dependence of these two tests on the parameter estimates.    
All models in this study were identifiable. Therefore, we used uninformative priors 
(beta (1,1)) for sensitivity and specificity of both tests and also for the prevalences in three 
populations. For all analyses, we ran 20,000 iterations of the models with the first 10,000 
discarded as the burn-in phase. To assess convergence of the Markov Chain Monte Carlo 
(MCMC) chain we visually inspected the time-series plots of selected variables as well as 
the Gelman-Rubin diagnostic plots using three sample chains with different initial values 
(Toft et al., 2007b).  
The hypotheses of the differences between test parameters were tested by 
calculating the Bayesian posterior probabilities (POPR) for e.g. H0: SeM > SeB. The 
deviance information criterion (DIC) statistics of the resulting models were compared to 
assess the goodness of fit (the smaller the value the better the fit). We also computed the 
differential positive rate (DPR= (Se + Sp) – 1), which indicates the cut-off value at which 
the sensitivity and specificity are maximized simultaneously. Selection of cut-off for 
diagnostic tests based on DPR implies an equal misclassification cost of false positive and 
false negative interpretations (Greiner et al., 2000). 
Results 
There were 362 (63.73%), 141 (24.82%) and 65 (11.44%) cows included in the eight 
positive, the six negative and the three intermediate herds, respectively. The cross-
tabulated distribution of the dichotomous outcome of the two tests at cut-off 40 is shown 
in Table 1.  
Based on the data shown in Table 1, the sensitivity and specificity of the two tests and 
three population-specific prevalences were estimated using two different types of models; 
one assuming CID between the two tests given serology status, and one assuming COC 
between the two tests. Results of these two methods are shown in Table 2. Comparison of 
the results of these methods shows that the sensitivity of the two tests changed 
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significantly only for COC ≥ 0.40 and no visible changes and differences was observed in 
the specificity estimates of the two tests (Table 2). Remarkable changes in the population-
specific prevalence estimates for positive and intermediate herds were also seen in the 
models with COC ≥ 0.40 (Table 2). The CID model has the smallest DIC among the 
resulting models suggesting the CID model as the preferred one (Table 2). 
Table 1: Cross-tabulated results for milk and blood ELISA at cut-off S/P= 40 for 568 cows 
stratified by herd status. 
Herd status POSM/POSBa POSM/NEGBb NEGM/POSB NEGM/NEGB Total 
Positive  76 17 14 255 362 
Intermediate  6 1 3 55 65 
Negative 0 1 1 139 141 
Total 82 19 18 449 568 
M: milk; B: blood 
a Positive 
b Negative 
DPR estimates of the CID models confirmed that both tests performed better at cut-
off S/P = 40 than at any other cut-offs (Table 3). At this cut-off the sensitivity of the milk 
ELISA was slightly higher than the sensitivity of the blood ELISA. However, this variation 
of estimates was not statistically significant. The specificity estimates of the two tests at 
this cut-off were similar (Table 3). No improvement in the sensitivity and specificity 
estimates of two tests was observed when the cut-off was reduced to S/P = 30, but the 
sensitivity estimates decreased for both tests when cut-off S/P = 50 was used.  
Discussion 
We estimated the sensitivity and specificity of an ELISA applied to blood and milk 
samples of dairy cows using latent class analysis to avoid the implications of an assumed 
perfect reference test. The analysis showed that both tests are equally highly specific 
whereas milk ELISA has marginally higher sensitivity than the blood ELISA. However, this 
difference of sensitivity estimates is of negligible practical importance. The sensitivity and 
specificity estimates of blood ELISA are comparable with estimates of the study of Horigan 
et al. (2011) but disagree with the relative estimates reported by Kittelberger et al. (2009). 
In the latter study an ELISA was compared with the imperfect reference CFT, which 
defined the cases and might have influenced the parameter estimates of the test under 
evaluation (Nielsen and Toft, 2002). To the best of our knowledge, there are no recent 
studies that report the sensitivity and specificity of milk ELISA in individual cows. 
However, a high agreement (Kappa=0.89) between blood and milk ELISA was reported by 
Guatteo et al. (2007). 
A previous study showed that the apparent prevalences of C. burnetii seropositivity within 
the three strata used in this analysis varied significantly (Paul et al., 2012). Posterior 
estimates of stratum specific prevalences in this study were also very different, which 
support that the stratification of the population into subpopulations with differences in 
prevalence was successful. The assumption of consistency in sensitivity and specificity 
estimates across the population was difficult to evaluate in the current study. However, in a 
separate analysis considering negative and intermediate herds as a single population we  
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Table 3: The mean estimates and 95% PCI of the sensitivity (Se) and specificity (Sp) of 
milk and blood ELISA, and population specific prevalences of the conditionally 
independent (CID) models at different cut-offs. 
Test parameter Estimates (95% PCI) DPRMa DPRB 
Cut-off 30 
SeM 0.86 (0.76; 0.96) 0.85 0.82 
SpM 0.99 (0.97; 1.00)   
SeB 0.84 (0.75; 0.92)   
SpB 0.98 (0.96; 1.00)   
PPOS 0.29 (0.24; 0.36)   
PINT 0.16 (0.08; 0.27)   
PNEG 0.02 (0.01; 0.06)   
Cut-off 40 
SeM 0.86 (0.76; 0.96) 0.85 0.83 
SpM 0.99 (0.97; 1.00)   
SeB 0.84 (0.75; 0.93)   
SpB 0.99 (0.96; 1.00)   
PPOS 028 (0.23, 0.34)   
PINT 0.14 (0.06; 0.25)   
PNEG 0.01 (0.00; 0.03)   
Cut-off 50 
SeM 0.82 (0.73; 0.91) 0.81 0.81 
SpM 0.99 (0.97; 1.00)   
SeB 0.82 (0.73; 0.92)   
SpB 0.99 (0.98; 1.00)   
PPOS 0.28 (0.23; 0.33)   
PINT 0.12 (0.04; 0.19)   
PNEG 0.01 (0.00; 0.03)   
P: prevalence; POS: positive herds; INT: intermediate herds; NEG: negative herds  
a DPR: (Se+Sp-1) 
did not find any changes in the sensitivity and specificity estimates (results not shown). We 
therefore believe that the assumptions of constant sensitivity and specificity across the 
populations were justified. Toft et al. (2005) demonstrated that difference in population 
prevalences can influence the sensitivity estimate of the tests and estimates increase with 
increasing population prevalence. However, in our case changes in population prevalence 
did not change the sensitivity estimates of the tests. 
The assumption of conditional independence between the two tests was questionable 
since it is the same test applied to two different media. These two tests are supposed to be 
correlated given antibody status, unless the antibody definition is selected to reflect this. 
We accounted for this correlation in the COC models to avoid the overestimation or 
underestimation of the performance of the tests (Vacek, 1985). Our analyses showed that 
the specificity estimates of the tests did not change even when a high proportion of 
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conditional covariance (0.75) was used. Significant reductions in the sensitivity and 
prevalence estimates were observed when the proportion of conditional covariance 
exceeded 0.40 (Table 2). The estimates of a COC model without fixing the maximum limit 
of the covariance parameters also suggest that there is no significant conditional 
dependence between the sensitivity and specificity of two ELISA methods (results not 
shown). Biologically it may not be true as both tests are based on the same biological 
principle. These two tests have very high sensitivity and almost perfect specificity. 
Therefore, the proportion of absolute dependence between these two tests might be very 
small and the estimates of COC models do not differ greatly from the estimates of CID 
models. It implies that the two tests might be conditionally dependent but this dependence 
does not affect sensitivity and specificity estimates when evaluated against each other. A 
positive correlation between tests could be expected if the tests are based on the same 
physiological phenomenon. In our case, both tests are based on the same antibody 
reaction; hence something which inhibits the reaction or causes a false reaction for one of 
the tests may have a similar effect on the other (Vacek, 1985). An increasing degree of 
correlation between two tests implies that this reaction is becoming more pronounced. In 
our study this is most notable in the sensitivity estimates, where an increase in the degree 
of correlation reduces the sensitivity of both tests, which then as a consequence forces the 
true prevalence estimates to increase. The latter is most notable in the populations where 
disease is most prevalent (Table 2). 
As the sensitivity and specificity estimates of CID model and COC models with 
conditional covariance < 40 were almost similar the estimates of test parameters found in 
the CID model seem valid. We compared the test parameter estimates of the CID model 
using recommended cut-off with the models with two other cut-offs. Results showed that 
the sensitivity and the specificity estimates did not change when S/P= 30 was used as cut-
off. On the other hand, the sensitivity estimate reduced slightly when S/P=50 was used as 
cut-off (Table 3). DPR estimates also confirmed that S/P = 40 was the best cut-off for both 
blood and milk ELISA. Therefore, cut-off at S/P = 40 can be recommended for ELISA for 
classifying the serological status of a cow. Both milk and blood ELISAs for detecting C. 
burnetii seropositive cows can provide false positive and false negative results as neither 
are analytically perfect at any cut-off. False positive interpretation may result from cross 
reaction with antibodies provoked by other pathogens. Antigens of C. burnetii for example, 
can cross-react with antibodies of Bartonella spp., Legionella spp. and Chlamydiae spp. 
(Finidori et al., 1992; LaScola and Raoult, 1996; Lukacova et al., 1999; Musso and Raoult, 
1997; Vermeulen et al., 2010; Wilson et al., 1992). On the other hand, a cow with recent 
infection during sampling time may not produce sufficient amount of antibodies that are 
detectable in both blood and milk yet. This might give false negative results (Greiner and 
Gardner, 2000). 
In this analysis the target condition was reflecting an objective to identify seropositive 
cows as an indication of exposure to C. burnetii bacteria. C. burnetii infection has a long 
persistence and can evoke a long lasting antibody response (Garcia-Ispierto et al., 2011; 
Lang, 1990). Estimation of test performance of serological tests using LCA is 
recommended for chronic, persistent diseases where an antibody response can be 
detectable for a long period (Branscum et al., 2005). Therefore, LCA seems like a viable 
approach for evaluating serological tests for C. burnetii infection.  
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Conclusion 
This LCA for estimating the sensitivity and the specificity of milk and blood ELISAs 
for detecting C. burnetii antibodies in Danish dairy cows showed that the sensitivity of 
milk ELISA (0.86) is almost similar to that of blood ELISA (0.84) at the cut-off S/P = 40. 
In addition, the specificity of milk ELISA (0.99) is equal to that of blood ELISA (0.99) at 
the same cut-off. Although both test methods have similar test characteristics, milk ELISA 
has some practical and less cumbersome advantages over blood ELISA. Collection of milk 
is non-invasive, easy and less expensive and less physically risky for the sampling person 
as compared to the collection of blood. Hence, milk ELISA as a screening test might be a 
better option for C. burnetii surveillance programs in lactating dairy cows. 
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Abstract  
Antibodies to Coxiella burnetii have been found in the Danish dairy cattle 
population with high levels of herd and within herd seroprevalence. However, the 
prevalence of antibodies to C. burnetii in Danish beef cattle remains unknown. The 
objectives of this study were to (1) estimate the prevalence and (2) identify risk factors 
associated with C. burnetii seropositivity in beef and dairy cattle based on sampling at 
slaughter in Denmark.  
Eight hundred blood samples from slaughtered cattle were collected from six 
Danish slaughter houses from August to October, 2012, following a random sampling 
procedure. Blood samples were tested by a commercially available C. burnetii antibody 
ELISA kit. A sample was defined as positive, if the sample-to-positive ratio was greater 
than or equal to 40. Animal and herd information were extracted from the Danish Cattle 
Database. Apparent (AP) and true prevalence (TP) were specific to the breed, breed 
groups, gender and herd type; and breed-specific true prevalence with a random effect of 
breed was estimated in a Bayesian framework. A Bayesian logistic regression model was 
used to identify risk factors of C. burnetii seropositivity. Test sensitivity and specificity 
estimates from a previous study involving Danish dairy cattle were used to generate prior 
information.  
The prevalence was significantly higher in dairy breeds (AP=9.11%; TP=9.45%) than 
in beef breeds (AP=4.32%; TP=3.54%), in females (AP=9.10%; TP=9.40%) than in males 
(AP=3.62%; TP=2.61%) and in dairy herds (AP=15.10%; TP=16.67%) compared to beef 
herds (AP=4.54%; TP=3.66%). The Bayesian logistic regression model identified breed 
groups along with age and number of movements, as contributors for C. burnetii 
seropositivity. The risk of seropositivity increased with age and increasing number of 
movements between herds. Results indicate that seroprevalence of C. burnetii is lower in 
cattle sent for slaughter than in Danish dairy cows in production units. A greater 
proportion of this prevalence is attributed to slaughtered cattle of dairy breeds or cattle 
raised in dairy herds rather than beef breeds. 
 
 
 
 
 
Key words: Coxiella burnetii; cattle; seroprevalence; true prevalence; test uncertainty; 
Bayesian analysis.    
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Introduction 
Coxiella burnetii, the causative agent of Q fever, is an obligate intracellular 
bacterium from the family Coxiellaecae (Angelakis and Raoult, 2010). This bacterium can 
infect a wide range of animals, but cattle, sheep and goats are the principal reservoirs and 
sources of human infection (Angelakis and Raoult, 2010). Infection in cattle usually 
remains unrecognised (Rodolakis, 2009), but it may cause sporadic reproductive problems 
such as abortion (Agerholm, 2013). Infected animals may shed large quantities of bacteria 
during parturition and in milk, faeces, urine and vaginal mucus for a long period (Guatteo 
et al., 2006; Rodolakis et al., 2007).  
In 2008, bulk tank milk (BTM) samples of 100 randomly selected Danish dairy 
herds were tested to estimate the prevalence of C. burnetii antibody positivity (Agger et al., 
2010). In that study, 59% of the herds tested positive at a cut-off of 40 sample-to-positive 
(S/P) ratio in the test used (milk antibody ELISA, Chekit-Q-fever, IDEXX, Liebefeld-Bern, 
Switzerland), 30% tested negative (S/P < 30) and 11% of the samples gave doubtful 
(intermediate) results (S/P 30-39). A within herd prevalence study carried out in the 
autumn of 2008 involving 24 herds from the previous study (Agger et al., 2010) showed 
that 27% , 23% and 0.9% of cows tested positive in BTM positive, intermediate and 
negative herds, respectively (Paul et al., 2012). However, knowledge about herd or animal 
levels of C. burnetii seroprevalence in Danish beef cattle is scarce. Danish beef cattle herds 
generally operate extensively and with a mean herd size of only 12 animals (Anonymous, 
2012). Although there are some variations in Danish dairy and beef cattle production 
systems, these two populations are not completely separated. Thus, if C. burnetii infection 
is present in the beef cattle population, this might potentially be a source of infection for 
other domestic ruminants and humans. 
In most of the survey or surveillance programs, a readily available serological test is 
used to test a group of animals to obtain an indirect measure of disease or exposure (e.g., 
apparent prevalence (AP)). This might provide an overview of the level of seropositive 
animals within a specific population. However, very few diagnostic tests appear to be 
perfect. Ignorance of test uncertainty may lead not only to misclassification of diseased 
(exposed) and non-diseased (non-exposed) animals, and biased estimates of measures of 
association in risk factor studies, but also to provide a higher level of confidence than the 
reality. These may negatively affect the surveillance and/or control and eradication 
program. Bayesian analysis provides a framework for adjustment for imperfections or the 
uncertainties of the diagnostic tests to obtain an unbiased estimate (e.g., true prevalence 
(TP)) (Tu et al., 1999). Similar adjustments for misclassifications can also be included in 
the logistic regression model in the Bayesian framework in the form of prior distribution. 
This will allow for an estimation of the effect of a risk factor on the true (latent) occurrence 
of the disease/infection (McInturff et al., 2004). Most prevalence surveys do not include 
adjustment for test uncertainty, due to lack of the reliable parameter estimates in the 
literature, or parameter estimates are only available for specific populations and locations 
(Greiner and Gardner, 2000).  
Several evaluations of ELISA to detect C. burnetii antibodies have been reported in 
recent years. In some of these studies, serum ELISA was evaluated against a complement 
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fixation test (CFT), which gave relative estimates of sensitivity (Se) and specificity (Sp) 
(Emery et al., 2012; Kittelberger et al., 2009). Horigan et al. (2011) studied the 
performance of CFT and serum ELISAs in a latent class analysis (LCA) framework by 
fitting the model using maximum likelihood estimation. Paul et al. (2013) estimated the Se 
and Sp of milk and serum antibody ELISAs in a Bayesian framework, and found the Se 
(84%) and Sp (99%) of blood ELISA.  
The objectives of this study were to (1) estimate the AP and TP of C. burnetii sero-
positivity and (2) identify the risk factors associated with C. burnetii seropositivity in cattle 
raised for meat production and sampled at slaughter in Denmark using the Bayesian 
framework where the uncertainty about the Se and Sp of the diagnostic test was accounted 
for. 
Materials and methods 
Sample selection and diagnostic test 
Blood samples for the study were collected from slaughter cattle in the Danish 
surveillance programs for Bovine Virus Diarrhea Virus infection, Infectious Bovine 
Rhinotracheitis virus infection and Salmonella Dublin infection. According to these 
programs, blood is sampled from at least one slaughtered cattle per herd at least every 
fourth months, provided the herd sent animals to slaughter. The blood samples were tested 
at the Eurofins Steins Laboratorium A/S Denmark for antibodies to these infections, and 
the remaining serum of samples collected during August to October 2012 were used in this 
study and tested for C. burnetii antibodies.  
The blood samples were only marked with the animal id-number, and therefore, it 
was not possible for the technician to differentiate between samples of beef cattle breeds, 
and samples of bulls of dairy breeds or dairy x beef cattle raised for meat production; and 
thus, we accounted for this in the sample size computation. The necessary sample size was 
estimated to 196 samples under the assumption of a maximum prevalence of test positivity 
of 15% in the sampling population, and an allowable error of 5% in a population of 
>50,000 slaughtered cattle. As cattle of both beef and dairy herd origins were selected, we 
decided to test 800 blood samples for antibodies of C. burnetii, and to account for the 
cattle type in the statistical analyses. At the slaughter houses, the surveillance system 
focused on cattle from non-dairy herds, as dairy herds are monitored on BTM samples. 
Therefore, our sample primarily contained cattle from non-dairy herds. However, most 
slaughter houses receive cattle of beef as well as dairy breeds, both males and females, and 
from several regions of Denmark. Therefore, few animals of dairy breeds (both male and 
female) in the study population originated from dairy herds, and we included them in the 
statistical analyses for comparative purposes. As the sampled cattle were randomly 
selected, we considered them representative of Danish slaughtered cattle.  
The blood samples were tested for IgG antibodies to C. burnetii based on phase I 
and II antigens using a commercial antibody ELISA kit (Chekit-Q-fever, IDEXX, Liebefeld-
Bern, Switzerland), following a protocol prescribed by the manufacturer. A sample with the 
sample-to-positive (S/P) ratio ≥ 40 was defined as positive. The Se and Sp estimates of this 
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diagnostic test were obtained from a previous study (Paul et al., 2013). This information 
was used to generate the corresponding Beta distribution from the BetaBuster software 
(www.epi.ucdavis.edu/diagnostictests /betabuster.html).   
The following data was obtained from the Danish Cattle Database: Birth date, 
slaughter date, breed, gender, herd of origin (i.e. herd where the animal was born), 
delivering herd (i.e. herd from where the animal was sent for slaughter), type of delivering 
herd (i.e. dairy vs. beef herd), number of movements (i.e., how many times an animal was 
moved from one herd to another since birth to slaughter) and local cattle density 
measured, as the total number of animals and herds within circles of a 1 or 5 km radius of 
the herd of last housing before slaughter. 
Statistical analysis 
Prevalence model 
The prevalence was estimated in a Bayesian analysis based on the model used by Okura et 
al. (2011). Because blood ELISA is not a perfect test (Paul et al., 2013), we accounted for 
the uncertainty of the diagnostic test in the models. The apparent antibody status of an 
animal was linked to the true (but latent) antibody status in terms of the Se and Sp of the 
diagnostic test. Thus, the test result for the ith animal of the jth breed is: 
resulti ~ Bernoulli (APj) 
APj=Se x TPj+(1-Sp) x (1-TPj)  
Se ~ Beta (56.02, 11.48) 
Sp ~ Beta (125.79, 2.26) 
Two models were developed to estimate the TPj: (1) a model assuming that prevalence 
varied among the breeds, i.e. a fixed effect model, where:  
TPj ~ Beta (1,1)  
and (2) a model assuming within breed prevalence (breed specific prevalence) was similar, 
i.e. a random effect model, where:  
logit (TPj ) = αj 
αj ~ N(µ,τ)  
Non-informative priors for both mean µ~Norm (0, 0.001), and precision τ~Gamma (0.01, 
0.01) were modeled in the random effect model using the OpenBUGS (Thomas et al., 
2006) parameterization. We also estimated AP and TP specific for gender, breed group and 
herd type from the fixed effect model. Prior Beta distributions for the Se (Beta (56.02, 
11.48)) and Sp (Beta (125.79, 2.26)) used in all models were obtained from the BetaBuster 
software using the Se and Sp estimates stated in Paul et al. (2013). 
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We ran all prevalence models in OpenBUGS, which acquires a Monte Carlo (MC) sample 
from the posterior distribution by employing a Markov Chain Monte Carlo (MCMC) 
sampling algorithm. The MCMC models were run for 20,000 iterations with the first 
10,000 discarded as burn-in and the posterior inferences was calculated from the 
remaining MC samples. To assess convergence of the MCMC chain we visually inspected 
the time-series plots of selected variables as well as the Gelman-Rubin diagnostic plots 
using three sample chains with different initial values (Brooks and Gelman, 1998). Median 
and 95% posterior credibility intervals (PCI, the Bayesian analogous of a confidence 
interval) of AP and TP were calculated to draw posterior inferences. The hypotheses of the 
differences between prevalences in different trait groups were tested by calculating the 
Bayesian posterior probabilities (POPR) e.g., H0: TPfemale> TPmale or H0: TPdairy> TPbeef. The 
Bayesian PORP used to test the H0 was calculated using the Step function in OpenBugs 
model and interpreted as the proportion of MC samples for which H0 was true. For 
example, if the PORP for H0: TPfemale> TPmale was 0.98, it can be interpreted as for 98% of 
the MC samples the TPfemale was greater than TPmale. In other words, it can be interpreted 
as statistical significance in a one sided test.  
Risk factor model 
The effect of possible risk factors extracted from the Danish Cattle Database on the 
probability of C. burnetii seropositivity was assessed by a Bayesian logistic regression 
model. We accounted for the uncertainty of the diagnostic test in this model as we did in 
the prevalence models. The true (but latent) antibody status of an animal was used as a 
dependent variable in the logistic regression model: 
resulti ~ Bernoulli (APi) 
APi=Se x TPi+(1-Sp) x (1-TPi) 
Logit (TPi) = α0 + α1X1 + α2X2 
Se ~ Beta (56.02, 11.48) 
Sp ~ Beta (125.79, 2.26) 
where, α0 represents intercept, X1 and X2 are the risk factors for the i’th animal; and 
α1 and α2 represent regression coefficients for X1 and X2 respectively. 
First, univariable logistic regression was done by entering each risk factor in the 
model separately to assess the association between an independent variable and animal 
antibody status (positive vs negative). A variable was assessed significant if the 95% PCI 
value of the odds ratio did not include 1. Correlations among the variables found 
significant in the univariable analysis were assessed and variables with the correlation 
coefficient ≤ 0.5 in pairwise test were included in the multivariable model (Dohoo et al., 
2003). Both forward selection and backward elimination procedure were used in the 
multivariable logistic regression to identify the significant risk factors. In forward selection 
procedure the independent variables were added to the model one by one and were kept in 
the model if the 95% PCI of the alpha estimate did not include 1. Check for biologically 
meaningful interactions were also done. Furthermore, model selection was also done by 
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comparing the deviance information criteria (DIC) before and after adding a variable in the 
model. Model with smallest DIC was selected for further analysis and a decrease in DIC ≥ 5 
was deemed a significant improvement in goodness of fit of the model (Osterstock et al., 
2008). In a univariable analysis DIC value of a model was compared with the DIC of the 
null model.  
The Bayesian logistic regression models were developed in OpenBUGS. Posterior 
inference of parameter estimates and assessment of model convergence was done 
following the same procedure as used for prevalence models. However, few models which 
did not converge perfectly in 20,000 iterations were run for more iterations (up to 50,000) 
to achieve satisfactory convergence. 
Table 1: Distribution of Coxiella burnetii antibody positivity in blood samples from cattle 
according to breed, gender, herd type and herd location collected between August and 
October 2012 from Danish slaughterhouses following a random sampling procedure. 
 No. of positive  
samples 
Total no. 
samples 
Proportion (%) 
test positive 
Overall  44 800 5.50 
Breed group    
Dairy breeds 23 258 8.91 
Holstein 17 207 8.21 
Jersey 3 25 12.0 
Danish Red Cattle 3 26 11.54 
Beef breeds 13 315 4.13 
Aberdeen Angus 1 27 3.70 
Charolais 0 21 0.00 
Hereford 2 80 2.50 
Limousine 4 84 4.76 
Simmental 4 61 6.56 
Othera 2 42 4.76 
Crossbreeds 8 227 3.52 
Gender    
Female 28 307 9.12 
Male 16 493 3.25 
Type of delivering herds    
Beef herds 32 716 4.47 
Dairy herds 12 84 14.29 
Herd location    
Funen 4 110 3.64 
South and West Jutland 30 401 7.48 
North and East Jutland 7 177 3.95 
Zealand and Bornholm 3 112 2.68 
aIncludes all beef breeds with less than 10 animals 
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Results 
The 800 cattle slaughtered at six abbattoirs originated from 753 herds and included cattle 
of 15 beef breeds and three dairy breeds i.e., Danish Holstein, Danish Jersey and Danish 
Red cattle. Thirty-nine per cent of the samples originated from beef cattle, 32% from dairy 
cattle and 29% from non-specified crossbreeds. Table 1 shows the distribution of the 
samples stratified by breed, gender, herd type and location. Breeds with less than 10 
animals were excluded from the prevalence analysis. Only five beef breeds including 
Angus, Charolais, Hereford, Limousine and Simmental comprised ≥ 10 animals. Hence, 
758 blood samples from 9 breeds were used for prevalence estimation. The overall 
proportion of test seropositive samples was 5.5% with noticeable variations between 
breeds, breed groups, gender and herd types. Discrete numerical variables such as number 
of movements; number of herds within a 1km and 5km radius; and number of animals 
within 1km and 5km radius were used as continuous variables. The median age of the 
cattle included in this study was 1.39 years with a lower quartile (Q1) and upper quartile 
(Q3) of 1.11 years and 2.49, respectively. The median age of female cattle was higher than 
that of male cattle. Summary statistics of continuous variables are presented in Table 2. 
Table 2: Descriptive analysis of continuous variables on age, animal movements, herd size 
and density as used in a study of 800 blood samples from cattle collected between August 
and October 2012, at Danish slaughterhouses following a random sampling procedure.        
 Median Lower quartile 
(Q1) 
Upper quartile 
(Q3) 
Age (year) 1.39 1.11 2.49 
Female 3.17 1.90 5.59 
Male 1.19 0.98 1.42 
No. of movementsa 2 1 3 
Herd size of delivering herd 56 23 133 
No. of herds within 1km radiusb 2 1 4 
No. of herds within 5km radius 53 41 65 
No. of animals within 1km radius 57 11 279 
No. of animals within 5km radius 3481 1763 5962 
a How many times an animal since birth was moved from one herd to another and to 
slaughter. 
b Radius was calculated from the final herd before the animal was sent to the 
slaughterhouse. 
Prevalence model 
Table 3 shows the posterior median estimated with 95% PCI of breed-specific AP 
and TP estimates, using a fixed effect model and the TP from a random effect model. The 
combined AP of three dairy breeds (9.11%) obtained from a fixed effect model was 
significantly higher (POPR=1) than that of beef breeds (4.32%) (Table 4). However, the 
difference between the APs of beef breed groups and crossbred cattle was not significant. 
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Similar trends were also observed in the TP estimated of different breed groups from the 
fixed effect model (Table 4). Significant differences between the AP and TP estimates were 
also noticed in female versus male and dairy herd versus beef herds (Table 4).  
Table 3: Estimates of apparent and true prevalence of Coxiella burnetii seropositivity in 
different cattle breeds from 758 randomly selected blood samples from Danish 
slaughterhouses collected between August and October 2012. 
 Apparent prevalence  True prevalence  True prevalence with 
random effect of breed 
 Prev.a 95% PCIb  Prev. 95% PCI  Prev. 95% PCI 
Aberdeen Angus 6.26 1.54 18.92   6.38 0.45 22.79   1.74 0.00 8.52 
Charolais 4.30 0.88 16.33  3.87 0.15 19.31  1.51 0.00 7.62 
Hereford 3.60 1.19 8.93  2.98 0.19 9.84  1.43 0.00 6.84 
Limousine 5.58 2.15 11.60  5.51 0.93 13.22  1.83 0.00 7.76 
Simmental 7.49 2.72 15.85  7.99 1.62 18.90  2.22 0.00 9.19 
Holstein 8.49 5.21 12.76  9.26 4.63 15.13  3.82 0.00 10.33 
Jersey 13.94 4.35 30.13  16.04 3.79 37.10  2.75 0.00 14.33 
Danish Red Cattle 13.54 4.41 28.68  15.58 3.88 35.28  2.71 0.00 13.93 
Cross breed 3.85 1.94 6.83  3.35 0.52 7.43  1.47 0.00 6.01 
Overall 5.61 4.15 7.45   5.61 2.81 8.42   2.05 0.00 7.15 
a Prevalence (%) 
b 95% posterior credibility interval 
Table 4: Estimates of apparent and true prevalence of Coxiella burnetii seropositivity in 
different categories from 758 randomly selected blood samples from cattle sampled at 
slaughter in Denmark, collected between August and October 2012. 
 Apparent prevalence  True prevalence 
 Prev.a 95% PCIb  Prev. 95% PCI 
Gender        
Female  9.10 6.16 12.80  9.40 5.08 14.64 
Male 3.62 2.21 5.52  2.61 0.26 5.50 
Breed group        
Beef 4.32 2.41 7.18  3.54 0.51 7.39 
Crossbred 3.90 1.98 6.77  2.98 0.32 6.86 
Dairy 9.11 6.07 12.97  9.45 5.01 14.84 
Type of delivering herds        
Beef herds 4.54 3.16 6.30  3.66 0.62 6.51 
Dairy herds 15.10 8.53 23.64  16.67 8.06 27.86 
a Prevalence (%). 
b 95% posterior credibility interval. 
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Risk factor model  
The DIC value of the null model was 348.3. Based on the 95% PCI of the alpha 
estimate and DIC value, six variables, i.e. age (DIC=342.4), gender (DIC=332.2), breed 
group (DIC=327), type of delivering herd (DIC=339.9), number of movements 
(DIC=331.3) and herd location (DIC=334.1), were found significant in the univariable 
logistic regression analyses and they were all included in the multivariable model. Both 
forward selection and backward elimination procedures revealed the same final model. 
The result of the final multivariable model is shown in Table 5 (DIC=303.3). In the final 
model, age, breed group and number of movements showed significant association with 
animal antibody status.  
Discussion 
In this study, both apparent and true prevalence of C. burnetii antibody positivity for 
different breeds of cattle raised for meat production delivered for slaughter in Denmark 
were estimated using Bayesian analysis. Moreover, we also estimated the effect of several 
risk factors for C. burnetii seropositivity using a Bayesian logistic regression model 
adjusting for diagnostic misclassification. The first part of the discussion is about methods 
and results of the prevalence models, followed by a discussion about risk factors. Finally, 
we discussed the usefulness of the statistical methods and data quality of this study. 
Table 5: Multivariable Bayesian logistic regression analysis to identify risk factors 
associated with Coxiella burnetii seropositivity estimated from 800 randomly selected 
blood samples from cattle sampled at slaughter in Denmark, collected between August and 
October 2012. 
Beta ORa 95% PCIb 
Age (year)d 0.33 1.39 1.12 1.57 
Breed group 
 Dairy breeds 1.28 3.59 1.69 8.63 
 Crossbreds 
-0.01 1.00 0.37 2.52 
 Beef breeds Ref.c Ref.   
No. of movementsd,e  0.49 1.59. 1.32 1.90 
a Odds ratio. 
b 95% posterior credibility interval. 
c Reference category. 
d OR calculated per unit change in measurement. 
e How many times an animal moved from birth to slaughter. 
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Prevalence estimation 
 Estimation of AP is a straight forward way of indicating the proportion of diseased 
animals. It does not require information about the Se and Sp of the diagnostic test, and 
uncertainty of AP estimates are narrower than the corresponding TP estimates. However, 
AP estimates of two studies are only comparable when both studies are similar in terms of 
study design and they use the same diagnostic test. Furthermore, AP estimates may 
underrate the true prevalence, thus, may mislead the belief of decision makers about the 
true presence of a disease. Hence, TP estimates are the frequently presented outcome of 
recent prevalence studies, where the test Se and Sp, along with their uncertainties are 
known.   
The conclusion about the fixed effect prevalence models is that both AP and TP were 
significantly higher in dairy breeds vs. beef breeds, females vs. males and dairy herds vs. 
beef herds. The breed was also identified as a risk factor for C. burnetii seropositivity with 
higher prevalence in dairy breeds than beef breeds. The herd management system may be 
the primary explanation for these differences in prevalence, although the study does not 
rule out genetic factors. Beef cattle were maintained for a shorter management cycle than 
dairy cattle. Many beef cattle are slaughtered at a young age, apparently with a low 
probability of infection. In Denmark, most of the beef herds are small and extensively 
managed, as opposed to dairy herds. Moreover, beef cattle often spend a significant part of 
the year outside the farm buildings. This provides potentially more space for the beef 
cattle, and therefore, the exposure load probably remains low and may result in fewer 
infections. The small herd size could also be a reason for the lower seroprevalence in beef 
cattle; as C. burnetii seroprevalence was reported to increase with increasing herd size in 
previous studies (McCaughey et al., 2010; Paul et al., 2012; Ryan et al., 2011). However, we 
did not find herd size to be a risk factor in this study. 
In this study, the TP estimates for dairy and beef breeds were 9.1% and 4.3%, 
respectively. These estimates could be compared to the prevalence estimates found in the 
other studies using serum ELISA. Very few studies have focused on C. burnetii 
seroprevalence in beef cattle in Europe (Alvarez et al., 2012; Kampen et al., 2012; 
McCaughey et al., 2010; Ruiz-Fons et al., 2010; Ryan et al., 2011). However, none of these 
were based on slaughtered cattle and did not calculate TP accounting for uncertainty of the 
diagnostic tests. The reported AP estimates in beef cattle from the studies in Europe varied 
from 0 to 18.3%, and some of the estimates were close to our findings (McCaughey et al., 
2010; Ruiz-Fons et al., 2010). A study in Norway did not detect any cases of C. burnetii 
seropositivity in dairy and beef cattle (Kampen et al., 2012), while seroprevalence was 
16.8% in beef cattle in Queensland, Australia (Cooper et al., 2011). APs and TPs within the 
dairy breed were similar, whereas these estimates came out to be much lower in beef 
breeds, as pointed out by the significant difference of prevalence between these two breed 
groups. It was expected that prevalence would be high in dairy breeds or cattle raised 
within the dairy herds, as previous studies in Denmark reported high prevalence in dairy 
herds and dairy cows (Agger et al., 2010; Paul et al., 2012). Indeed, 32% of cattle included 
in this study were dairy breeds, and 10% of the sampled cattle were raised in dairy herds. 
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For most of the breeds, the simulated TP estimates were close to the AP. The 
possible explanation for this is that we used prior values for the Se and Sp from a test with 
a reasonably high sensitivity (84%) and an almost perfect specificity (99%). But, the 
uncertainty around the TP estimates showed larger variation compared to AP estimates, as 
illustrated in Table 3. This variation is partly due to small sample size in some breeds, as 
also found in other studies (Okura et al., 2011; van Schaik et al., 2003). So, more data is 
required to get TP estimates with high precision. However, even in the larger breeds, 
uncertainties of TP estimates were larger than for AP estimates. Therefore, this variation 
might also be due to the uncertainty of the priors used for the Se and Sp, although we used 
a highly sensitive and specific test. To extract more information from the existing data, we 
imposed some restriction on the data as suggested by Okura et al. (2011), i.e. we developed 
a random effect prevalence model assuming that breed-specific prevalence was similar. 
The output of this model was in accordance with the results of the aforementioned study, 
i.e. estimates were moved towards the population mean prevalence, uncertainty of TP 
estimates became narrower, and as expected, the effect of the random effect of breed was 
more evident in breeds with fewer animals in the study population. However, the 
underlying assumption of within breed prevalence similarity might be questionable, as all 
breeds are not genetically identical and management systems vary according to the 
production type. Moreover, comparison of DIC values identified the model without 
random effect as a better fit than the random effect model.   
Risk factors 
The age and number of animal movements were identified as risk factors of C. 
burnetii seropositivity in the final logistic regression model, along with breed groups. The 
model showed that the risk of positivity increased with increasing age, as also found in a 
previous study (Alvarez et al., 2012). A likely explanation is that the probability of exposure 
to the bacterium increases with animal age. Similar age effects were also observed in dairy 
cattle (Muskens et al., 2012; Paul et al., 2012). In contrast to other studies, where beef 
cattle were included as a subpopulation, age was not identified as a risk factor (Ruiz-Fons 
et al., 2010; Ryan et al., 2011). This variation may not only be due to differences in study 
designs in terms of population and sample sizes, but also different modeling approaches 
used. Both univariable and multivariable analyses confirmed our hypothesis that the risk 
of seropositivity increased with an increasing number of movements. A probable 
explanation is that it is not the transport per se, but that the accumulation of animals from 
different herds increased the risk of exposure, simply because some animals may excrete 
the bacterium.  
In recent years, the Bayesian approach has been used frequently to account for test 
uncertainty in estimation of TP, and for risk factor studies (Enøe et al., 2000; Tu et al., 
1999).The Bayesian models of this study were flexible and allowed us to estimate TP and 
associated risk factors from fixed and random effect models. The ELISA used in this study 
has a high Se and Sp when the target condition is detection of C. burnetii seropositive 
animals (Paul et al., 2013). The Se and Sp of this test were achieved from a diagnostic test 
evaluation study using a Bayesian framework in the Danish cattle population. With the 
inclusion of risk factors in the logistic regression model, the posterior estimates of the Se 
(83%) and Sp (98%) did not change significantly. This indicates that the test 
characteristics are less likely to be influenced by these covariates. Descriptive analysis 
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showed that all regions of Denmark were well represented by the samples used in this 
study. The animal and herd information are recorded and routinely updated in the Danish 
Cattle Database, and farmers are obliged to report this information immediately after the 
birth of an animal.  
Conclusion 
The prevalence of C. burnetii seropositivity in cattle raised for meat production and 
sent to slaughter houses in Denmark was lower than the prevalence in Danish dairy cows. 
The prevalence in slaughtered cattle of dairy breeds was within the range of what was 
found in Danish dairy herds, while beef breeds showed a much lower prevalence. 
Therefore, for exploring the further epidemiological information, future research should be 
focused more on dairy cattle than on beef cattle. Age and animal movement were also 
found to have significant associations with the level of C. burnetii antibodies. Similar AP 
and TP estimates for most breeds explained that estimation of AP is a reliable measure 
when a highly sensitive and specific diagnostic test is used. Hence, results from the 
seroepidemiological studies of C. burnetii in cattle carried out using the same ELISA as in 
the present study may not need to be adjusted for diagnostic test uncertainty. 
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CHAPTER 7 
GENERAL DISCUSSION 
 
 
 
 
 
 
SYNOPSIS 
This chapter summarises the knowledge derived from the previous chapters on research 
and literature review and discusses the perspectives for further research on the 
epidemiology of Coxiella burnetii infection, and options for practical applications in 
surveillance and control of the infection. 
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Introduction 
Emerging infectious diseases (EID) with the ability to produce a serious epidemic 
are highly prevalent worldwide. More than 60 percent of EIDs, including Q fever are 
zoonotic and have the ability to exhibit negative social and economic impacts (Jones et al., 
2008). It is being regarded as a formidable challenge to prevent EIDs in a new 
environment, but possible control measures can be installed to mitigate their impact on 
animals and humans. Epidemics may last for a few weeks or a few months and can 
overwhelm the existing situation. In the early stage, the mechanisms of the process of 
disease emergence and consecutive diffusion remain nearly unknown, and could vary over 
time (Gonzalez et al., 2006). A multidisciplinary reaction across sectors, professions and 
functional roles is the key element for planning how to manage the disruptions and 
disasters caused by an EID. Targeted surveillance, disease management and an adoptive 
control program for EIDs requires adequate information (data) on emergence, spread and 
the persistence of diseases (Bonneux and Damme, 2011). A multidisciplinary approach, 
when supported by evidence of the observed virulence, epidemiological indices and 
effectiveness of the control measures assists in reducing the lag time between detection of 
pathogens, laboratory verification and response (Gonzalez et al., 2006). Complete field 
based observational studies are essential for obtaining knowledge of emergence, spread 
and persistence of a disease. Questions related to the mechanisms behind the process of 
emergence, spread and persistence of the disease cannot be answered sufficiently by the 
information gained from the observational studies, which are incomplete or of an 
exemplary situation (Gonzalez et al., 2006).  
Q fever is endemic in many European countries (ECDC, 2010; Frankel et al., 2011) 
and is considered as an emerging or re-emerging disease in countries such as the 
Netherlands and France (Frankel et al., 2011; Roest et al., 2011). In the Netherlands, the 
emergence of Q fever was notified in humans in 2007 with a peak occurrence in 2009, 
despite the fact that the disease was considered endemic for several decades (Roest et al., 
2011). However, adoptive veterinary control measures based on previous knowledge were 
able to reduce the magnitude of the epidemic in the subsequent year (Roest et al., 2011). 
Since the recent epidemic in the Netherlands, epidemiological research on Q fever in both 
animals and humans has gained sufficient attention from researchers in many European 
countries, including Denmark. In Denmark, like in most other European countries, the 
existence of C. burnetii has been reported for several years. However, information on 
virulence, and epidemiological indices such as emergence, prevalence, spread and 
persistence of infection in different hosts based on field observations were limited. Thus, 
field based epidemiological research on Q fever was necessary to assess the occurrence and 
to explore the risk factors of the disease in Denmark. Acquired knowledge from the studies 
included in this thesis may support developing targeted surveillance, disease management 
and an adoptive control program in the future.  
The overall objective of this thesis was to investigate the epidemiology of C. burnetii 
seropositivity in Danish cattle with a focus on the occurrence and the risk factors in a series 
of field based observational studies. 
  
Data quality and statistical tools
The study designs and the sample size calculations of the studies included in this 
thesis were based on the purpose of the respective stud
used to calculate prevalence in dairy herds (Chapter 3) and in slaughtered cattle (Chapter 
6). To ensure the representativeness of the target population and to avoid selecti
study units were selected randomly in both of these studies. A relatively high allowable 
error (l=0. 10) was used to estimate the sample size for calculating herd level prevalence. 
The choice of such high allowable error was in accordance with the
project. It 
estimates. For calculating sample size in chapter 6
major administrative divisions of Denmark were covered 
Figure 1:
against Coxiella burnetii
types). 
Chapter 4a identified several herd level risk factors associated with 
antibody positivity in BTM. However, this study was based on the cross
and therefore
cohort study
confidence intervals for parameter estimates of management and biosecurity factors found 
to be significant by logistic regression analysis. Results indicate that
parameter estimates could be improved by increasing the sample size. Another herd risk 
factor analysis was also included in Chapter 3, although the main focus of this chapter was 
to estimate the dairy herd prevalence in 2012
in a previous study in 2008 (Agger et al. 2008). However, this risk factor analysis included 
reduced the sample size
 Distribution of 120 randomly selected Danish dairy herds tested for antibodies 
, could not determine the causality
 (Ersbøll et al., 2004)
 in July 2012
; however, 
, and 
. The 100 herds included in this study resulted in wide 
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only those variables readily available in the Danish Cattle Database, aiming particularly to 
identify an association between cattle density and C. burnetii antibody positivity in BTM.  
Whereas, the risk factor analysis in Chapter 4a mainly focused on the relationship between 
management and biosecurity factors and C. burnetii antibody positivity in BTM. Only 
variable 'Herd size' was common in these two risk factor analyses. Hence, the overlap 
between the datasets of these two studies was minimal. Therefore, the outcome of these 
two studies can be considered to be complimentary to each other.  A cross-sectional study 
with a follow-up was implemented to assess the factors associated with seropositivity in 
dairy cows, and to estimate the within herd seroprevalence in 24 dairy herds (Chapter 4b). 
The included herds were selected by a stratified random sampling procedure from three 
strata, based on the level of antibodies in BTM samples (BTM antibody positive, negative 
and intermediate). Along with this, the inclusion of all lactating cows from the selected 
herds might probably minimise the selection bias, if any. But, due to the inclusion of only 
24 herds, uncertainty around the parameter estimates of herd level variables in the 
statistical analysis was very high. Moreover, although selected randomly, the number of 
herds selected from each stratum was not proportional to the proportion of the 
corresponding stratum in the initial population (Paul et al., 2012); and the BTM statuses of 
the herds were not followed repeatedly. Hence, the overall seroprevalence of within herd 
seropositivity could not be estimated. The rationale behind the inclusion of herd level risk 
factors was that the cows within a herd share common management traits. The 
management routine might differ from herd to herd, and might influence the risk of 
infection of individual cows.  For some of the included cow level factors such as fat and 
protein contents and individual milk yield, it was difficult to establish causal associations 
with C. burnetii  antibody status in the individual cow. Individual milk yield was included 
in the analysis to see its dilution effects on antibody concentration in the milk samples. 
Inclusion of fat and protein contents in the analyses was due to the use of milk yield 
without adjustment for energy. The variable 'Leg problems' was used as a proxy for the 
farmers’ attitudes towards farm management and hygiene. C. burnetii is reported to be 
able to cause mastitis. It was hypothesised that this organism also has association with 
other udder problems and hence, ‘udder problems’ were included in the analyses. The 
management of cattle raised for meat production in Denmark is different from dairy cattle 
production. The risk factors for C. burnetii infection in Danish slaughter cattle might be 
different from that for Dairy cattle. Thus, to evaluate risk factors for C. burnetii in Danish 
slaughter cattle, an analysis was also carried out in Chapter 6. This study also included 
only those variables readily available in the Danish Cattle Database.  
The diagnostic test evaluation study (Chapter 5) also followed a cross-sectional 
design involving 17 dairy herds. The selection procedure for herd selection was described 
in Chapter 4b. The three strata (BTM positive, BTM negative and BTM intermediate herds) 
were used as subpopulations with an assumption of differences in animal-level prevalence. 
The selected study units and study population, therefore, fulfilled the criteria to be 
involved in this study.  
Supplementary registered data from the Danish Cattle Database was used in all of 
the studies included in this thesis. Registered data was already collected, and hence, it was 
cheap and available. Detailed information regarding farm management practice, however, 
is not routinely collected. Therefore, information on herd management practice was 
necessary to answer the objectives set in Chapter 4a and Chapter 4b. Thus, information on 
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herd level management was gathered from the farmers in structured telephone interviews 
with questions at herd level. Data obtained from the questionnaire interviews might have 
introduced recall bias, due to farmers’ loss of memory which could not be ruled out. 
Apparent herd prevalence (Chapter 3) and within herd prevalence (Chapter 4b) was 
estimated as the proportion of test positive animals among the total number of animals 
tested, assuming 100% sensitivity (Se) and specificity (Sp) of the diagnostic test. The true 
prevalence (apparent prevalence adjusted for the diagnostic test uncertainty) could not be 
calculated due to the lack of reliable Se and Sp estimates during the study periods, which 
might introduce bias in the parameter estimates (Greiner and Gardner, 2000; Tu et al., 
1999). A Bayesian approach of prevalence estimation is a widely used statistical tool in this 
context where misclassification errors due to a suboptimal diagnostic test can be taken into 
account (Enøe et al., 2000; Speybroeck et al., 2012). This approach was used to estimate 
the true prevalence of seropositive animals in Danish slaughter cattle (Chapter 6), where 
estimates were adjusted for test uncertainty evaluations in a previous study (Paul et al., 
2013). Logistic regression analyses were used to identify the factors associated with C. 
burnetii antibody positivity in dairy herds (Chapter 4a) and cows (Chapter 4b). Logistic 
regression is a traditional and widely used statistical tool for identifying risk factors for 
diseases (Dubuc et al., 2010; Saa et al., 2012; Van den Brom et al., 2013). However, a 
potential problem is that misclassification of the study units may take place due to lack of 
perfection of the diagnostic test (Greiner and Gardner, 2000). Hence, it is likely that some 
herds or cows have been included as positive to C. burnetii antibodies in the studies when 
in fact they were not positive (false positive), and vice-versa (false negative). This might 
bias the results, and it is likely that the effect has been diluted and that the estimated 
effects of risk factors on C. burnetii positivity were conservative. It is recommended that 
the Se and Sp estimates of diagnostic tests, if known, should be taken into account in 
logistic regression models to obtain the true effect of risk factors (McInturff et al., 2004). 
This was implemented in assessing risk factors of C. burnetii seropositivity in Danish 
slaughter cattle (Chapter 6). The performance of the diagnostic tests used in different 
studies of this thesis was evaluated using the Bayesian approach of latent class analysis. 
This is a recommended and commonly used approach of diagnostic test evaluation, which 
can minimise biases in the parameter estimates and does not require a gold standard 
(reference) test (Enøe et al., 2000).  
Synthesis of epidemiological findings of Coxiella burnetii antibody 
positivity in Danish cattle 
Magnitude in cattle 
The apparent prevalence of C. burnetii antibody positive Danish dairy herds was 
79% in 2012 (Chapter 3). This prevalence was significantly higher than the prevalence 
(59%) found in 2008 (Agger et al., 2010). The latter study concluded an increasing trend in 
the seroprevalence or prevalence of antibody positivity from 2003 through 2008, by 
comparing its results with the results of other studies based on clinically suspected 
samples. This conclusion is supported by the results of the 2012 study (Chapter 3). 
Reporting of only clinical cases of Q fever in cattle was made mandatory in Denmark in 
2005. However, as there were no clear indications of serious zoonotic potential and 
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economic impact, no further national or regional surveillance or control programs (beyond 
notification of clinical cases) have been implemented. The estimated herd prevalence in 
2012 in Denmark was within the range of prevalence reported from different European 
countries in recent years (EFSA, 2012; Guatteo et al., 2011), but was one of the highest 
estimates, if not the highest, among them. Herd positivity was found in all major 
administrative regions of Denmark, and no regional differences in prevalence were 
identified (Figure 1). Herd density was not associated with the herd test categories. These 
two findings were consistent with the findings of the 2008 study (Agger et al., 2010). 
Findings of these two studies might indicate homogeneous distribution of C. burnetii in 
Denmark and might probably indicate no spatial clustering. However, cluster analysis was 
not included in any of these two studies.  It was observed that prevalence increased with 
the increasing average herd size of dairy herds. Herd size has been identified as a risk 
factor for many diseases, including Q fever. The effect of herd size on C. burnetii infection 
in Danish cattle is discussed later in this chapter. 
 
Figure 2: The posterior median and 95% posterior credibility interval for the apparent 
prevalence (AP), true prevalence (TP) and true prevalence using a random effect model 
(TP-R) for different breeds estimated from 758 blood samples of slaughtered Danish cattle 
collected between August and October 2012.   
Stratum specific (low, intermediate and high BTM antibody levels) within herd 
seroprevalence showed a high prevalence in initially BTM positive (27%) and initially BTM 
intermediate (23%) herds; and a very low prevalence in initially BTM negative herds 
(0.9%) (Chapter 4b). Within herd prevalence, in initially BTM positive and BTM 
intermediate herds did not change significantly over time, i.e. for an 11-month follow-up 
period (Chapter 4b); which might indicate long-lasting stability of within herd 
seroprevalence, if the infection is introduced to a population. A significant increase in 
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within herd prevalence was observed in herds which were initially BTM negative. A careful 
evaluation of the data indicated that these abrupt increments of within herd prevalence 
were observed in only two out of ten negative herds. Newly purchased cattle were not 
quarantined in one of these two herds; whereas, the other herd did not purchase new 
animals during a one-year period before data collection. Therefore, it was not conclusive 
for these two herds that purchasing new animals or lack of quarantine contributed to this 
sudden increase of within herd prevalence. Nevertheless, these changes in within herd 
prevalence indicated different dynamics in some of the cows in these herds, i.e. conversion 
of their antibody status during the study period.  
The overall true seroprevalence in Danish slaughter cattle was 5.6%, regardless of 
breed, type of delivering herd and gender (Chapter 6). A significant difference of 
prevalence was observed between the slaughtered dairy cattle (9.45%) and of beef (3.54%) 
breeds. Prevalence in all major dairy breeds (e.g., Danish Holstein, Jersey, and Danish Red 
Cattle) was higher than the population average (Figure 2). The overall findings of a higher 
prevalence of the C. burnetii antibody positivity in dairy breeds agree with the findings 
from other seroprevalence studies (McCaughey et al., 2010; Ryan et al., 2011). Genetic 
differences among the cattle breeds might be a possible explanation for these variations 
between dairy and beef types of cattle. Management factors might also contribute to this 
breed variation, as management of dairy and beef cattle productions are different in 
Denmark. This was also reflected by the finding of a difference in prevalence between types 
of delivering herds, i.e. higher prevalence in dairy herds (16.67%) than in beef herds 
(3.66%). However, a study in Norway did not find any prevalence either in dairy or in beef 
cattle (Kampen et al., 2012). The effect that breed has on C. burnetii seropositivity in 
Danish cattle has been discussed further in the risk factor section of this chapter, since this 
variable was also included in the risk factor analyses of individual cow level study (Chapter 
4b) and Danish slaughter cattle study (Chapter 6). It was also found that female cattle 
(9.40%) contributed more in overall prevalence than males (2.61%). The difference of 
prevalence between female and male slaughter cattle might be due to the fact that females 
were relatively older (median age 3.17 years) than males (median age 1.19 years). 
Therefore, it was hypothesised that the seropositivity of C. burnetii could be better 
explained by the age effect rather than the gender effect. McCaughey et al. (2010) also did 
not find any gender related effect on the C. burnetii seroprevalence in cattle.  
Risk factors of C. burnetii antibody positivity in dairy cattle herds 
Herd factors found to be associated with the level of C. burnetii antibodies in the 
BTM of Danish dairy herds were: 1) use of common farm equipment, 2) contact with 
visitors (with people from outside the farm), 3) insemination by people other than an AI 
technician, 4) herd health contract with the veterinarian, and 5) hygienic precautions 
(changing boots/clothes etc.) by the veterinarian before entering the barn. Increased 
antibody positivity was observed in herds where animals came in contact with visitors, 
where farm utensils were shared with other herds and in herds with a herd health contract 
for routine health checks by the veterinarian. The hypothesis is that visitors, herd 
veterinarian and common equipment might mechanically transmit C. burnetii bacteria 
into the herd they enter. A review article stated the possibility of mechanical transmission 
of bacteria (Woldehiwet, 2004). However, contrary to this, Taurel et al. (2011) did not find 
any association between herd antibody status and animals’ contact with farm personnel 
and sharing common equipment. The AI technicians probably have a high level of 
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working-hygiene, and hence, the probability of transmission of the agent to herds where 
cows were inseminated by the AI technicians was low. It was also found that the 
probability of a herd being positive declined when improved hygienic precautions were 
taken by the herd veterinarian before entering the barn. A similar finding was also 
reported in a cow level study in Denmark (Paul et al., 2012).  
Additional to the above mentioned factors, herd size, stable type, number of 
workers, use of maternity and disease pens, purchasing animals and quarantine practice 
were also found to have significant associations with herd antibody status in univariable 
analyses. In some previous studies, increasing herd size (McCaughey et al., 2010; Paul et 
al., 2012; Ryan et al., 2011) and loose housing (Czaplicki et al., 2012) were shown to have a 
positive relationship with antibody positivity in herds. Contrary to the findings of the 
current study, ‘purchasing new animals’ and ‘quarantine of newly purchased animals’, 
were not found significant in a study by Taurel et al. (2011). Random movement of the 
animals in loose housing probably results in closer contact between non-infected and 
infected animals and contaminated environments than in tie stalls. Thus, transmission 
probability is relatively high in a loose housing system. Maternity pens might be used for 
diseased animals - and they are possibly not being cleaned and disinfected properly, hence, 
the transmission probabilities increase. The purchase of animals (introducing new 
animals) is a classical factor for introducing a new infection into herds, as reported in 
Nielsen et al. (2007). However, this can be prevented if the newly purchased animals are 
properly quarantined.  
Factors associated with C. burnetii antibody positivity in cattle 
Several factors that were unravelled were closely associated with C. burnetii 
seropositivity in Danish dairy cows (Chapter 4b), and cattle slaughtered for meat 
production (Chapter 6). Among those, some factors were individual animal traits and some 
were herd level factors (management factors). Cow-level factors that found to have 
significant association were breed, parity, milk yield, fat and protein content in milk. 
Seropositivity in slaughtered cattle was positively associated with age, breed group and 
number of movements. Among the herd-level factors, herd size, stable type, quarantine of 
newly purchased animals and improved hygienic precautions taken by the veterinarian 
before entering the barn (washing hands and changing clothes and boots before entering 
the barn) were associated with positivity in dairy cows. In addition, the season was 
significantly associated with C. burnetii antibody positivity in Danish dairy cows. One of 
the important features of epidemiology of C. burnetii antibody positivity in Danish dairy 
cows is that somatic cell count and reproductive problems were not found to be associated 
with an increased risk of antibody positivity in cows. Identified risk factors to a great 
extent demonstrated similarity with factors unravelled in other countries, but some 
differences were also observed. These country specific differences probably indicate a 
different epidemiological profile of C. burnetii antibody positivity in Danish dairy cows, 
and the underlying mechanisms explaining its distribution and dissemination are yet to be 
defined. 
 Danish Holstein cows have a higher risk of being C. burnetii antibody positive than 
Jersey cows, and these results correspond with the findings of a study in Northern Ireland 
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(McCaughey et al., 2010). Significant variations in breed susceptibility were also seen in 
the Danish slaughtered cattle, with a higher prevalence in dairy breeds than beef breeds. 
Genetic variation among the breeds is a probable reason for this breed variation. However, 
further research is required to confirm this hypothesis. Variation of seroprevalence 
between dairy and beef breeds may also be influenced by the herd management system. 
Danish beef cattle are generally managed extensively in relatively smaller herds as opposed 
to dairy herds. Beef cattle often spend a significant part of the year outside the farm 
buildings, which gives them potentially more space and minimises the buildup of a 
sufficient exposure level of bacterial density. The small herd size could also be a reason for 
the lower seroprevalence in beef cattle, as seroprevalence was reported to increase with 
increasing herd size in previous studies (McCaughey et al., 2010; Paul et al., 2012a; Ryan et 
al., 2011). 
C. burnetii seroprevalence increases with increasing age in both dairy cows and 
cattle slaughtered for meat production. The probability of being exposed to the bacterium 
increases with the age of the animal. The longer the animal lives, the higher the chances of 
being infected or having seroconverted. So it is likely that prevalence will be higher in older 
cattle than younger. A positive age relation with C. burnetii seropositivity has also been 
found in other studies (Alvarez et al., 2012; Bottcher et al., 2011; Capuano et al., 2004; 
Guatteo et al., 2007; Muskens et al., 2012). In contrast to these, Ruiz-Fons et al. (2010) 
and Ryan et al. (2011) did not find age as an important factor for seroprevalence.  
It was observed that the seroprevalence increased with an increasing number of 
movements before the cattle were slaughtered. It might not be the transport per se, but it is 
probably due to the accumulation of cattle from different herds that increased the risk of 
exposure, simply because some animals may excrete the bacterium.  
A negative association between milk yield and seroprevalence was identified in dairy 
cows contrary to the findings of Garcia-Ispierto et al. (2011). Dilution factors on antibody 
concentration in milk samples, rather than biological factors, might be a possible 
explanation for this association. Antibodies are likely to be diluted more in high yielding 
cows than in low yielding cows, and hence, the chance of being identified as positive 
reduces in high yielding cows, even if they are positive.  
Seroprevalence increased with increasing protein and decreasing fat content in raw 
milk in dairy cows. However, the exact mechanisms for such findings are not yet known. 
Thus, further investigation is necessary to clarify the reasons behind these associations. 
Contrary to this finding, Rose et al. (1994) found a negative association between milk 
protein content and the level of milk antibodies.  
A temporal trend in the occurrence of C. burnetii antibody positivity was observed 
in Danish dairy cows, with a higher risk in the summer (Chapter 4b). Occurrence declined 
steadily to the lowest level in winter. Results indicated that the occurrence of C. burnetii 
seropositivity in Danish dairy cattle followed a consistent decrease in temperature, 
distinguishing the transition from summer to winter. High ambient temperatures in 
summer might probably favour the growth of the bacteria. Moreover, high ambient 
temperatures might also have an influence on tick burden, which passively influences the 
 137 
 
occurrence of C. burnetii infection. Ticks can transmit C. burnetii mechanically, and the 
organism has been isolated from more than 40 species of ticks (Angelakis and Raoult, 
2010; Lang 1990; Maurin and Raoult, 1999). However, the effect of a tick burden on the 
occurrence of C. burnetii seropositivity was not looked at in this study. Seasonality in the 
occurrence of C. burnetii infection has been reported in cattle in Cyprus and Japan (Cantas 
et al., 2011; Yanase et al., 1997). The temporal trend found in Cyprus was as similar as the 
present study, whereas, an opposite trend, i.e. highest occurrence in winter and lowest in 
summer, was found in Japan. Temporality was also described in recent outbreaks of Q 
fever in small ruminants and humans in the Netherlands. However, these seasonal 
outbreaks were said to be associated with lambing or kidding seasons (Roset et al. 2011); 
where in Denmark, there is no specific calving seasons. Consequently, an identified 
temporal trend in the occurrence of C. burnetii seropositivity in Denmark might not be 
associated with seasonal calving. 
Among the herd-level factors, i) increasing herd size, ii) cows raised in loose 
housing systems, iii) cows from herds where quarantine was not practised for newly 
purchased animals and iv) cows from herds where veterinarians did not take adequate 
hygienic precautions (washing hands and changing clothes and boots before entering the 
barn), were positively associated with C. burnetii antibody positivity in dairy cows. 
Identified risk factors indicate that factors associated with herd management and 
biosecurity can act as contributors for C. burnetii infection in Danish dairy cattle.  
The positive association of herd size with C. burnetii infection in cattle was also 
reported by McCaughey et al. (2010) and Ryan et al. (2011). Increasing the number of cows 
in a herd might increase the transmission probability between cows in close proximity. 
However, herd size was not identified as an influencing factor of C. burnetii seropositivity 
in Danish cattle used for meat production.  
It was observed that cows housed in loose housing systems were at higher risk of 
being C. burnetii seropositive than cows housed in tie stalls. In a loose housing system, 
there is more space than in a tie stall housing system, and therefore, the probability of 
random contact between uninfected and infected animals and between uninfected animals 
and contaminated environments is also higher. Hence, the risk of transmission is probably 
increased in loose housing systems. A similar finding was also reported in a study in 
Belgium (Czaplicki et al., 2012).  
It was also found that quarantine of newly purchased cattle reduced the occurrence 
of C. burnetii seropositive in Danish dairy cows.  The introduction of new animals in a herd 
increases the risk of introducing C. burnetii infection into cattle herds (EFSA, 2010). 
Therefore, practising quarantine for purchased animals is an important step to prevent the 
introduction of infection in a herd.  
A review article by Woldehiwet (2004) stated that herd veterinarians, as a 
mechanical carrier, might transfer the pathogen from infected to non-infected herds 
through, e.g. boots, clothing, etc. Therefore, Improvement of hygienic precautions by a 
herd veterinarian is an important biosecurity measure to prevent or to reduce the chance 
of introducing a new infection into a herd. This was also reflected in the current study 
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(Chapter 4b), where it had been shown that a deficit in hygienic precautions, such as not 
changing clothes or boots increased the chance of a cow being C. burnetii seropositive.     
Evaluation of the performance of diagnostic tests 
The performance of a commercially available ELISA, the diagnostic test kit used in 
all the studies in this thesis, was evaluated by latent class analysis using a Bayesian 
framework. Results showed that both milk and blood ELISAs are equally highly sensitive 
and specific in all the cut-offs used. Comparison of the test parameter estimates obtained 
by using three different cut-offs (i.e., S/P ≥ 30, S/P ≥ 40, S/P ≥ 50) showed that the best 
combination of the Se and Sp was obtained at cut-off S/P ≥ 40 for both tests. At this cut-
off, the Se and Sp of milk ELISA was 0.86 and 0.99, respectively; whereas the Se and Sp of 
blood ELISA was 0.84 and 0.99, respectively. The difference between the Se estimates of 
these two tests was not statistically significant. The Se and the Sp estimates did not change 
when cut-off S/P≥ 30 was used, but the Se reduced slightly at cut-off S/P≥50 (Figure 3). 
Differential positive rate (DPR) estimates also indicated that cut-off S/P≥40 should be 
used to obtain the best test performance for classifying the serological status of a cow. 
 
Figure 3: Sensitivity and 1-Specificity plots of milk and blood ELISAs using sensitivity 
and specificity estimates from conditionally independent models at different cut-offs.   
All of these estimates were obtained from a model which assumed that these two 
tests are conditionally independent (CID). This assumption may not be valid, as both tests 
were detecting the same biological element (antibodies) in two different media (milk and 
blood). A different conditionally dependent (COC) model was therefore developed to 
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evaluate this assumption. Analyses showed that the Se and Sp estimates of the tests did not 
change unless a very high proportion of conditional covariance (≥40) was used (Figure 4). 
This could be explained by the fact that these two tests may be biologically dependent; 
however, this is not an absolute dependence due to the high Se and Sp of both tests. Thus, 
this correlation does not affect the parameter estimates when tests are evaluated against 
each other. Therefore, estimates obtained from the CID models at cut-off S/P ≥ 40 seem 
valid.  
 
Figure 4: Plots of the posterior mean estimates of the sensitivity (Se) and specificity (Sp) 
of blood and milk ELISAs from conditionally dependent (COC) models with varying 
proportions of the maximum conditional covariance. 
Practical application of the findings 
The situation of C. burnetii seropositivity (an indirect indication of infection) should 
be addressed more in Denmark than it is presently. Reporting C. burnetii infection in cattle 
is mandatory in Denmark (Anonymous, 2010). Epidemiological investigations conducted 
on C. burnetii seropositivity in Denmark in 2008 and 2012 revealed a very high herd level 
prevalence and identified an increasing trend of herd level seroprevalence in dairy herds. 
Thus, the country should not rely only on reported clinically suspected samples. In order to 
achieve a complete scenario, it is imperative to implement nationwide adoptive 
surveillance, like what is currently available for Salmonella Dublin, and a control strategy 
based on this data driven evidence. By far, probably due to no indication of serious 
zoonotic potential and apparently no visible economic impact of Q fever, the concerning 
authority in Denmark has not yet prioritised such a control program against this disease. 
However, recent outbreaks of Q fever in the Netherlands exhibited zoonotic consequences 
of this disease. Therefore, adoptive surveillance and a control program for Q fever in 
Denmark need to be implemented to mitigate such future emergency situations.   
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Epidemiological studies identified several risk factors associated with the prevalence 
and spread of C. burnetii infection in Danish cattle, thus also revealing that the infection 
load of C. burnetii is much higher in dairy cattle than beef cattle. Based on this acquired 
knowledge, an adoptive targeted surveillance can be implemented primarily focusing on 
dairy cattle. Several biosecurity measures were found to be associated with C. burnetii 
seropositivity. Therefore, implementation of strict biosecurity and legislative measures 
might be helpful for improving the situation. Strict veterinary legislative measures were 
found to be effective in controlling Q fever epidemics in the Netherlands (Roest et al., 
2011). It is important to mention that the situation in Denmark is completely different 
from the Netherlands, as the recent epidemic in the Netherlands originated from small 
ruminants (Roset et al. 2011), whereas no such epidemic has been reported in Denmark.  
Conclusions 
This thesis used data from two observational studies and has demonstrated the 
usefulness of such studies to draw a valid inference on the epidemiology of C. burnetii 
seropositivity in Danish dairy cattle. This thesis has presented epidemiological information 
on frequencies in different populations and the associated herd level and animal level risk 
factors of C. burnetii seropositivity in Danish cattle; these had not previously been studied 
thoroughly, and therefore the new developments have helped form a basis for further 
epidemiological investigations. The main conclusions which can be drawn from this thesis 
are: 
• The estimated prevalence of C. burnetii antibody positivity in Danish dairy herds has 
increased since the latest survey in 2008, and is one of the highest among the 
European countries. High within herd prevalence of antibody positivity was also 
observed in dairy herds, and ranged from 1% to 27%. The overall true seroprevalence 
in cattle raised for meat production and sent to slaughter was 5.6%, with noticeable 
differences between dairy and beef breed cattle. The major proportion of the positive 
animals was attributed to the cattle of dairy breeds.  
• Several herd management and biosecurity factors such as contact with farm 
personnel and visitors, a health agreement with the veterinarian, lack of hygienic 
precautions taken by the veterinarian and sharing of machines were associated with 
an increased risk of antibody positivity in Danish dairy herds. This stressed the 
importance of efficient farm management and strict biosecurity in preventing C. 
burnetii infections. 
• The C. burnetii antibody status in Danish dairy cows was significantly associated with 
the individual animal factors like breed, parity, days in cow barn, milk yield, milk 
protein contents and the herd level factors like herd size, stable type, biosecurity 
related factors and season. Factors unravelled in Danish cows demonstrated 
similarities with factors identified in other countries, but some differences were also 
observed. These risk factors should therefore, be taken into account to prevent or 
control the introduction and spread of C. burnetii. 
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• Milk and blood ELISAs, the diagnostic tests used in the different studies included in 
this thesis, have similar diagnostic capabilities. Therefore, the choice of test should be 
based on the context of the study. For serological survey or surveillance involving 
dairy cows, milk ELISA should be the preferred method; and blood ELISA should be 
useful for serological studies in non-lactating cattle. 
Using the findings of this thesis, pertinent bodies responsible for disease control 
and prevention could implement adoptive targeted surveillance and control strategies for 
C. burnetii infections in the Danish cattle population. The concepts and methodologies 
used in this thesis are generic and widely used in epidemiological studies of other 
infectious diseases as well.  
Perspectives 
This thesis tries to form a basis to understand the epidemiology of C. burnetii 
infections in Danish cattle. However, in the light of new findings and targets to optimise 
the knowledge about the complete epidemiological profile of C. burnetii infection, further 
research needs to be done. 
Small ruminants (e,g., sheep and goats) are important sources of C. burnetii 
infection abroad and have been involved in recent Q fever outbreaks. Further research is 
needed to investigate the burden of C. burnetii infection in small ruminants in Denmark. 
Additional research is necessary to investigate the economic impact of C. burnetii 
infection in the Danish cattle population. C. burnetii infection is often said to be a cause of 
reproductive disorders. Information about reproductive problems available in the Danish 
Cattle Database is not systematically recorded, and therefore, the association between the 
infection status and reproductive problems cannot be evaluated based on this data. More 
data and systematic studies are required to investigate this association. 
More large-scale studies on the effect of management and biosecurity factors on 
prevention and control of C. burnetii infection are necessary to validate the results found 
in this thesis. In addition, further studies of environmental contamination of C. burnetii 
and consequences of such contamination in epidemiology in Denmark are also needed. 
Research is needed to explore the spatio-temporal distribution of C. burnetii 
infected/seropositive herds in Denmark. Such additional studies require a nationwide 
surveillance and could help to understand the distribution in terms of time and space. 
The studies in this thesis identified C. burnetii antibodies in samples collected from 
individual animals or herds (BTM), thus providing an indirect measure of infection. 
Further studies based on identification of bacteria are needed to identify the actual burden 
of infection. Besides this, there is a need for additional research on simultaneous 
identification of antibodies and bacteria from repeatedly sampled herds and animals for a 
longer period. Such research will help to understand the infection dynamics and will also 
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be able to establish the relationship of the antibody status and the shedding pattern of the 
bacteria. 
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ANNEX (QUESTIONNAIRE) 
  
 148 
 
  
 149 
 
Questionnaire (English version) 
 
 
 
 
Questionnaire used in telephone interviews of dairy herd 
owner/manager for collecting herd level information. 
 
Employee: 
Responsible: 
Jens Frederik Agger, Associate Professor, Department of Large Animal Sciences, Section 
for Population Biology (Epidemiology), LIFE, University of Copenhagen. Gronnegaardsvej 
8, DK-1870 Frederiksberg C.   
 
Student Employee:  
Lærke Boye Thomsen, student of Veterinary Medicine.  
Remember that courtesy is a matter of course. We would indeed like to come back. ☺  
 
 
Name of interviewer: 
Name: ___________________________________________________ 
 
 
General information 
Date of interview : ____ /____ / 2008 
Project number (1-150) : _________________________________ 
CHR number : _________________________________ 
Telephone number : _________________________________ 
Farmer’s name / address : 
 
_________________________________ 
 
Introduction: 
Good afternoon / evening, my name is xxx.  
I'm calling from the Faculty of Life Sciences, University of Copenhagen, where we conduct 
a study of Q fever in Danish dairy cattle herds. A few days ago the Dairy Board sent you a 
letter with an invitation to participate in this study. 
 
1. Have you received this letter? (If NO, we 
need to explain why we called. Then they 
probably say YES). 
: YES NO 
 
Q fever survey 2008 
Project I: Prevalence Survey 
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2. Are you willing to participate in this study? : YES NO 
 
 
 
If NO 
 3. Are there any special reasons why you do not want to participate? 
 
______________________________________________________________
______________________________________________________________
______________________________________________________________ 
 
Sorry for the inconvenience and have a good day / evening.  
 
 
If YES 
Thank you. You will be attended soon. 
We will shortly send you a plastic tube to take a milk sample from your bulk milk tank. The 
sample is to be send to the National Veterinary Institute, Technical University of Denmark.  
 
In the letter, there will be instructions on how the sample must be taken and send to the 
laboratory. We will enclose a stamped addressed envelope. 
 
I would like to ask you some questions about your farm. It will take 20-30 minutes. 
 
 
 
Questions about the herd 
 
About number of employees: 
4. How many people help in milking, feeding and caring for 
your animals (cows, heifers, old calves and young calves)? 
: Number: 
 
About stables and health of animals 
5. What type of housing do you use for the cows? 
 
Tie stall house                  Cubicle house                               Deep bed house 
 
Further elaboration here: 
_____________________________________________________________ 
 
6. Where do the cows calve in the herd? 
Calving pen Tie stall          Cubicle or deep bed 
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7. Do you have a disease pen for sick cows? 
YES YES, but it also serves as a calving pen NO 
 
 
8. Have there been changes in the pattern of disease in cows during the last 6 months 
compared with earlier times? 
 Syndrom YES  NO 
 Abortions    
 Stillborn calves   
 Weak-born calves   
 Retained placenta   
 Endometritis   
 Reproductive problems   
 Other   
    
9. Have there been changes in the pattern of disease in old calves/heifers the last 6 months 
compared with earlier times? 
YES NO 
If YES, please specify: ______________________________________________ 
______________________________________________________________ 
 
10. Have there been changes in the pattern of disease in young calves the last 6 months 
compared with earlier times? 
YES NO 
If YES, please specify: ______________________________________________ 
______________________________________________________________ 
 
Biosecurity procedures, including contact with other herds 
 
11. Have you purchased cattle to the herd during the last 12 months? 
Number of purchased cows 
 
Number of purchased heifers  
and old calves 
Number of purchased young calves  
 
 
12. How many suppliers have delivered the purchased cattle? 
 
13. How many suppliers have a herd health advisory contract with the veterinarian? 
Number 
 
Don’t know 
14. Do you buy cattle from the assembly sites (e.g. livestock auctions)? 
YES 
 
NO 
15. Do you bring your animals to shows or other exhibitions? 
YES NO 
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16. Do you buy fodder from other herds? 
YES NO 
 
17. Do you buy straw or bedding material from other herds? 
YES NO 
 
18. How often you visit other herds or stables? 
NEVER RARELY OFTEN 
 
19. How often do other farmers visit your herd or stables? 
NEVER RARELY OFTEN 
 
20. Do you share machines with other herds? 
YES, cattle trucks YES, field machines 
 
YES, Other                                   Specify:      
                                                                      ___________________________________ 
NO 
 
 
21. Who inseminates the cows in your herd? 
Artificial insemination (AI) technician 
 
Veterinarian 
By own bull 
 
Other 
If other, please specify:___________________________________________ 
 
22. Who is (are) the herd veterinarian(s)? 
Name :  ________________________________________________________ 
______________________________________________________________ 
 
23. Do you have a herd health agreement contract with your veterinarian? 
YES NO 
 
24. What other people get in contact with your cattle? 
Livestock consultant  
 
Truck driver 
Other                                                                Specify:____________________________ 
 
25. Do you bring cattle on pasture during summer? 
YES NO            (if No, go to question 27) 
 
26. If YES to question 24:  
Do your cattle come into physical contact with animals in neighboring fields (across a 
common fence)?  
YES NO 
Describe: _______________________________________________________ 
______________________________________________________________ 
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27. Do you bring cattle on common pasture with cattle from other herds? 
YES NO 
Describe: _______________________________________________________ 
______________________________________________________________ 
 
28. Have you prohibited other people from entering your stable without your permission? 
YES NO 
 
29. Do you require hygiene and biosecurity precautions before people enter your stable? 
Yes NO 
If Yes, please describe: _____________________________________________ 
 
30. Do you quarantine purchased supply cattle?  
Yes NO Don’t buy new animals 
Explain: _______________________________________________________ 
______________________________________________________________ 
 
31. Which hygienic measures does the herd veterinarian take before entering the stable? 
Nothing 
 
Change clothes 
Wash/change boots  
 
32. What hygienic measures does the herd veterinarian take at the end of the visit? 
Nothing 
 
Change clothes 
Wash/change boots  
 
33. What hygienic measures does the AI technician take before entering the stable? 
Nothing 
 
Change clothes 
Wash/change boots  
 
34. What hygienic measures does the AI technician take at the end of the visit? 
Nothing 
 
Change clothes 
Wash/change boots  
 
35. What hygienic measures does the livestock consultant take before entering the stable? 
Nothing 
 
Change clothes 
Wash/change boots Does not enter the stable 
 
36. What hygienic measures does the livestock consultant take at the end of the visit? 
Nothing 
 
Change clothes 
Wash/change boots Does not enter the stable 
 
37. What hygienic measures does the truck driver take before entering the stable? 
Nothing 
 
Change clothes 
Wash/change boots Does not enter the stable 
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38. What hygienic measure does the animal consultant take at the end of the visit? 
Nothing 
 
Change clothes 
Wash/change boots Does not enter the stable 
 
 
39. What hygienic measure do OTHER people take before entering the stable? 
 
Specify who is (are) the OTHER(S):_____________________________________ 
Nothing 
 
Change clothes 
Wash/change boots Do not enter the stable 
 
40. What hygienic measure do OTHER people take when finishing the visit? 
Nothing 
 
Changes cloths 
Washes/changes boots  
 
41. Do you disinfectant foot ware before entering the stable? 
Yes No 
 
42. Do you in other ways take action to protect the herd against infection? 
YES NO 
Explain: ________________________________________________________ 
______________________________________________________________ 
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Questionnaire (Danish version) 
 
Q-feber-undersøgelsen 2008 
Delprojekt II: Prævalens-undersøgelse 
 
Spørgeskema til brug ved telefoninterview om deltagelse 
og om drift af besætninger. 
 
Medarbejdere: 
Ansvarlig: 
Lektor Jens Frederik Agger, Institut for Produktionsdyr og Heste, Sektion for 
Populationsbiologi (Epidemiologi), LIFE, Københavns Universitet. Grønnegårdsvej 8, 
1870 Frederiksberg C. Telefon: 3533 3013. Mobil: 2021 1208. 
 
Studentermedarbejder:  
Stud.med.vet. Lærke Boye Thomsen. Telefon: 3284 9420. Mobil: 2031 6577 
 
Husk at høflighed er en selvfølge. Vi skulle jo gerne kunne komme igen. ☺ 
 
Interviewer: 
Navn: ______________________________________________________ 
 
 
Den udspurgte: 
Dato for Interview : ____ /____ / 2008 
Projektnummer (1-150) : _________________________________ 
CHR-nummer : _________________________________ 
Telefonnummer : _________________________________ 
Landmandens navn og 
adresse  
: 
 
 
 
__________________________________ 
 
 
Introduktion:  
Goddag / aften, mit navn er xxx.  Jeg ringer fra Det Biovidenskabelige Fakultet ved 
Københavns Universitet (tidligere KVL eller Landbohøjskolen), hvor vi har startet en 
undersøgelse af Q-feber i danske malkekvægbesætninger. For få dage siden sendte 
Mejeriforeningen dig et brev med opfordring om at deltage i denne undersøgelse. 
 
1. Har du modtaget dette brev? (Hvis Nej, må vi 
forklare. Så siger de sikkert JA). 
: JA NEJ 
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2. Er du villig til at deltage i denne undersøgelse? : JA NEJ 
 
 
 
Hvis NEJ: 
3. Er der nogen særlige grunde til, at du ikke ønsker at deltage?  
______________________________________________________________
______________________________________________________________
______________________________________________________________ 
 
Undskyld ulejligheden – og fortsat god dag/aften. 
 
 
Hvis JA: 
Tak for at du vil deltage.  
Vi vil inden længe sende dig et plastikglas til at udtage en mælkeprøve fra mælketanken. 
Prøven skal du sende til Veterinærinstituttet, Danmarks Tekniske Universitet. 
 
I brevet vil der være instruktion om, hvorledes prøven skal udtages og sendes. Der 
vedlægges frankeret svarkuvert. 
 
Jeg vil gerne have lov at stille nogle spørgsmål om din besætning.  Det tager kun ca. 20-30 
minutter! 
 
 
Spørgsmål om besætningen 
Om antal medarbejdere: 
4. Hvor mange forskellige mennesker hjælper med til 
malkning, fodring og pasning i øvrigt af dine kreaturer (køer, 
kvier o.a. ungdyr, og kalve)? 
: Antal: 
 
Om stalden og sundhed hos dyrene 
 
5. Hvilken staldtype holder du køerne i? 
 
Bindestald           Sengestald                    Dybstrøelsesstald 
 
Kan evt. uddybes her  
_____________________________________________________________ 
6. Hvor kælver køerne i besætningen? 
Kælveboks Båsen Løsdrift 
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7. Bruger du en sygeboks til syge køer? 
Ja JA, men fungerer også som kælvningsboks NEJ 
 
8. Er der sket ændringer i sygdomsmønstret hos køerne de seneste 6 måneder 
sammenlignet med tidligere tider? 
 Sygdom JA  NEJ 
 Aborter   
 Dødfødte kalve   
 Svagtfødte kalve   
 Tilbageholdt efterbyrd   
 Børbetændelse   
 Reproduktionsproblemer   
 Andet?   
9. Er der sket ændringer i sygdomsmønstret hos ungdyrene / kvierne de seneste 6 
måneder? 
JA NEJ 
Hvis JA, forklar: _________________________________________________ 
______________________________________________________________ 
 
10. Er der sket ændringer i sygdomsmønstret hos kalvene de seneste 6 måneder? 
JA NEJ 
Hvis JA, forklar: _________________________________________________ 
______________________________________________________________ 
 
Om smittebeskyttelse, herunder kontakt med andre besætninger 
 
11. Har du indkøbt kreaturer til besætningen de seneste 12 mdr? 
Antal indkøbte køer Antal indkøbte kvier og  
ungdyr 
Antal indkøbte kalve  
 
12. Hvor mange leverandører har leveret de købte kreaturer? 
 
13. Hvor mange af leverandørerne har en sundhedsrådgivningsaftale med dyrlægen?  
Antal 
 
Ved ikke 
14. Køber du kreaturer fra samlesteder (f.eks. husdyrauktioner)?  
JA 
 
NEJ 
15. Deltager besætningens dyr i dyrskue eller andre udstillinger?  
JA NEJ 
 
16. Køber du foder fra andre besætninger? 
JA NEJ 
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17. Køber du halm/strøelse fra andre besætninger?  
JA NEJ 
  
18. Hvor ofte kommer du på besøg i andre besætninger/stalde? 
Aldrig Sjældent Ofte 
 
19. Hvor ofte kommer andre landmænd på besøg i din besætning/stald? 
Aldrig Sjældent Ofte 
 
20. Deler du maskiner med andre besætninger? 
JA, kreaturvogn JA, markmaskiner  
 
JA, andet                                    Beskriv:      
                                                                      ___________________________________ 
NEJ 
 
 
21. Hvem inseminerer besætningens kreaturer?  
Kvægavlsforening 
 
Dyrlæge 
Egen tyr Andre 
 
Hvis ANDRE,  Beskriv :____________________________________________ 
 
22. Hvem er besætningens dyrlæge?  
Navn :  _________________________________________________________ 
______________________________________________________________ 
 
23. Har du indgået Sundhedsrådgivningsaftale (SRA) med din dyrlæge? 
JA NEJ 
 
24. Hvilke andre personer kommer i kontakt med dit kvæg? 
Kvægbrugskonsulent  
 
Vognmand 
Andre                                                                 Beskriv:____________________________ 
 
25. Sender du kvæg på græs om sommeren? 
JA NEJ            (Hvis NEJ, Gå til spørgsmål 27) 
 
26. Hvis JA til spørgsmål 25:  
Kan dine kreaturer på græs komme i fysisk kontakt med kreaturer på tilstødende marker 
(fælles hegn)? 
JA NEJ 
Beskriv: ________________________________________________________ 
______________________________________________________________ 
 
27. Sender du kvæg på fælles græsgang? 
Ja NEJ 
Beskriv: ________________________________________________________ 
______________________________________________________________ 
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28. Har du givet forbud mod at andre personer må gå ind i stalden uden din tilladelse? 
JA NEJ 
 
29. Stiller du krav om hygiejne og smittebeskyttelse, når andre personer går ind i din 
stald? 
JA NEJ 
Hvis JA, Forklar: _________________________________________________ 
______________________________________________________________ 
 
30. Bruger du karantænestald ved indkøb af nye kreaturer?  
JA NEJ Don’t buy new animals 
Forklar: ________________________________________________________ 
______________________________________________________________ 
 
31. Hvilke hygiejneforholdsregler foretager dyrlægen før han /hun går ind i stalden? 
Intet 
 
Skifter kittel/tøj 
Vasker/skifter støvler boots  
 
32. Hvilke hygiejneforholdsregler foretager dyrlægen når han/hun er færdig med besøget? 
Intet 
 
Skifter kittel/tøj 
Vasker/skifter støvler boots  
 
33. Hvilke hygiejneforholdsregler foretager inseminøren før han/hun går ind i stalden?? 
Intet 
 
Skifter kittel/tøj 
Vasker/skifter støvler  
 
34. Hvilke hygiejneforholdsregler foretager inseminøren når han/hun er færdig med 
besøget? 
Intet 
 
Skifter kittel/tøj 
Vasker/skifter støvler  
 
35. Hvilke hygiejneforholdsregler foretager kvægkonsulenten før han/hun går ind i 
stalden? 
Intet 
 
Skifter kittel/tøj 
Vasker/skifter støvler Går ikke ind i stalden  
 
36. Hvilke hygiejneforholdsregler foretager kvægkonsulenten når han/hun er færdig med 
besøget? 
Intet 
 
Skifter kittel/tøj 
Vasker/skifter støvler Går ikke ind i stalden  
 
37. Hvilke hygiejneforholdsregler foretager vognmanden før han/hun går ind i stalden? 
Intet 
 
Skifter kittel/tøj 
Vasker/skifter støvler Går ikke ind i stalden  
 160 
 
 
 
 
38. Hvilke hygiejneforholdsregler foretager vognmanden når han/hun er færdig med 
besøget? 
Intet 
 
Skifter kittel/tøj 
Vasker/skifter støvler Går ikke ind i stalden  
 
39. Hvilke hygiejneforholdsregler foretager ANDRE før han/hun går ind i stalden? 
Hvem er ANDRE:_____________________________________ 
Intet 
 
Skifter kittel/tøj 
Vasker/skifter støvler Går ikke ind i stalden  
 
40. Hvilke hygiejneforholdsregler foretager ANDRE når han/hun er færdig med besøget? 
Intet 
 
Skifter kittel/tøj 
Vasker/skifter støvler  
41. Bruges der desinficerende fodbad før indgang i stalden? 
JA NEJ 
 
42. Bruger du andre tiltag for at beskytte besætningen mod smitte? 
JA NEJ 
Forklar: ________________________________________________________ 
______________________________________________________________ 
 
 
 
 
 
 
